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Résumé 
 
La psychose est une maladie invalidant, préjudiciable à l'individu et à la société. Depuis 
que la détection précoce de la maladie est associée à une évolution plus bénigne, les 
facteurs de détection précoce de la psychose font l'objet l'investigation. Dans la présente 
thèse, nous nous concentrerons sur deux facteurs de risque potentiels, à savoir la 
schizotypie et l'usage de drogue. Le concept de schizotypie, initialement développé par 
Meehl (1962), comprend le fait que les symptômes de la schizophrénie se trouvent sur 
un spectre, et que leur sévérité va croissante de l'individu le moins touché de la 
population générale jusque aux patients schizophrènes les plus atteints. Sur ce spectre 
des troubles schizophréniques, on trouve souvent des troubles cognitifs, par exemple la 
diminution de l'asymétrie hémisphérique ou des fonctions du lobe frontal. Le deuxième 
facteur de risque (usage de drogues), affecte les mêmes fonctions cognitives. En outre, 
la consommation de drogues est élevée dans la schizophrénie et chez les individus ayant 
des scores élevés sur les échelles mesurant la schizotypie. Par conséquent, nous avons 
décidé d'investiguer si des atténuations cognitives, précédemment attribuées à des 
symptômes schizotypiques, pourraient avoir été associées à un usage de substances 
élevé dans cette population. Pour tester cette idée, nous avons évalué l'usage de 
différentes drogues (nicotine,  cannabis, méphédrone, dépendance à une substance en 
général), mesuré des symptômes de schizotypie (O-LIFE), et mesuré soit l'asymétrie 
hémisphérique de la fonction (dominance de l'hémisphère gauche pour le langage, et la 
domination du droit pour le traitement des informations faciales ), soit le 
fonctionnement du lobe frontal (tels que la flexibilité cognitive, la mémoire de travail, la 
mémoire verbale à court terme, l'apprentissage verbal et de la fluidité verbale). Les 
résultats de toutes ces études suggèrent que c'est surtout l'usage de drogues et non la 
schizotypie qui prédit le fonctionnement cognitif. Ainsi, les atténuations cognitives 
précédemment attribuées aux dimensions de schizotypie sont susceptibles d'être 
associées à une utilisation accrue de drogues. Les études futures devraient étendre la 
liste des facteurs de risque potentiels (par exemple la dépression et le QI) et obtenir un 
aperçu plus général des prédicteurs les plus fiables des profils désavantageux. 
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Abstract  
Psychosis is a debilitating disease, causing harm to the individual and society. Since 
early detection of the disease is associated with a more benign course, factors are 
warranted that enable the early detection of psychosis. In the present thesis we will be 
focusing on two potential risk factors, namely schizotypy and drug use. The schizotypy 
concept, originally developed by Meehl (1962), states that schizophrenia symptoms 
exist on a spectrum, with symptoms ranging from the most severe in patients with 
schizophrenia to the least affected individual in the general population. Along the 
schizophrenia spectrum cognitive impairments are commonly found, for instance 
reduced hemispheric asymmetry or frontal lobe functions. The second risk factor (drug 
use), affects similar cognitive functions as those attenuated along the schizophrenia 
spectrum, and drug use is elevated in schizophrenia and people scoring high on 
schizotypy. Therefore, we set out to investigate whether cognitive attenuations formerly 
allocated to schizotypal symptoms could have been influenced by elevated substance 
use in this population. To test this idea, we assessed various drugs (nicotine, cannabis, 
mephedrone, general substance dependence) and schizotypy symptoms (O-LIFE), and 
measured either hemispheric asymmetry of function (left hemisphere dominance for 
language, and right hemisphere dominance for facial processing) or functions largely 
relying on the frontal lobes (such as cognitive flexibility, working memory, verbal 
short-term memory, verbal learning and verbal fluency). Results of all studies suggest 
that it is mostly drugs, and not schizotypy in general that predict cognitive functioning. 
Therefore, cognitive attenuations subscribed to schizotypy dimensions are likely to have 
been affected by enhanced drug use. Future studies should extend the list of potential 
risk factors (e.g. depression and IQ) to acquire a comprehensive overview of the most 
reliable predictors of disadvantageous cognitive profiles.  
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I. General introduction 
A. Synopsis 
Psychosis is a mental condition that haunts societies, families and individuals alike. 
Lifetime prevalence of any psychotic disorder (e.g. schizophrenia) varies considerably 
depending on the diagnostic criteria employed, however it most commonly lies between 
1-3% in the general population (Perala et al., 2007; van Os & Kapur, 2009). Suffering 
from schizophrenia and psychotic disorders can have serious implications for the 
individual, e.g. the inability to manage and maintain occupational functions (Salize et 
al., 2009) and/or social interactions (see J. M. Ernst & Cacioppo, 1999 for overview). 
Additionally, these debilitating illnesses can inflict high social costs to relatives or 
friends of those affected, but also to society as a whole (Patel et al., 2006). Importantly, 
detecting individuals at an early stage of the disease seems to result in better outcomes 
for the patient, including a milder form of the illness as well as shorter duration (Bird et 
al., 2010; Larsen et al., 2011; M. Marshall & Rathbone, 2006).  Therefore, risk factors 
that enable screening of at-risk individuals are warranted. 
One potential risk factor relates to certain personality traits reminiscent of those seen in 
psychosis (e.g. schizotypy). As will be outlined in more detail below, the schizotypy 
concept is based on the idea that schizophrenia symptoms exist on a spectrum, with 
most severe symptoms encountered in patients, and mildest symptoms being present in 
healthy individuals from the general population. In the past decade the schizotypy 
concept has become increasingly popular to infer about the etiology of schizophrenia 
(van Os, Linscott, Myin-Germeys, Delespaul, & Krabbendam, 2009). One of the 
reasons for this increased interest in the schizotypy concept is certainly that schizotypal 
individuals are commonly not medicated, and do not suffer from other secondary 
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illness-related consequences such as frequent hospitalizations (Claridge, 1988; 
McGorry, Yung, & Phillips, 2003). Support for the spectrum idea of schizophrenia 
symptoms comes from observations that schizotypal individuals yield for instance 
similar -though quantitatively milder- cognitive impairments than psychotic patients, 
e.g. in frontal lobe functioning (Giraldez, Caro, Rodrigo, Pineiro, & Gonzalez, 1999; 
M.-S. Kim, Oh, Hong, & Choi, 2011; Park & McTigue, 1997; Pflueger, Gschwandtner, 
Stieglitz, & Riecher-Rössler, 2007; Simon et al., 2007) and hemispheric asymmetry 
(Broks, 1984; Brugger, Gamma, Muri, Schafer, & Taylor, 1993; Løberg et al., 2006; 
Mason & Claridge, 1999; Mohr, Krummenacher, et al., 2005; Suzuki & Usher, 2009).  
Another risk factor relevant to the present doctoral thesis is drug use. A generally 
elevated drug use has been observed in both psychotic patients (Barkus & Murray, 
2010; Schimmelmann et al., 2011) and schizotypal populations (Barkus & Murray, 
2010; Fumero, Santamaria, & Navarrete, 2009) when compared to their respective 
controls. This enhanced drug use along the schizophrenia spectrum could be 
problematic if one considers the above mentioned cognitive functions to be sensitive to 
changes in schizotypal symptoms. It is well known that cognitive functioning is affected 
by drug use (Fernández-Serrano, Pérez-García, & Verdejo-García, 2011), and therefore 
the elevated drug use along the schizophrenia spectrum could be problematic for the 
interpretation of cognitive attenuations in schizotypal populations in previous studies. In 
other words, with this overlap in cognitive functions affected in schizotypy and chronic 
drug use it is unclear if certain links between schizotypal symptoms and cognition could 
at least partially be explained by the enhanced drug use. Elucidating the relationship 
between schizotypal symptoms and drug use on a psychotic-like cognitive profile in 
healthy individuals was therefore the main aim of this PhD-project. We will begin by 
giving a brief overview over the categorical and dimensional models of psychosis, then 
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review the evidence for cognitive impairments sensitive to illness-related changes, and 
afterwards show that drug use equally relates to schizotypal symptoms and cognitive 
impairments. Finally, we will give a brief summary of the empirical studies that form 
the present doctoral thesis, before we present them in detail in article format. 
1. Categorical model 
Schizophrenia is diagnosed if someone expresses a certain amount of symptoms for a 
certain period of time. These symptoms can be clustered into several symptom 
dimensions, e.g. the positive dimension, encompassing psychotic symptoms 
(characterized by delusions and hallucinations), and the negative dimension, with 
alterations in drive and volition (lack of motivation, reduction in spontaneous speech, 
and social withdrawal). Additionally, thought disorder or cognitive disorganization has 
been identified as a separate symptom cluster (Liddle, 1987), linked to alterations in 
cognition (difficulties in memory, attention, and executive functioning) and affective 
dysregulation as also seen in depressive and manic (bipolar) symptoms (van Os & 
Kapur, 2009).  
Kraepelin described the illness at the turn of the last century, and coined it ´dementia 
praecox´, to stress his observations of slow mental deterioration beginning in early 
adulthood (Deelman, Eling, de Haan, Jennekens-Schinkel, & van Zomeren, 2003; 
Kraepelin, 1899, 1919). Around the same time, Bleuler (1911) introduced the term 
schizophrenia. The US-based Diagnostic and Statistical Manual of Mental Disorders 
(DSM), currently in its 4
th
, revised edition [DSM-IV-R (APA, 2000)], is one of the most 
widely used tools to diagnose schizophrenia. Based on the classical psychiatric view, 
schizophrenia and psychotic symptoms are viewed as markers of an illness, and 
therefore regarded as qualitatively different from the healthy mental profile. However, 
as will be outlined in detail below, strong evidence exists for a dimensional view on 
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schizophrenia symptoms, and the American Psychiatric Association (APA) is currently 
debating whether or not to include a psychosis risk syndrome in the revised DSM-V 
version, to be published in 2013 (Corcoran, First, & Cornblatt, 2010; B. Nelson & 
Yung, 2011; Ruhrmann, Schultze-Lutter, & Klosterkötter, 2010). Therefore, we will 
revise the most prominent dimensional models (quasi-, totally and fully dimensional) 
for schizophrenia in the following. 
2. Dimensional models 
Bleuler (1911), coming from the medical tradition (see also Figure 1), noted that healthy 
relatives of patients with schizophrenia were exhibiting qualitatively similar, though 
quantitatively milder, symptoms than their relatives suffering from the illness, and this 
raised doubts about a strictly categorical view of the disorder. In the personality 
tradition Pavlov and Kretschmer observed that psychotic states could represent normal 
personality variation (von Zerssen, 2002). Pavlov noted that the ability of the central 
nervous system to tolerate strong stimulation was reflected in natural personality 
variations (distinguishing of ‘nervous types’, see Figure 1; Pavlov, 1928). Around the 
same time Kretschmer (1921) observed personality traits like ‘schizothymia’ as closely 
resembling traits as those described in ‘dementia praecox’ by Kraepelin (1919), and 
schizoid traits as seen in patients with schizophrenia described by Bleuler (1911), see 
Figure 1.  
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Figure 1. Historical overview of the development of the schizotypy concept and 
research (figure provided by Gordon Claridge, on request). 
 
In fact, nowadays there is a wealth of evidence suggesting that unaffected relatives of 
patients with schizophrenia show psychotic-like traits themselves (Baron, 1985; 
Lenzenweger & Loranger, 1989; Parnas & Jorgensen, 1989; see also van Os, et al., 
2009 for overview). All these observations led several psychiatrist and researchers to 
develop more dimensional/taxometric models of the schizophrenia spectrum disorders, 
rather than the conservative taxonic, or qualitative approach most diagnostic manuals, 
e.g. the DSM, are based on. Bleuler distinguished symptom dimensions ranging from 
patients to relatives, but also from patients before and after illness onset. Yet, it took 
another 50 years, until the concept of schizotypy, a trait disposition to psychosis, was 
developed (Meehl, 1962; Rado, 1953). This marked the official development of quasi-
dimensional models of schizophrenia symptoms (see also Figure 2). Here, schizotypy is 
a trait disposition that increases vulnerability for schizophrenia in interaction with other 
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factors (e.g. social learning, or other genetic components), e.g. environmental influences 
in individuals with a predisposition to schizophrenia (schizotaxia). The symptoms exist 
on a disease-based spectrum, with increasing symptoms representing more severe 
schizophrenia symptoms. However, not all individuals with a predisposition to 
psychosis necessarily develop a psychotic disorder according to the quasi-dimensional 
model, and benign environmental influences could have protective effects (see also 
Lenzenweger, Maher, & Manschreck, 2005 for overview).   
Around the same time Eysenck (1960) developed his totally dimensional approach to 
the schizophrenia spectrum. He continued developing the concept of ‘psychoticism’, by 
regarding patients with schizophrenia as simply occupying the extreme end of a 
schizophrenia spectrum (M. J. Green, Boyle, & Raine, 2008). The term ‘psychoticism’ 
referred to psychotic-like personality features in the healthy population as lying on a 
dimension, predisposing to the development of psychosis if certain disadvantageous 
environmental influences are met (Heath & Martin, 1990). Symptoms included 
recklessness, disregard for common sense, and inappropriate emotional expression. 
Eysenck’s work influenced other researchers to develop the fully dimensional concept 
of schizotypy (Claridge & Hewitt, 1987; Eckblad & Chapman, 1983; Grove, 1982; 
Hewitt & Claridge, 1989; Kendler, Lieberman, & Walsh, 1989; Raine, 1987). The fully-
dimensional approach as developed by Claridge sees schizotypal symptoms as part of 
normal behaviour and experiences. These can be broken down into similar symptom 
clusters as seen in schizophrenia, namely positive, negative and disorganized symptoms 
(Liddle, 1987). These symptoms can also be linked to positive characteristics, such as 
enhanced creativity and/or spiritual experiences (Batey & Furnham, 2008; Claridge & 
Blakey, 2009; Schofield & Claridge, 2007, see also Figure 2). The dimensional view 
deviates from quasi-dimensional models in the sense that the latter have the disease 
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model at their reference point. This means that they assume that the expression of 
dimensionality of schizophrenia varies only according to the degree of illness-related 
symptoms (Claridge, 1994), see also Figure 2.  
Figure 2. Comparison of quasi-dimensional (disease-based) and fully dimensional 
(personality-based) continuity models of schizotypy and schizophrenia [figure provided 
by Claridge (1994) on request]. The fully dimensional model (turquoise) assumes 
schizophrenia symptoms to vary naturally in the healthy general population as 
personality traits (below the striped line). Progression to disease (above the striped line) 
may occur when environmental and genetic influences exert disadvantageous 
influences. The quasi-dimensional model (yellow) assumes dimensionality of 
schizophrenia only with the severity of illness-related symptoms, ranging from 
comparatively mildest (schizotypal personality disorder) to most severe (schizophrenia) 
symptoms. 
 
The fully dimensional models, however, base their predictions on personality traits that 
deviate naturally in the general population, and therefore represent healthy diversity 
(Claridge, 1994). They also assume a certain discontinuity of function (e.g. due to 
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genetic predisposition or environmental influences, see also Figure 2) as marker of 
disorder-related processes, which represents the main difference between the fully-
dimensional model and the totally dimensional model (M. J. Green, et al., 2008). 
3. Assessment tools of psychosis proneness 
Psychosis-proneness and its’ correlates can be measured by 1) preselecting at risk 
populations, or 2) by assessing schizotypal personality traits in the general population 
with questionnaires.  
Regarding the first point, high risk populations for the development of schizophrenia are 
typically defined in two ways (please see also: Myles-Worsley et al., 2007; Smieskova 
et al., 2010): a) Either by genetic predisposition to the disease, or b) clinical high-risk 
subjects.  With regards to a): genetic predisposition can either be investigated with 
monozygotic and dizygotic twins discordant for schizophrenia, or subjects with at least 
two first- or second-degree relatives of patients affected with psychosis [e.g. the New 
York High Risk Project, NYHRP (Erlenmeyer-Kimling et al., 1997), the Edinburgh 
High Risk Study (Johnstone, Ebmeier, Miller, Owens, & Lawrie, 2005)]. With regards 
to b): studies can be conducted in ultra-high risk subjects, those with an at-risk mental 
state, as well as subjects presenting basic symptoms such as thought and perception 
disturbances [e.g., the Personal Assistance and Crisis Evaluation or PACE Clinic in 
Melbourne Australia, (McGorry, Edwards, Mihalopoulos, Harrigan, & Jackson, 1996; 
McGorry, et al., 2003), the Recognition and Prevention or RAP Program at Zucker 
Hillside Hospital in New York, (Cornblatt et al., 2003), the Center for the Assessment 
and Prevention of Prodromal States or CAPPS at UCLA, (Niendam et al., 2006), and 
the prospective Zurich Cohort Study (Rössler, Hengartner, et al., 2011; Rössler, Vetter, 
et al., 2011), and also Smieskova et al. (2010) for overview]. 
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Apart from preselecting at-risk populations to investigate psychosis-proneness, 
schizotypal traits can also be assessed. Typically, schizotypal personality traits reflect 
symptom dimensions that are reminiscent of schizophrenia symptoms, however in a 
milder, non-clinical form in the general, healthy population. Therefore, they can aid in 
understanding the etiology of schizophrenia. This is particularly the case since healthy 
schizotypal individuals from the general population are not affected by factors 
associated with the chronic forms of schizophrenia, e.g. medication, the lack of 
motivation, or hospitalization to name just a few (McGorry, et al., 2003; Sellen, 
Oaksford, & Gray, 2005). Typically, these schizotypal personality traits are assessed 
using self-report questionnaires (L. J. Chapman, Chapman, Kwapil, Eckblad, & Zinser, 
1994; L. J. Chapman, Chapman, & Raulin, 1976; L. J. Chapman, Chapman, & Raulin, 
1978; Claridge & Broks, 1984; Eckblad & Chapman, 1983; Eckblad, Chapman, 
Chapman, & Mishlove, 1982; Edell, 1995; Eysenck & Eysenck, 1975; Launay & Slade, 
1981; Mason, Claridge, & Jackson, 1995; Mason, Linney, & Claridge, 2005; Peters, 
Joseph, Day, & Garety, 2004; Raine, 1991; Raine & Benishay, 1995; Rawlings & 
MacFarlane, 1994; Winterstein et al., 2011). People can respond either with ‘yes/no’, 
´true/false´, or on a Likert-scale. Generally, higher scores indicate higher schizotypy.  
Most schizotypy scales have been developed in the USA and the UK (see Table 1 
below). The schizotypal personality questionnaire (SPQ), a widely used schizotypy 
assessment tool in the USA, has been developed to assess illness-based DSM-criteria of 
the American Psychiatric Association [e.g.(Raine, 1991; Raine & Benishay, 1995)]. 
UK-based questionnaires almost exclusively represent the dimensional view in line with 
the personality research tradition (Eysenck & Eysenck, 1975; Launay & Slade, 1981; 
Mason, et al., 1995; Mason, et al., 2005; Peters, et al., 2004; see also Figure 1). The 
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most recently validated questionnaires in UK-samples are the original and short version 
of the O-LIFE, and Peter´s Delusional Inventory (see Table 1).  
Table 1. Overview of schizotypy assessment tools and the location of their development, 
sorted by year.  
Scale Author Year Location 
Eysencks Personality Questionnaire  Eysenck & Eysenck 1975 UK 
Chapman Scales: Physical Anhedonia  Chapman, Chapman, & 
Raulin 
1976 USA 
Chapman Scales: Perceptual 
Abberation Scale  
Chapman, Chapman, & 
Raulin 
1978 USA 
Hallucinatory predisposition  Launay & Slade 1981 UK 
Chapman Scales: Revised Social 
Anhedonia Scales  
Eckblad, Chapman, 
Chapman, & Mishlove 
1982 USA 
Chapman Scales: Magical Ideation 
Scale  
Eckblad & Chapman 1983 USA 
Schizotypy Traits Questionnaire  Claridge & Broks 1984 UK 
The structured interview for 
schizotypy  
Kendler, Lieberman, & 
Walsh 
1989 USA 
Schizotypal Personality Questionnaire  Raine 1991 USA 
Multidimensional Schizotypal Traits 
Questionnaire  
Rawlings & MacFarlane 1994 AUS 
Oxford and Liverpool Inventory for 
Feelings and Experiences  
Mason, Claridge, & 
Jackson 
1995 UK 
Schizotypal Personality Questionnaire 
– Brief  
Raine & Benishay 1995 USA 
Chapman Scales: Wisconsin 
Psychosis-Proneness Scales  
Edell 1995 USA 
Peters Delusional Inventory  Peters, Joseph, Day, & 
Garety 
2004 UK 
Oxford and Liverpool Inventory for 
Feelings and Experiences - Short 
version 
Mason, Linney, & Claridge 2005 UK 
Chapman Scales: Wisconsin 
Psychosis-Proneness Scales - Short 
version  
Winterstein et al. 2011 USA 
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Whereas Peter´s Delusional Inventory is focusing on delusion proneness only, the O-
LIFE is assessing a more encompassing range of symptom dimensions as found in 
patients with schizophrenia (Liddle, 1987; Vollema & Hoijtink, 2000). These symptom 
dimensions incorporate positive schizotypy (e.g. cognitive-perceptual distortions, 
unusual experiences, magical thinking, paranoia etc.), negative schizotypy (e.g. 
social/physical anhedonia) and disorganized symptoms (e.g. odd speech and behaviour, 
difficulties with decision-making and/or attention, etc.). Additionally, the O-LIFE 
(Mason, et al., 1995; Mason, et al., 2005) implicates a fourth factor, impulsive non-
conformity, which relates to impulsive and disinhibited behaviours. Due to its´ highly 
adequate internal consistency (Mason, et al., 1995), and high test-retest reliability 
(Burch, Steel, & Hemsley, 1998), the O-LIFE is a schizotypy assessment tool that is 
widely used in (but not limited to) UK-based studies. 
 
B. Cognitive impairments and their relationship to the schizophrenia 
spectrum 
The questionnaires assessing schizotypal symptoms tap into cognitive and perceptual 
biases, reflected in the similarities along the schizophrenia spectrum with regards to 
cognitive attenuations. We will therefore continue by elucidating cognitive impairments 
that are comparable along the dimension of schizophrenia, and hence relevant to the 
present thesis. We will review the evidence in patients with schizophrenia, high risk 
populations (e.g. relatives of patients with schizophrenia), and psychometrically defined 
schizotypy (e.g. via preselection of high versus low schizotypal individuals based on 
median-splits, or considering only those deviating 2xSD from the mean) for a selection 
I     General introduction 
 
12 
 
of cognitive domains discussed as potentially sensitive to pathological changes, e.g. 
frontal lobe functioning and hemispheric asymmetry. 
 
1. Frontal lobe functioning 
The frontal lobes entail a large proportion of the human brain (see Figure 3). Due to the 
vastness of the area, it is not surprising that the frontal lobes are associated with a large 
amount of cognitive functions, which usually correspond to either motor (see Figure 3, 
area 4), premotor (see Figure 3 area 6), prefrontal (see Figure 3 area anterior to area 6 
and 44) and limbic regions of the frontal lobes (see Vanderploeg, 2000 for overview). 
The prefrontal areas are further divided into the dorsolateral (see Figure 3, areas 9, 10, 
45, 46), orbitofrontal (see Figure 3, area 11, 12, 47) and medial (see Figure 3, medial 
portion of area 6, plus area 8 and 9) frontal lobe. The limbic area encompasses the 
frontal paralimbic regions together with the cingulate gyrus (see Figure 3, area 24 and 
26). The associated functions range from motor functioning, language expression, 
olfaction, and/or eye-hand coordination to executive functions which are usually 
involved with the higher aspects of executing and managing behaviour (see 
Vanderploeg, 2000 for overview).  
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Figure 3. Brain areas (in different colours) and associated functions. The numbers 
correspond to the Brodman areas (Motor cortex= Area 4; premotor cortex= Area 6; 
prefrontal cortex= Area 6, 8, 9, 10, 11, 12, 45, 46, 47). This figure was provided by Dr. 
Robert Thatcher (http://www.appliedneuroscience.com/NeuroGuide.htm) on request 
(see approval in Appendix). 
 
Executive functions encompass for instance short-term and working memory, cognitive 
flexibility, planning, problem solving, abstract reasoning, organization, initiation, self-
monitoring, error detection and correction, control functions, self-awareness and 
reflection (see Chan, Shum, Toulopoulou, & Chen, 2008 for overview; Damasio, 1995; 
Grafman & Litvan, 1999; Stuss, Shallice, Alexander, & Picton, 1995; see Vanderploeg, 
2000 for overview). In the laboratory, these cognitive impairments can be measured 
with specific tasks sensitive to modulations in these particular key functions of the 
frontal lobes, e.g. cognitive flexibility (Reitan, 1955; Tombaugh, 2004), verbal fluency 
(Bechtoldt, Benton, & Fogel, 1962; see Jurado & Rosselli, 2007 for overview), verbal 
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learning (e.g. Badcock, Dragović, Dawson, & Jones, 2011; Delis, Kramer, Kaplan, & 
Ober, 1987; Delis, Kramer, Kaplan, & Ober, 2000; Spreen & Strauss, 1998), and 
working memory (Barch, 2005; Owen, McMillan, Laird, & Bullmore, 2005; Schoofs, 
Preuß, & Wolf, 2008). 
For instance, cognitive flexibility and set shifting is frequently measured with the trail 
making task (Reitan, 1955; Tombaugh, 2004). The Trail making task consists of two 
parts. In the Trail making test A, participants have to draw a line from numbered circles 
in chronological order (1 to 25), as fast as possible. On Trail making task B participants 
are presented with circles containing numbers and letters, and are instructed to draw a 
line in chronological order from 1 to 13, and A to L, but to switch back and forth 
between numbers and letters, resulting in constant switching of strategies. The reaction 
time of both tasks are recorded, and an index subtracting RT’s of Trail making task A 
from RT’s of Trail making task B results in an estimate of cognitive flexibility (Lezak, 
1995) adjusted for individual differences in motor functioning and visual search 
strategies (Reitan & Wolfson, 1985). Additionally, working memory can be assessed 
with the n-back task (Barch, 2005; Owen, et al., 2005; Schoofs, et al., 2008), where 
participants see a string of items sequentially on the screen. Individuals have to indicate 
whether the current item n is the same as a previous item (for instance in trial n-2). 
Since individuals are required to continuously compare the current information with 
previous information, they have to use their working memory to update stored 
information (the item that was presented n trials back) and compare this with new 
information (current item on the screen) at each moment in time. Other memory tasks 
measure verbal learning, e.g. the Rey’s auditory verbal learning test (e.g. Badcock, et 
al., 2011; Spreen & Strauss, 1998) or California verbal learning test (Delis, et al., 1987; 
Delis, et al., 2000). Here participants are asked to recall lists of words presented to them 
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over repetitive trials. Additionally, verbal memory is measured with story recall tasks 
(Bowden, Carstairs, & Shores, 1999; Ivison, 1993; Wechsler, 1987), e.g. by reading a 
short story (similar to short newspaper stories) to participants, which they are asked to 
reproduce in as much detail as possible. Verbal production can be measured with the 
verbal fluency test or COWAT (Bechtoldt, Benton, et al., 1962; see Jurado & Rosselli, 
2007 for overview), where participants are asked to produce as many words as they can 
think of within a minute that either start with a particularly given letter (e.g. F), or 
belong to a certain category (e.g. animals). 
Whereas healthy people use their frontal lobes efficiently to perform the above 
mentioned tasks, hypofrontality has been reported in patients with schizophrenia from 
imaging studies (see Hill et al., 2004 for overview; Ingvar & Franzen, 1974; Ragland, 
Yoon, Minzenberg, & Carter, 2007; Weinberger & Berman, 1988), and 
neuropsychological tasks similar to those mentioned above (see Dibben, Rice, Laws, & 
McKenna, 2009 for meta-analysis; M. F. Green, 2006).  Taken together, the findings 
support the view that frontal lobe functioning is sensitive to pathological changes 
associated with schizophrenia. We will elaborate on this idea by reviewing cognitive 
impairments along the schizophrenia spectrum that relate to frontal lobe functioning. 
Schizophrenia 
Cognitive impairments are one of the major concerns among patients with 
schizophrenia (M. F. Green, Kern, Braff, & Mintz, 2000), especially since frontal lobe 
functions are crucial for everyday functioning, e.g. the ability to maintain 
occupational/educational functioning, to function independently at home, or to develop 
and maintain appropriate interpersonal relations (Goel, Grafman, Tajik, Gana, & Danto, 
1997; M. F. Green, 1996; M. F. Green, et al., 2000). Specific frontal lobe functions 
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affected in this population in comparison to healthy controls are e.g. verbal short-term 
and working memory (Barch, 2005; Simon, et al., 2007), verbal fluency and cognitive 
flexibility (Dickinson, Ramsey, & Gold, 2007; Palmer, Dawes, & Heaton, 2009; Rajji, 
Ismail, & Mulsant, 2009). Therefore, impairments in frontal lobe functioning have been 
discussed as a risk marker in schizophrenia (Buchsbaum et al., 2002; Weickert et al., 
2000; Weinberger & Berman, 1988), and seem to be crucial to the psychopathology of 
the disease (Elvevag & Goldberg, 2000; Weinberger, Aloia, Goldberg, & Berman, 
1994). Additionally, this marker seems to be evident particularly for negative and 
disorganization symptom clusters (see Dibben, et al., 2009 for overview). As will be 
shown in the subsequent paragraph, these cognitive impairments are also present in 
individuals along the schizophrenia spectrum. For instance, high risk groups (e.g. 
relatives of patients with schizophrenia, or those showing prodromal symptoms) and 
healthy psychometrically defined schizotypes.  
High risk populations 
Relatives of patients with schizophrenia and those at high risk for developing psychosis 
and/or schizophrenia show similar cognitive impairments as those seen in 
schizophrenia/psychosis patients. For instance, relatives as compared to controls show 
reduced performance in verbal fluency (Bhojraj et al., 2009; Franke, Maier, Hardt, & 
Hain, 1993; Krabbendam, Myin-Germeys, Hanssen, & van Os, 2005; Meijer et al., 
2011; Pukrop & Klosterkötter, 2010), working memory (Pflueger, et al., 2007; Pukrop 
& Klosterkötter, 2010), verbal learning and memory (Pukrop & Klosterkötter, 2010; 
Trandafir, Méary, Schürhoff, Leboyer, & Szöke, 2006) and cognitive flexibility 
(Klemm, Schmidt, Knappe, & Blanz, 2006; Pukrop & Klosterkötter, 2010). Some 
researchers even report a reduced global neurocognitive performance (Eastvold, Heaton, 
& Cadenhead, 2007). Comparatively reduced performance has also been reported from 
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clinically defined prodromal individuals, e.g. for verbal fluency (H. S. Kim et al., 2011; 
Magaud et al., 2010; Meijer, et al., 2011; Pukrop & Klosterkötter, 2010), verbal 
learning and memory  (H. S. Kim, et al., 2011; Niendam, et al., 2006; Pukrop & 
Klosterkötter, 2010), cognitive flexibility (Pukrop & Klosterkötter, 2010) and working 
memory (Jahshan, Heaton, Golshan, & Cadenhead, 2010; H. S. Kim, et al., 2011). 
Finally, relative reduced performance has been observed in schizotypal personality 
disorder, again for verbal fluency (Voglmaier et al., 2000), cognitive flexibility (Diforio, 
Walker, & Kestler, 2000; Trestman et al., 1995), working memory (Mitropoulou et al., 
2002), and verbal memory / learning (Voglmaier, et al., 2000). 
Schizotypy 
To provide a comprehensive overview of studies investigating whether cognitive 
attenuations extend from schizophrenia to high-risk samples to psychometrically 
defined schizotypy, we searched PubMed, Web of Science and ScienceDirect for 
relevant literature combining keywords representing the schizophrenia spectrum 
(including schizotypy, psychosis-proneness, O-LIFE, SPQ, high-risk, schizophrenia 
spectrum and schizophrenia dimension etc.) and cognitive functioning (including 
cognition, frontal lobe functioning, executive functioning, neuropsychology, cognitive 
flexibility, verbal memory, working memory, verbal fluency, laterality, hemispheric 
asymmetry etc.). Detailed results are presented in the Appendix (Table 30). To 
summarise, similar cognitive functions to those seen affected in patients with 
schizophrenia and high risk populations are reduced in schizotypal populations. For 
instance, studies report reductions in cognitive flexibility (e.g. Laws, Kondel, Clarke, & 
Nillo, 2011; Suhr, 1997), verbal fluency (e.g. Giraldez, et al., 1999; Koychev et al., 
2011), verbal learning and memory (e.g. Burch, Hemsley, Corr, & Gwyer, 2006; 
Kaczorowski, Barrantes-Vidal, & Kwapil, 2009) as well as working memory (e.g. 
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Koychev, et al., 2011; Park & McTigue, 1997; see Table 30 in Appendix for overview). 
To note: the amount of findings will likely exceed the amount of studies, as several 
studies reported more than one finding on the link between schizotypy and cognition 
(see Table 30 in Appendix). Additionally, the direction of effect (increase, decrease or 
equal performance) is related to Table 30, and does not necessarily represent within-
subjects effects. 
2. Hemispheric asymmetry 
The human brain is naturally divided into two hemispheres, communicating via the 
corpus callosum (see Figure 4). These two hemispheres show asymmetries in various 
domains in healthy individuals, be it anatomically, neurochemically or functionally (see 
Hugdahl & Westerhausen, 2010 for overview). For instance, the left hemisphere is 
usually dominant for language processing, and the right for face processing (see also 
Figure 4). It is suggested that it is this functional segregation that has enabled human 
beings to develop and communicate via language (Cooper, 2006). However, this human 
hemispheric specialization may also predispose individuals to develop psychosis, the 
latter being firstly associated with changes in brain regions seen as uniquely human 
(Crow, 2000; Southard, 1915) and secondly characterized by a reduction in the usual 
patterns of hemispheric asymmetry (Angrilli et al., 2009; Crow, 2000, 2008; Shagass, 
Roemer, Straumanis, & Amadeo, 1978). Therefore, the development of high-level 
language abilities via hemispheric specialization may coincide with –or at least partially 
explain- the development of psychosis (Crow, 1997, 2000, 2008; Ketteler & Ketteler, 
2010). We will outline this argument in the following sections by looking at 
attenuations of hemispheric asymmetry along the schizophrenia spectrum.  
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Figure 4. The functional hemispheric segregation in right handed individuals. The two 
hemispheres communicate with each other via the corpus callosum. Among other 
functions, the left hemisphere is usually dominant over the right for language 
processing, and the right is usually dominant over the left for face processing. This 
figure was provided by Bruno Dubuc (http://thebrain.mcgill.ca; see approval in 
Appendix). 
 
Schizophrenia 
In Crow’s view, hemispheric asymmetry is necessary for healthy brain functioning. 
However, the development of language and the accompanying hemispheric 
specialization may have enabled the occurrence of psychotic disorders such as 
schizophrenia in the first place, as the core symptoms of schizophrenia (hallucinations 
and delusions) may derive from a failure to develop the typical cerebral dominance for 
language in the left hemisphere. According to Crow (1998, 2000) the lateralization of 
language occurred via information transmission constraints on the corpus callosum, a 
brain structure connecting both hemispheres. In most healthy individuals, certain 
components relating to speech output (e.g. the phonological output sequence) lateralized 
to the dominant left hemisphere, whereas other associated components relating to 
concept formation and thoughts were partially lateralized to the right hemisphere. 
I     General introduction 
 
20 
 
Whereas in healthy subjects this asymmetry may enable them to distinguish between 
internal and external speech due to time constraints of inter-hemispheric transmission, 
in hallucinations and delusions this mechanism would be missing due to a reduction in 
hemispheric asymmetry (Crow, 2000). Therefore, internal speech signals may be 
perceived as external by the hallucinating individual. Empirical evidence supports this 
theory, as atypical hemispheric asymmetry is frequently found in patients with 
schizophrenia (see Mitchell & Crow, 2005 for overview). For instance, during verb 
generation and semantic decision tasks patients with schizophrenia show a reduced left 
hemisphere activation as compared to healthy controls (Bleich-Cohen, Hendler, Kotler, 
& Strous, 2009; Sommer, Ramsey, & Kahn, 2001). These effects seem to be 
independent of general auditory processing (music listening; Bleich-Cohen, et al., 
2009), or medication (van Veelen et al., 2011; Weiss et al., 2006). Additionally, patients 
with schizophrenia show a reduction in the typical right hemisphere dominance for face 
processing when compared to controls, as is evident from studies on chimeric faces 
(Kucharska-Pietura, David, Dropko, & Klimkowski, 2002; Phillips & David, 1997). 
Since this reduction in right hemisphere bias does not seem to be correlated with 
general face processing deficits (Kucharska-Pietura, et al., 2002), one can conclude that 
there is a specific deficit in right hemisphere processing of facial information in 
patients. Taken together, atypical asymmetry of the two hemispheres may reflect 
illness-related processes (Crow, 2000; Noguchi, Hori, & Kunugi, 2008).  
High risk populations 
In relatives of patients with schizophrenia similar reductions in language dominance 
have been observed. FMRI studies showed that relatives of patients with schizophrenia 
show a more bilateral activation as compared to the typical left hemisphere activation 
pattern seen in healthy controls when performing a lexical decision task (Li, Branch, 
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Bertisch, et al., 2007), and during reading, verbal comprehension and vocabulary tasks 
(Li, Branch, Ardekani, et al., 2007). Additionally, an abnormal lateralization pattern in 
schizotypal personality disorder is also partially supported (Voglmaier et al., 2009). 
Therefore, in high risk subjects, comparable cognitive impairments and potentially 
structural attenuations are seen when compared to healthy controls. 
Schizotypy 
To provide a comprehensive overview of studies investigating whether attenuations in 
hemispheric asymmetry extend from schizophrenia to high-risk samples to 
psychometrically defined schizotypy, we did the same literature review as outlined in 
section I. B. 1. c., combining keywords representing the schizophrenia spectrum 
(including schizotypy, psychosis-proneness, O-LIFE, SPQ, high-risk, schizophrenia 
spectrum and schizophrenia dimension etc.) and hemispheric asymmetry (including 
hemispheric asymmetry, laterality, hemispheres, lexical decision, facial decision, word 
bias, face bias etc.). The results are presented in the Appendix (Table 30), and in Figure 
5. In summary, as a function of schizotypy (either by comparing high versus low 
schizotypes, or by correlating schizotypy scores with the outcome measures) decreases 
in hemispheric asymmetry were reported 12 times, suggesting similar attenuations of 
laterality patterns along the schizophrenia spectrum. To note: as with reports on frontal 
lobe functioning, the amount of findings will likely exceed the amount of studies, as 
several experiments reported more than one finding on the link between schizotypy and 
cognition (see Table 30 in Appendix). Additionally, the direction of effect (increase, 
decrease or equal performance) is related to Table 30, and does not necessarily represent 
within-subjects effects. 
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3. Heterogeneity of cognitive attenuations in schizotypy 
Generally, similar functions are affected along the schizophrenia spectrum, and 
functions affected in patients extend to reduced performance in these functions in 
schizotypes (Asai, Sugimori, & Tanno, 2009; Mason & Claridge, 1999). 
Figure 5. Proportion of findings on the effect of psychometrically defined schizotypy on 
cognitive functioning, split by cognitive task and performance, e.g. relative impaired, 
enhanced or equal performance as a function of schizotypy (e.g. by comparing high 
versus low schizotypes, or by correlating schizotypy symptoms with the outcome 
measures). 
 
However, this similarity between schizophrenia and schizotypy is only evident at the 
first glance. When considering other studies including these tasks in psychometrically 
defined schizotypy, it appears that, while the vast majority of all experimental findings 
(Figure 5) suggest an overall reduced cognitive performance relating to schizotypy (see 
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also Appendix Table 30), there is a substantial amount of heterogeneity of results 
(Giraldez, et al., 1999; Laws, Patel, & Tyson, 2008; Liouta, Smith, & Mohr, 2008; Park 
& McTigue, 1997; Spitznagel & Suhr, 2002), depending on the measures used. 
For instance, for frontal lobe functioning an equal amount of findings suggest no effect 
of schizotypy, or reduced performance in frontal lobe measures overall as a function of 
schizotypy (see Figure 5, and Appendix Table 30). When looking at the specific 
cognitive functions, cognitive flexibility, verbal fluency, working memory and laterality 
seem most consistently affected by schizotypy, whereas for verbal learning and memory 
the majority of reports suggest no effect of schizotypy.  
In the following we will outline one major reason that might explain this heterogeneity, 
namely drug use. 
C. Schizophrenia spectrum and drugs  
The rationale to focus on drug use to explain heterogeneity in cognitive attenuations in 
schizotypes comes from a wealth of studies that suggest a link between drug use and 
psychotic (-like) thinking, e.g. enhanced drug use along the schizophrenia spectrum (see 
below, and Figure 6). As can be seen in Figure 6, using the keywords psychosis, as well 
as psychosis and drug use, we find an increasing amount of studies investigating these 
variables between 1993 and 2011. 
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Figure 6. Amount of research articles published on ScienceDirect, using the keywords 
´drug use and psychosis´, and ´psychosis only´ as search terms.  
  
1. Drug use and schizophrenia spectrum 
For years, it has been reported that patients with schizophrenia consume more drugs 
than healthy people, but also more than patients suffering from other mental illnesses 
(please see details below, and in the following sections). These drugs concern drugs 
currently considered legal and illegal. When controls are not simply treated like a 
homogenous population, but are accounted for according to their schizotypy levels, we 
find again support for the schizophrenia spectrum. This is because a higher incidence of 
drug use is reported for substances such as i) tobacco in schizotypy (Esterberg, 
Goulding, McClure-Tone, & Compton, 2009) and patients with schizophrenia (de Leon, 
Diaz, Rogers, Browne, & Dinsmore, 2002), and ii) cannabis in schizotypy (Barkus, 
Stirling, Hopkins, & Lewis, 2006; Skosnik, Spatz-Glenn, & Park, 2001; J. H. Williams, 
Wellman, & Rawlins, 1996) and schizophrenia (Archie et al., 2007; Barnes, Mutsatsa, 
Hutton, Watt, & Joyce, 2006). Additionally, higher rates of amphetamine use have been 
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reported in both schizophrenia and schizotypal populations (see Barkus & Murray, 2010 
for overview). We will try to elucidate this in the following paragraphs, separating 
between some of the most popular drugs along the schizophrenia spectrum as 
mentioned above [nicotine, cannabis, and (meth)amphetamines]. 
Nicotine and schizophrenia spectrum 
About 25% of the general population smoke daily (Bogdanovica, Godfrey, McNeill, & 
Britton, 2011; see also Figure 7), while it is 62% in the case of patients with 
schizophrenia (de Leon & Diaz, 2005). Additionally, cigarette use is elevated in 
unaffected relatives of patients with schizophrenia (Lyons et al., 2002; M. J. Smith, 
Barch, Wolf, Mamah, & Csernansky, 2008), as well as in schizotypal individuals from 
the general population (Esterberg, et al., 2009; Kolliakou & Joseph, 2000; Stewart, 
Cohen, & Copeland, 2010; J. H. Williams et al., 1996). There is evidence that in 
patients nicotine is frequently used to self-medicate (see Kumari & Postma, 2005 for 
overview). For instance, nicotine use in this population leads to a reduction in 
psychiatric symptoms [(Glynn & Sussman, 1990; R. C. Smith, Singh, Infante, Khandat, 
& Kloos, 2002), but see (Dalack, Becks, Hill, Pomerleau, & Meador-Woodruff, 1999; 
A. Williams & Farrell, 2007)], or a reduction in side-effects induced by anti-psychotic 
medication (Anfang & Pope Jr, 1997; Goff, Henderson, & Amico, 1992; Yang, Nelson, 
Kamaraju, Wilson, & McEvoy, 2002). Additionally, it seems to improve illness related 
cognitive deficits (Sacco, Bannon, & George, 2004), but the specific relevance of 
nicotine to cognitive functioning will be elaborated upon later. 
Whereas this suggests that nicotine may be beneficial to the adverse effects of psychotic 
illness and related factors, one should note that the evidence is not as clear-cut. For 
instance, there is also evidence opposing the self-medication hypothesis for nicotine, as 
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smoking patients with schizophrenia are hospitalized more often and show poorer 
childhood social adjustment than their non-smoking counterparts (Kelly & McCreadie, 
1999). In the same study there is limited evidence that earlier onset of smoking (in 
female patients) is associated with earlier onset of psychotic symptoms. Additionally, 
smoking may predict the use of other drugs and additional mental health issues 
(Degenhardt & Hall, 2001).  
 
Figure 7. Prevalence rates (in %) of smoking in the general, healthy European 
population (age 12-75 years), split by smoking frequency [Source: Bogdanovica et al. 
(2011)]. 
 
Cannabis and schizophrenia spectrum 
Cannabis use in the past 12 months is reported by approximately 6% of the general 
population (see Figure 8), whereas 29% in people diagnosed with any form of psychotic 
disorder have used this substance in the past 12 months (B. Green, Young, & Kavanagh, 
2005). For lifetime use these rates are even higher, with a prevalence rate of 22% in the 
general population (see Figure 8), and 42% prevalence rate in patients with psychosis 
(B. Green, et al., 2005). In relatives of patients with schizophrenia, about 40% classify 
for cannabis abuse or dependence (M. J. Smith, et al., 2008), and individuals with 
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elevated psychosis proneness (schizotypy) in the general population also show a 
relatively elevated cannabis use (A. S. Cohen, Buckner, Najolia, & Stewart, 2011). 
Furthermore, the severity of schizotypal symptoms seems to relate to frequency (Barkus 
& Murray, 2010; Fridberg, Vollmer, O'Donnell, & Skosnik, 2011) and recency of use 
(Hides et al., 2009). There is nowadays also sufficient research to suggest that cannabis 
use relates to an increased risk for developing psychotic disorders later in life 
(Andreasson, Engstrom, Allebeck, & Rydberg, 1987; Fergusson et al., 2003; Hall & 
Degenhardt, 2000; van Os et al., 2002; Zammit, Allebeck, Andreasson, Lundberg, & 
Lewis, 2002). In particular, early onset of use at a young age increases the risk 
(Casadio, Fernandes, Murray, & Di Forti, 2011). Additionally, acute administration of 
THC, the psychoactive compound in cannabis, can induce psychotic symptoms in 
healthy individuals, and exaggerate symptoms in patients (D'Souza, 2007; D'Souza et 
al., 2004).  
(Meth) amphetamines and schizophrenia spectrum 
In the general, healthy population use of amphetamines ranges between 1% for past 12-
month use, and 4% for lifetime use (European Monitoring Centre for Drugs and Drug 
Addiction 2011; see Figure 8). Along the schizophrenia spectrum use of (Meth) 
amphetamines is elevated (e.g. Barkus & Murray, 2010). Not many studies have 
assessed prevalence rates of general amphetamine use in patients with schizophrenia 
and their relatives. However, there have been reports on stimulant/hallucinogen abuse 
and dependence rates of around 7% in patients with schizophrenia (Cantor-Graae, 
Nordström, & McNeil, 2001). Additional to this, (meth-) amphetamine use is elevated 
in those with a schizotypal personality disorder (see Barkus & Murray, 2010 for 
overview), and in schizotypes from the general population (L. Wood & Barkus, 2010). 
These substances can induce transient psychotic(-like) symptoms in the healthy 
I     General introduction 
 
28 
 
population (see Curran, Brignell, Fletcher, Middleton, & Henry, 2002 for review; 
Featherstone, Kapur, & Fletcher, 2007; N. S. Gray, Pickering, & Gray, 1996). There is 
also evidence to suggest that its’ use relates to an increased risk for developing 
psychosis later in life (B. D. L. Marshall & Werb, 2010; Zammit, et al., 2002). The 
evidence suggesting an increased risk for psychosis development with elevated ecstasy 
(or methamphetamine) is strong (McGuire, Cope, & Fahy, 1994; McGuire & Fahy, 
1991), and earlier and longer stimulant use (such as amphetamines) predict worse 
symptom severity (Lichlyter, Purdon, & Tibbo, 2011).  
Figure 8. Prevalence rates of drug use in the past 12 months, assessed in healthy adults 
(age 15-64 years) from the general European population (Source: Statistical bulletin of 
the European Monitoring Centre for Drugs and Drug Addiction, 2011; link: 
http://www.emcdda.europa.eu/stats11/gps). 
 
2. Drugs and cognition 
So far, we have presented evidence for the schizophrenia spectrum by accounting for 
cognitive functioning and for drug use. If one goes back to Figure 5 (and Table 30 in 
Appendix), however, it becomes obvious that schizotypy does not always relate to 
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cognitive impairments. We here argued that the frequently elevated drug use along the 
schizophrenia spectrum may partially explain inconsistencies between studies. In other 
words, it may be the drug use that relates to cognitive performance. This argument is 
indeed not far-fetched. In tasks measuring verbal fluency, set shifting, planning, multi-
tasking and interference, studies showed that polydrug users generally perform worse 
than non-users (Fernández-Serrano, Pérez-García, Perales, & Verdejo-García, 2010). It 
seems that drugs generally affect cognitive functions comparable to schizotypal 
symptoms, independent of the specific substances used (see Fernández-Serrano, et al., 
2011 for overview). To systematically account for this argument, we will outline 
whether drugs of elevated use in schizotypy have also been found to impact cognition 
reported as relatively impaired in schizotypy.   
Nicotine and cognition 
(1) Frontal lobe functioning 
Smokers generally seem to perform worse on a variety of cognitive tasks. For instance, 
relatively impaired performance has been reported for tasks measuring working memory 
(M. Ernst, Heishman, Spurgeon, & London, 2001; Jacobsen et al., 2005) and verbal 
memory, both immediate and delayed (Dunne, Macdonald, & Hartley, 1986; Jacobsen, 
et al., 2005). Smokers also show deficits in verbal learning during withdrawal compared 
to non-smokers, and these deficits are alleviated by nicotine administration (Soar, 
Dawkins, Begum, & Parrott, 2008). However, acute administration of nicotine seems to 
have beneficial effects on working memory, learning and attentional functions (see 
Levin, McClernon, & Rezvani, 2006 for overview). Acute nicotine consumption was 
also found to improve verbal memory and working memory in overnight abstinent 
smokers, as well as alertness (Kleykamp, Jennings, & Eissenberg, 2011). 
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(2) Hemispheric asymmetry 
The effects of nicotine on hemispheric asymmetry are relatively sparse. However, there 
are indications that would suggest that functional hemispheric asymmetry might be 
influenced by nicotine. Studies on the acute effects of nicotine exposure on laterality 
report on increasing left hemisphere contribution with enhanced nicotine use (Gilbert et 
al., 2008; McClernon, Gilbert, & Radtke, 2003), matching findings from fMRI studies 
where nicotine withdrawal was related to a reduced left frontal activation during a 
verbal working memory task (Sweet et al., 2010). However, other studies would 
indicate that nicotine results in a general reduction of cerebral asymmetry (Hahn et al., 
2011).  
Cannabis and cognition 
(3) Frontal lobe functioning 
Whereas cannabis use in patients with schizophrenia seems generally associated with 
improved cognitive functioning (see Rabin, Zakzanis, & George, 2011 for meta-
analysis), in the healthy population cannabis use seems to relate to impairments in 
memory and attentional functions (see Lundqvist, 2005 for overview). For instance, 
cannabis users show attenuations in verbal memory and learning, (Fried, Watkinson, & 
Gray, 2005; Sofuoglu, Sugarman, & Carroll, 2010; Solowij & Battisti, 2008; Wagner, 
Becker, Gouzoulis-Mayfrank, & Daumann, 2010) as compared to non-users, and heavy 
marijuana use is associated with small but significant impairments in memory retrieval, 
and verbal expression (Block & Ghoneim, 1993). Additionally, heavy cannabis use is 
associated with reduced function of the attentional/executive system, as indicated by 
decreased mental flexibility and increased perseveration and reduced learning, functions 
associated with the prefrontal cortex (Pope & Yurgelun-Todd, 1996). These 
impairments may even persist after 6 weeks of abstinence, particularly in verbal story 
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recall (Schwartz, Gruenewald, Klitzner, & Fedio, 1989). Moreover, these attenuations 
seem to worsen with increasing dose (Bolla, Brown, Eldreth, Tate, & Cadet, 2002), and 
elevated lifetime use (Solowij & Grenyer, 2002). 
(4) Hemispheric asymmetry 
The literature on functional hemispheric asymmetry and cannabis use is sparse, however 
fMRI studies showed an increased right prefrontal activation in cannabis users as 
compared to non-users when performing a task reflecting control of attention 
(Abdullaev, Posner, Nunnally, & Dishion, 2010), and elevated cannabis use is 
associated with increased  left hemisphere as compared to right hemisphere 
hippocampal volume (Medina et al., 2007), a brain structure crucially involved in 
memory performance (see Battaglia, Benchenane, Sirota, Pennartz, & Wiener, 2011 for 
overview).  
Amphetamines and cognition 
(5) Frontal lobe functioning 
Amphetamine use (see Fernández-Serrano, et al., 2011; Kalechstein, De La Garza, 
Mahoney, Fantegrossi, & Newton, 2007 for overview) negatively affects cognitive 
functions such as working memory (Curran & Travill, 1997), verbal fluency (Hanson & 
Luciana, 2004), cognitive flexibility (King, Alicata, Cloak, & Chang, 2010), and verbal 
learning (Gonzalez et al., 2004; Laws & Kokkalis, 2007; McCardle, Luebbers, Carter, 
Croft, & Stough, 2004; Parrott & Lasky, 1998). Verbal learning is even affected in non-
addicted amphetamine users, suggesting that only small amounts of these substances are 
needed to create functional impairments (Reske, Eidt, Delis, & Paulus, 2010). This is 
not surprising given that chronic amphetamine use relates to cortical gray matter loss, 
particularly in frontal, temporal and occipital areas (Nakama et al., 2011). 
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(6) Hemispheric asymmetry 
To our knowledge, no studies have investigated the relationship between amphetamine 
use and functional laterality directly. Therefore we would have to infer about the effects 
of these substances via other means, such as brain imaging. There is evidence that the 
blood flow to the Brodman area in the left hemisphere is increased as a function of 
quantity of MDMA use (Bauernfeind et al., 2011). Additionally, amphetamines have 
been shown to increase the release of certain neurotransmitters in the brain, e.g. 
dopamine (Steinkellner, Freissmuth, Sitte, & Montgomery, 2011). A natural dopamine 
receptor asymmetry in healthy participants, e.g. structures in the right frontal lobe, show 
elevated dopamine release during a set-shifting/cognitive flexibility task (Ko et al., 
2009), which suggests that performance in this region may be affected if substances 
target this specific neurotransmitter such as amphetamines. More specifically, the 
normal asymmetry pattern that relates to healthy cognitive flexibility may be distorted 
with amphetamine use. This, in turn, may relate to altered hemispheric asymmetry 
patterns due to substance use.  
D. Schizophrenia spectrum, drugs and cognition 
Given the overlap between the effects of psychotic-like symptoms and drug use on 
cognition above, the question arises if some of the results in schizotypy research were 
influenced by this populations’ enhanced drug use. Most studies investigating the 
effects of schizotypy on cognition did frequently either not report on the specific 
substances they controlled for (by either excluding participants consuming them, or 
statistically controlling for them), or they used substance dependence or abuse as an 
exclusion criterion (see Table 30 in Appendix). Whereas reports on drug use are 
relatively common in schizophrenia research, it appears relatively uncommon in 
schizotypy research. 
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Fifteen findings regarded psychometrically defined schizotypy and cognitive flexibility 
(see Table 30 in Appendix). Eight of them did not report assessing drug use (e.g. either 
by reporting on drug use characteristics of the sample, excluding participants 
consuming them, or statistically controlling for them), while the others employed 
different exclusion criteria, e.g. excluding subjects with a substance dependence or 
abuse history, or indicating self-reported drug (ab)use. For verbal fluency, we gathered 
nine findings, of which five did not report controlling or assessing drug use, and others 
mostly used substance abuse as an exclusion criterion. Only one study considered 
urine/breath tests. We also found eight findings on verbal memory and learning. Of 
these, five did not report controlling or assessing drug use, while the others controlled 
for either substance abuse, or self-reported (ab)use. Of the eight studies investigating 
working memory, six did not report controlling for or assessing drug use, one used self-
reported cannabis and ecstasy use in the past 12 months as exclusion criterion, and one 
included urine/breath tests. The same we find for the 15 findings on the relationship 
between schizotypal symptoms and hemispheric asymmetry. Thirteen of these did not 
report controlling for or assessing drug use, while others controlled for self-reported 
drug use 24h prior to testing (see Table 30 in Appendix). It seems that studies 
controlling for substance use have a slightly higher rate of detecting decreases in 
performance as a function of schizotypy (see Figure 9). However, since most drug 
control measures a) used different assessments of drug use, e.g. self-report, interviews 
or drug tests, and b) varied in the substances they assessed, it is still unclear in which 
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way substance use may have influenced results.
 
Figure 9. Proportion of findings revealing equal, relative impaired or enhanced 
performance as a function of schizotypy, split by control for drug use (by either 
reporting on drug use, excluding participants consuming drugs, or statistically 
controlling for drug use).   
 
It is possible that the inconsistent findings are subject to individual differences in 
substance use in the samples tested. Therefore, we systematically assessed the impact of 
schizotypal symptoms on cognitive functions, whilst accounting for individuals’ 
substance use. 
E. Summary and conclusions 
Evidence from schizotypy research challenges the conservative categorical models that 
view schizophrenia symptoms as indicative of illness processes, and not represented 
along a dimension in the general healthy population. Evidence supporting the 
dimensional models comes from research investigating the cognitive effects of 
psychometrically defined schizotypy. For instance, frontal lobe impairments are 
frequently reported in patients with schizophrenia, their healthy relatives and also 
psychometrically defined schizotypes. The same is true for a schizophrenia-typical 
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reduction in hemispheric asymmetry that also seems attenuated in relatives and 
schizotypal individuals from the general population. In the latter group, cognitive 
impairments do not seem to be found as consistently as in patients and their unaffected 
relatives, raising the question of the importance of individual differences in this 
population. We here suggested that one factor that may explain differences between 
studies is drug use. When assessing the link between psychometrically defined 
schizotypy and cognition, it does not seem common to control for drug use. Drugs, 
however, seem to exert influences on brains structures similar to the ones affected in 
schizophrenia and schizotypy. This observation raises the question if cognitive 
impairments formerly associated with schizotypy symptoms could have been (at least 
partially) due to elevated drug use. 
F. Objectives 
To test the idea that elevated drug use could (at least partially) explain cognitive 
attenuations formerly ascribed to schizotypal symptoms we assessed the use of a variety 
of drugs and the possible effect of substance consumption on the relationship between 
schizotypal symptoms and cognitive functioning. The substances chosen were deemed 
the most popular amongst the schizotypal/schizophrenia population, i.e. nicotine, 
cannabis, and amphetamine-like drugs. On top of this, we investigated if individual 
substances are more consistent predictors of cognitive attenuations than schizotypy, or 
if a general severity of substance use may potentially explain the controversial results in 
psychometric schizotypal research independent of the individual substances used. 
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II. Experiments 
A. Overview 
In short, the first study investigated nicotine dependence, the second one cannabis use, 
and the third study mephedrone use. In all studies (including the fourth), participants 
filled in the O-LIFE as a measure of schizotypal traits and performed cognitive tasks. In 
the fourth and final study, we did not ask for a particular drug, but wanted to investigate 
whether cognitive impairments are not necessarily explained by the use of particular 
drugs, but rather associated with general drug dependence (whether the “drug” is an 
actual substance, or another addiction-relevant behaviour). The fourth study was a direct 
consequence of the outcomes of Study 1, started before the outcomes of Studies 2 and 3 
were known. Given the time-consuming efforts to find individuals with particular drug 
behaviours, Studies 2 - 4 were initiated and conducted in parallel. In this summary we 
only report on the most pertinent findings of the analyses performed, as all other results 
are described in detail in the four experimental chapters, i.e. in Herzig et al. (2010, see 
study 1), Herzig, Nutt and Mohr (under revision; see study 2), Herzig, Brooks and Mohr 
(submitted; see study 3), or Herzig and Mohr [(Herzig & Mohr, in press); see study 4].  
Please note that internal consistency was computed for the questionnaires used, and 
deemed acceptable (see Table 29 in Appendix). Additionally, the wording of these four 
experimental chapters might deviate slightly from the wording of the published or 
submitted articles because of consistency of word use across the dissertation and 
improvements suggested by the jury members.  
1. Study 1: Nicotine  
As previously mentioned, language dominance in the left hemisphere (LH) and visual 
face recognition dominance in the right hemisphere (RH) have been found to be 
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attenuated in schizophrenia and schizotypy. As also mentioned, in healthy individuals 
dopamine agonists (including nicotine) can affect hemispheric asymmetry. For instance, 
nicotine might enhance language functions (Gentry, Hammersley, Hale, Nuwer, & 
Meliska, 2000; Gilbert, et al., 2008; Knecht et al., 2004; McClernon, et al., 2003), 
which potentially stabilizes hemispheric asymmetry rather than attenuates it, 
particularly when reporting relatively elevated schizotypy (Mohr, Krummenacher, et al., 
2005). Whereas this would point to an increase in left hemisphere language laterality as 
a function of nicotine use, other studies suggest the opposite, namely a right 
hemispheric shift with increasing nicotine use (M. Ernst, et al., 2001; McClernon, et al., 
2003; Norton, Brown, & Howard, 1992; Rose et al., 2007). Independent of the direction 
of the effect, these results could indicate that reports on cognitive attenuations formerly 
associated with the schizophrenia spectrum - like modulations of hemispheric 
asymmetry of function (Broks, 1984; Brugger, et al., 1993; Mason & Claridge, 1999; 
Mohr, Krummenacher, et al., 2005; Suzuki & Usher, 2009) might be affected by 
enhanced nicotine consumption rather than personality traits associated with psychosis-
vulnerability. We set out to investigate the latter hypothesis. Since studies directly 
measuring the effect of nicotine dependence on functional hemispheric asymmetry are 
sparse, we tested hemispheric asymmetry as a function of nicotine consumption and 
schizotypy, exploring the nature of the effect. We predicted that nicotine dependence 
would explain more variance than schizotypy in the laterality measures. Schizotypy 
scores and cognitive performance were comparable for smokers and non-smokers. Yet, 
increasing nicotine dependence among smokers predicted a right hemisphere shift of 
function in both tasks. Schizotypy, on the other hand, was mostly unrelated to 
hemispheric asymmetry in this study, apart from a decreased left hemisphere language 
bias as a function of cognitive disorganisation for one outcome variable. These findings 
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indicate that nicotine consumption is a more consistent predictor of shifts in 
hemispheric asymmetry than schizotypy, and would also indicate that the right 
hemisphere is linked to addictive behaviour related to nicotine dependence. Results 
from this study raise the question whether the right-hemisphere shift of function is 
nicotine-specific, if other substances may influence the relationship between cognition 
and schizotypy (see studies 2 and 3), or if any effect of drug use is due to addictive 
(compulsive, impulsive) behaviour more generally, instead of individual substances (see 
study 4).  
2. Study 2: Cannabis 
We here investigated whether cannabis use might influence the effect of schizotypy on 
cognition. In more detail, we investigated whether severity of cannabis use (alcohol and 
nicotine were used as control measures) would predict an attenuation of performance in 
the amount of correctly identified items in a working memory and verbal short term 
memory task, and reaction times in a cognitive flexibility task. Comparable to Study 1, 
we also investigated whether drug use would be a more consistent predictor of cognitive 
performance than schizotypy. Group comparisons indicated that cannabis users 
performed worse on a task measuring verbal short-term memory when compared to 
non-using controls. The regression analyses confirmed the importance of cannabis use 
severity for reduced verbal short-term memory performance, and alcohol dependence 
rates for working memory. Schizotypy did not explain any additional amount of 
variance in cognitive functioning (apart from impulsive non-conformity and cognitive 
disorganization). Generally, these findings would indicate that it is likely that drugs 
rather than schizotypy attenuate cognition. Additionally, we observed that it was not 
cannabis use severity alone, but also alcohol use severity that was related to cognitive 
performance. Consequently, alcohol use was again taken into account in study 3.   
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3. Study 3: Mephedrone / Polydrug use 
Mephedrone is a derivative of cathinone, a compound found in the Khat plant (see 
Schifano et al., 2010 for overview). The chemical structure is similar to amphetamine, 
and research suggests that cathinones (like mephedrone) mimic the psychological and 
physiological actions of amphetamines (Kalix, 1992; Schifano, et al., 2010). However, 
evidence regarding the cognitive effects of mephedrone use is scarce, and research on 
this substance will inform about the drug’s potential harms. Furthermore, even less 
research has been carried out on the link between mephedrone use and schizotypy, even 
though there seems to be evidence that mephedrone use can invoke psychotic symptoms 
(ACMD, 2010; James et al., 2010; Vardakou, Pistos, & Spiliopoulou, 2011). For this 
purpose, individuals were tested over the course of a weekend during which they 
planned to go “clubbing”, an experience frequently associated with legal and illegal 
psychoactive drug use. In line with previous studies (Herzig, et al., 2010), we expected 
mephedrone (and / or other drug use) to exert a more consistent influence on cognition 
(particularly frontal lobe functioning) than schizotypy. In particular, we expected that 
performance after the clubbing experience should be most impaired for those who have 
used mephedrone (or closely related drugs) when compared to those who refrained from 
psychoactive drug use. This impaired functioning was expected for the cognitive 
measures of verbal learning, verbal fluency, and cognitive flexibility. An additional 
hypothesis expected mephedrone users (and those consuming related drugs) to be 
already relatively impaired before the clubbing experience (when having used 
mephedrone and related drugs) in the past, i.e. prior to the inclusion into the study. 
Results indicated that firstly, polydrug users scored higher on cognitive disorganization 
than non-using controls, and secondly the baseline performance differed prior to the 
actual clubbing experience between polydrug users and non-users, with the former 
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group performing worse to non-users on verbal recall (immediate and delayed) and 
verbal fluency. This performance inferiority of polydrug users was further exacerbated 
between the pre- and post-clubbing session (during which mephedrone was consumed). 
Thirdly, regression analyses (comparable to those in study 1 and study 2) showed that 
higher cannabis use predicted decreased immediate verbal recall performance, and 
elevated amphetamine use related to decreased verbal fluency pre-clubbing, whereas 
mephedrone use seemed unrelated to the cognitive outcome measures. Additionally, 
schizotypy did not predict performance on top of substance use and the control variables 
like premorbid IQ and depression (apart from cognitive disorganization pre-clubbing). 
Again, this further supports the theory that cognitive impairments previously linked to 
schizotypy may be associated to a significant degree with increased substance use, as is 
also evident from studies 1 and 2.   
4. Study 4: Compensatory behaviours 
It is possible that substance-based stress alleviating behaviours (= compensatory 
behaviours) give an estimation of general dependency of behaviour (rather than 
dependency on specific substances), and they may affect the influence schizotypy exerts 
on cognition, which is something we set out to investigate in this study (see also Herzig 
and Mohr, in press, or study 4). For this purpose, we again assessed hemispheric 
asymmetry as in study 1 to assess left and right hemisphere dominance for function, in 
times where students experience elevated stress (shortly before exam period). We 
anticipated that compensatory behaviours would predict an attenuation of performance 
in the lexical and facial decision task (specifically: RVF/LH bias for language, and 
LVF/RH bias for faces, respectively), and that schizotypy (including its four subscales 
unusual experiences, cognitive disorganization, introvertive anhedonia and impulse 
non-conformity) will not predict variance in the cognitive tasks on top of compensatory 
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behaviours. In line with our hypothesis, stress-relieving compensatory behaviour 
(substance use) was the most consistent predictor of a right hemisphere shift in language 
functioning. On top of this, only a few outcome measures were sensitive to schizotypal 
symptoms: unusual experiences predicted reduced left hemisphere language dominance 
in line with previous research (e.g. Kravetz, Faust, & Edelman, 1998; Nunn & Peters, 
2001), whereas cognitive disorganisation contributed to a left hemisphere shift in 
language functioning on top of the other variables. Consequently, it is discussed that i) 
former reports on right hemisphere shifts in language dominance with positive 
schizotypy might be more consistently explained by an associated higher substance use, 
and ii) the findings on cognitive disorganisation contribute to published reports on 
inconsistent laterality – schizotypy relationships.  
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B. Study 1: Nicotine  
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1. Abstract 
Tobacco use is positively associated with severity of symptoms along the schizophrenia 
spectrum. Accordingly it could be argued that neuropsychological performance, 
formerly thought to be associated with schizotypy, is actually influenced by drug use or 
an interaction of drug use and schizotypy. We tested whether habitual cigarette smokers 
as compared to non-smokers would show a neuropsychological profile similar to that 
observed along the schizophrenia spectrum and, if so, whether smoking status or 
nicotine dependence would be more consistent predictors of the neuropsychological 
profile than schizotypy. Because hemispheric dominance has been found to be 
attenuated along the schizophrenia spectrum, 40 right-handed male students (20 non-
smokers) performed lateralised left- (lexical decisions) and right- (facial decision task) 
hemisphere dominant tasks. All individuals completed self-report measures of 
schizotypy and nicotine dependence. Schizotypy predicted laterality in addition to 
smoking status. While positive schizotypy (unusual experiences) was unrelated to 
hemispheric performance, cognitive disorganization predicted reduced left hemisphere 
dominant language functions. These latter findings suggest that cognitive 
disorganization should be regarded separately as a potentially importantly relating to 
thought disorganization and language processing. Additionally, increasing nicotine 
dependence among smokers predicted a right hemisphere shift of function in both tasks 
that supports the role of the right hemisphere in compulsive/impulsive behaviour.  
 
Keywords: Smoking; Psychosis-Proneness; Hemispheric Asymmetry; Cognitive 
disorganization 
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2. Introduction 
The concept of schizotypy, which was originally introduced by Meehl (1962) as a 
genetic diathesis-stress model for schizophrenia (see also Lenzenweger & Korfine, 
1992), represents a mild and non-clinical thinking style in the general population 
reminiscent of the one reported from individuals with a clinical diagnosis of 
schizophrenia. Schizotypal symptoms in the general population are quantitatively less 
prominent yet qualitatively equivalent to those seen in schizophrenia (Gooding, Matts, 
& Rollmann, 2006; Rawlings, Williams, Haslam, & Claridge, 2008). However, while 
schizotypal symptoms are considered to lie at one extreme end of the schizophrenia 
spectrum (SSp) in the clinical population, in healthy people such symptoms are 
considered to express themselves in milder form along the SSp (Claridge & Broks, 
1984; van Os et al., 1999). Schizotypy is typically assessed using self-report 
questionnaires (L. J. Chapman, et al., 1994; Mason, et al., 1995; Raine, 1991) and high 
scores indicate enhanced proneness to psychosis (L. J. Chapman, et al., 1994; Gooding, 
Tallent, & Matts, 2005). The notion that schizotypy and overt clinical psychosis are 
linked is also supported by observations that high-scoring, pre-selected schizotypal 
individuals from the general population demonstrate cognitive-attentional (Buchy, 
Woodward, & Liotti, 2007; Gooding, Kwapil, & Tallent, 1999; Sarkin, Dionisio, Hillix, 
& Granholm, 1998), sensory-motor-behavioural (Lenzenweger & Gold, 2000), 
physiological (Klein, Berg, Rockstroh, & Andresen, 1999; Pizzagalli et al., 2000) and 
neurochemical (Laruelle & Abi-Dargham, 1999; Murray, Lappin, & Di Forti, 2008) 
peculiarities comparable to those described in patients with schizophrenia. 
Similarities between schizotypy and schizophrenia are not limited to pre-selected highly 
schizotypal individuals but present in randomly selected individuals from the general 
population (Mason & Claridge, 1999; Mohr, Bracha, & Brugger, 2003; Reed et al., 
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2008; Shaw, Claridge, & Clark, 2001; Steel, Hemsley, & Pickering, 2002) that supports 
the notion that the SSp dimension extends across the general population. Indeed, there is 
an advantage in testing schizotypal individuals since basic brain mechanisms in 
psychosis can be studied in individuals free from confounding factors and illness-related 
phenomena seen in patients with schizophrenia, such as antipsychotic medication, 
hospitalization, or duration of illness (Claridge, Clark, & Beech, 1992; Esterberg, Jones, 
Compton, & Walker, 2007; Gooding, et al., 1999; Mason & Claridge, 2006).  
Of particular interest to the present study is the enhanced consumption of readily 
available psychoactive substances as one moves along the SSp, such as i) tobacco in 
schizotypy (Esterberg, et al., 2009; J. H. Williams, Wellman, Allan, et al., 1996) and 
patients with schizophrenia (de Leon, et al., 2002), ii) cannabis in schizotypy (Barkus, 
et al., 2006; Skosnik, et al., 2001; J. H. Williams, Wellman, & Rawlins, 1996) and 
schizophrenia (Archie, et al., 2007; Barnes, et al., 2006), and iii) caffeine in schizotypy 
(Jones & Fernyhough, 2009) and schizophrenia (Gurpegui, Aguilar, Martinez-Ortega, 
Diaz, & de Leon, 2004).  While some authors have suggested that dopamine-enhancing 
drugs such as nicotine (Montgomery, Lingford-Hughes, Egerton, Nutt, & Grasby, 2007; 
Murphy et al., 2002) might be involved in the development of psychosis or some 
aspects of it (Abi-Dargham et al., 1998; Moore et al., 2007; G. N. Smith et al., 2009), 
others suggest that at-risk individuals may use nicotine as means of self- medication 
(Adler, Hoffer, Wiser, & Freedman, 1993; Kumari & Postma, 2005; Zabala et al., 2009; 
Zammit et al., 2003).  However, the reason for enhanced drug consumption along the 
SSp currently remains unexplained.  Indeed, in the absence of unequivocal evidence that 
would fully support one or the other hypothesis (Adler, et al., 1993; G. N. Smith, et al., 
2009) it could even be argued that behaviour formerly associated with the SSp might 
rather result from drug consumption. In line with this latter suggestion, in the current 
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study we focus on hemispheric asymmetry of function since language dominance in the 
left hemisphere (LH) and visual face recognition dominance in the right hemisphere 
(RH) have been found to be attenuated in schizophrenia (Bleich-Cohen, et al., 2009; 
Kucharska-Pietura, et al., 2002; Løberg, et al., 2006; Mitchell & Crow, 2005; Phillips & 
David, 1997; Sommer, et al., 2001) and schizotypy (Broks, 1984; Brugger, et al., 1993; 
Mason & Claridge, 1999; Mohr, Krummenacher, et al., 2005; Suzuki & Usher, 2009). 
While laterality studies in patients with schizophrenia frequently control for illegal drug 
use, this is less often the case for legal substances such as nicotine. In schizotypy 
research it does not seem to be common to screen for these substances; in fact, none of 
the above-mentioned schizotypy studies reported on controlling for either illegal or 
legal drug use. To lend further support to the importance of controlling for substance 
use in laterality research, functional hemispheric asymmetry might be affected by 
nicotine (Gentry, et al., 2000; McClernon, et al., 2003) as well as dopamine, which is 
considered to be enhanced by drugs such as nicotine (Dawe, Gerada, Russell, & Gray, 
1995; Montgomery, et al., 2007; Murphy, et al., 2002). For instance, decreased 
hemispheric asymmetry in patients with schizophrenia seems most prevalent in the un-
medicated state (Mohr, Krummenacher, et al., 2005; Purdon, Woodward, & Flor-Henry, 
2001 for overviews) and cognitive impairments in first episode patients with 
schizophrenia were more pronounced in non-smokers as compared to nicotine smokers 
(Zabala, et al., 2009). In healthy individuals dopamine agonists (including nicotine) 
might enhance language functions (Gentry, et al., 2000; Gilbert, et al., 2008; Knecht, et 
al., 2004; McClernon, et al., 2003), which potentially stabilizes hemispheric asymmetry 
rather than attenuates it, particularly when reporting relatively elevated schizotypy 
(Mohr, Krummenacher, et al., 2005).  
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Thus the present study aims to test the conjecture that neuropsychological performance 
formerly associated with schizotypy might actually be explained by elevated nicotine 
use.  If decreased hemispheric asymmetry is as a result of nicotine use rather than 
schizotypal symptoms, this might explain why studies on functional hemispheric 
asymmetry and schizotypy report findings that are heterogeneous (Liouta, et al., 2008) 
since the smoking status between studies might have differed. In line with this 
reasoning, we hypothesize that nicotine smokers as compared to non-smokers yield a 
reduced functional hemispheric asymmetry and might do so with increased nicotine 
consumption. This hypothesis does not rule out the possibility that nicotine 
consumption and schizotypy interact to produce reduced hemispheric asymmetry and 
might do so differently for separate schizotypy dimensions (Mohr, Krummenacher, et 
al., 2005; Mohr, Landis, Bracha, Fathi, & Brugger, 2005). We assume that any 
laterality: schizotypy relationship and its interaction with nicotine will be most 
pronounced for positive schizotypy because most studies reported on a decreased 
hemispheric asymmetry for positive schizotypy but less so for negative schizotypy 
(Liouta, et al., 2008). The limited knowledge on the influence of cognitive 
disorganization on hemispheric asymmetry would predict no influence on performance 
(Gruzelier & Richardson, 1994; Mason & Claridge, 1999).  Finally, since previous 
studies have found more consistent findings in male as compared to mixed-sex or 
female study groups (Mason & Claridge, 1999; Mohr, Rohrenbach, Laska, & Brugger, 
2001), the current study focused on male participants only. 
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3. Method 
Participants 
Forty male right-handed undergraduate students (20 smokers and 20 non-smokers) were 
recruited through public advertisement in and around the University of Bristol, and 
through personal contact. The smokers had a mean age (always in years, ± SD) of 22 (± 
2, range 19 – 28) and the non-smokers had a mean age of 21 (± 1, range 18 – 23). The 
non-smokers were required never to have been regular, daily smokers or casual smokers 
of more than 100 cigarettes (m = 27 ± 33, range 0 – 100) in their lifetime to qualify as a 
non-smoker (David et al., 2005). Right-handedness was determined with the Edinburgh 
Handedness Inventory (Oldfield, 1971) according to previously used scoring criteria 
(see also Kita, de Condappa, & Mohr, 2007). 
All participants were Caucasian native English speakers and had normal or corrected to 
normal vision. As indicated by self-report, none of the participants reported drug abuse 
(either recreational or psychiatric) in the past three months, or a previous history of 
psychiatric or neurological illness (Mohr, Landis, & Brugger, 2006). The study was 
approved by the local Ethics committee.  
Materials 
(1) Self-report questionnaires 
i. The O-LIFE questionnaire 
The O-LIFE questionnaire (Mason, et al., 1995) is a validated 150-item self-report 
questionnaire assessing schizotypy in terms of four dimensions. Positive schizotypy is 
assessed by 30 items pertaining to Unusual Experiences (UnEx, maximum score 30, 
including items such as ‘Are your thoughts sometimes so strong that you can almost 
hear them?’), negative schizotypy by 27 items assessing Introvertive Anhedonia (IntAn, 
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maximum score 27, including items such as ‘Have you had very little fun from physical 
activities like walking, swimming or sports?’), and Cognitive Disorganization is 
assessed by 24 items (CogDis, maximum score 24, including items such as ‘Do you find 
it difficult to keep interested in the same thing for a long time?‘). Finally, 23 items 
assessing Impulsive Nonconformity (maximum score 23), which does not represent a 
schizotypy dimension (Mason, et al., 1995), and 40 filler items and items measuring 
schizotypal personality (STA) and borderline personality (STB) (Claridge & Broks, 
1984), which will not be considered further. For each item, participants have to indicate 
whether the statement is true or false. The number of positive responses (some items are 
reversely formulated) is summed so that higher scores indicate higher schizotypy. 
Normative values can be found in Mason et al. (1995) and Mason and Claridge (2006) 
and the scale has shown high test-retest reliability (Burch, et al., 1998). The 
questionnaire also includes six lie items (taken from Eysenck’s Personality 
questionnaire (Eysenck & Eysenck, 1975). In line with a previous study (Krumm-
Merabet & Meyer, 2005), we only included participants with a lie-score ≤ 5 (mean lie 
score was 1 ± 1). 
ii. The Fagerström Test of Nicotine Dependency (FTND) 
The FTND is a widely used self-report questionnaire on nicotine dependence 
(Heatherton, Kozlowski, Frecker, & Fagerström, 1991). Participants have to rate their 
consumption of cigarettes for six questions (e.g.: “Do you find it difficult to refrain 
from smoking in places where it is forbidden?”) using a yes/no response. Each response 
is scored between 0 – 10 on levels of nicotine dependence, with positive responses 
scored as 1, and negative responses scored as 0. A score of 10 indicates high nicotine 
dependence while a score of 0 indicates low nicotine dependence (Heatherton, et al., 
1991; Japuntich, Piper, Schlam, Bolt, & Baker, 2009). 
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Hemi-field studies 
For both hemi-field tasks participants were sat centrally at a distance of 57 cm from the 
computer screen (eye-screen distance). The keyboard was centrally placed in front of 
the participant so that the response keys were to the right and left of the body midline. 
Stimuli were presented using the experimental software system E-Prime (Psychology 
Software Tools) with a monitor display refresh rate of 60 Hz.  
(2) Lateralized Lexical Decision Task (LDT) 
Participants were presented with an English version of the lateralized LDT used by 
Mohr, Krummenacher et al. (2005). The stimulus material consisted of 24 words and 72 
pronounceable non-words. The words consisted of four- and five-letter words, and were 
matched for neighborhood (=2), and the CELEX frequency values ranged from 7.15 to 
76.20 (m = 38.07, SD = 24.47). Each word was matched with a non-word of the same 
length. The remaining non-words were matched to result in an additional set of non-
word pairs. The word pairs were displayed in black (33 point Courier New Bold font) 
against a grey background on the computer screen (see Figure 10). Each letter string 
was presented with their centre 25 mm from central fixation (visual eccentricity: 2.5 
degrees of visual angle per half-field). In each trial, we presented a fixation cross for 
1000 ms before the word pair was shown for 150 ms, followed by a blank screen for 
4000 ms, or until a response was given (Figure 10). Participants were instructed to 
indicate whether they saw a meaningful English word on the left or right, or did not see 
a meaningful English word at all. To do so, participants had to press the shift key 
ipsilateral to the word with the index finger or space bar with both thumbs if they did 
not see a meaningful string of letters on the screen. Per block, there were 72 trials with 
three 24-trial conditions (word left/non-word right, non-word left/word right, non-
word/non-word). The order of the stimuli was randomized within blocks and between 
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participants. In addition, for the critical trials (in which a word was presented) each 
word stimulus appeared once in each visual field. Prior to the experimental task each 
participant undertook a practice block consisting of 10 trials with words not used in the 
experimental trial. We assessed the number of correct lexical decisions and the mean 
reaction times for correct lexical decisions for the left (LVF) and right (RVF) visual 
field separately. In the control condition, two non-words were displayed on either side 
of the screen (NoW). 
 
Figure 10. Example of word stimuli and procedure used in the LDT. 
 
(3) Lateralized Facial Decision Task (FDT) 
Participants were presented with facial stimuli against a grey background on the 
computer screen (see Figure 11). Due to the potential effect of emotional faces on 
laterality (Workman, Peters, & Taylor, 2000), all faces had neutral expressions and were 
photographed straight on so that the faces appeared as symmetrical as possible with the 
central plane of the face in line with the centre of the screen. The eccentricity of each 
face picture was ~ 4 degrees of visual angle and the pictures were 335 x 400 pixels. This 
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was to ensure that important facial information, such as eyes, nose and mouth, would 
fall in a similar visual angle as the words in the lexical decision task (~2.5 degrees). The 
pictures consisted of 10 male and 10 female facial images (example in Figure 11) that 
had been used in a previous study (Penton-Voak, Pound, Little, & Perrett, 2006). From 
these, 20 sexually-dimorphic composite faces were constructed (Figure 11) with an 
equal amount of female and male half-faces appearing in each visual field. The same 20 
composite faces were also presented mirror-reversed resulting in 40 composite faces. In 
each trial, a black central fixation point was presented on the screen for 1000 ms 
followed by the stimulus that was displayed for 150 ms Following presentation of the 
stimulus, a blank screen was presented for a maximum of 4000 ms, or until a response 
was provided. In this task participants had to press the left shift key if the face appeared 
to be female and the right shift key if the face appeared to be male. Prior to the test trials 
participants were presented with a practice block of 10 trials consisting of two whole 
faces and eight composite faces that were not included in the experimental trials. We 
assessed the number and response time of facial decisions towards the left visual field 
(LF decisions) and right visual field (RF decisions). In the control condition, whole 
faces (WF) were presented (Figure 11). 
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Figure 11. Example of face stimuli and procedure used in the FDT. 
 
Data analysis 
As in previous lateralized hemi-field studies (Allison, Puce, Spencer, & McCarthy, 
1999; Ratcliff, Gomez, & McKoon, 2004), individual response latencies faster than 200 
ms and slower than 2000 ms in both the LDT and FDT were excluded from further 
analysis. To test for differences in lateralized performance in smokers and non-smokers, 
we calculated 2 x 2 mixed sample ANOVAs with visual field (LVF/LF, RVF/RF) as the 
related samples factor and group (smokers vs. non-smokers) as the independent samples 
factor on mean reaction times (RT) of correct responses for the LDT and the FDT 
separately. The same ANOVA was also calculated for percent correct responses in the 
LDT. For the FDT, to ascertain that participants could distinguish between male and 
female whole faces (WF), and that the percentage of correct sex decisions (WF) was 
higher than the percentage of sex decisions according to the left side of the composite 
face (LF decisions), we performed a repeated measures ANOVA on percent correct 
(WF) and percent LF decisions (composite faces) as repeated measure and group as 
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between-subject measure. To also test whether there was a RT difference between WF 
and composite faces, and that LF decisions were potentially faster than those for RF 
decisions, we performed a repeated measures ANOVA on mean RT for sex decisions 
with face type (correct decisions for WF, LF decisions, RF decisions) as repeated 
measure and group as between-subject measure. Post-hoc tests correcting for multiple 
comparisons were performed using Tukey HSD tests or within subjects contrasts. Effect 
sizes are reported for all ANOVA-results.  
We also tested whether, within each group, the tasks resulted in lateralized performance 
at all (Mohr, Krummenacher, et al., 2005; Mohr, et al., 2006) using conventional 
laterality indices (J. C. Marshall, Caplan, & Holmes, 1975). In general terms, this would 
mean that inferior performance is subtracted from superior performance, and that this 
difference is divided by its sum. Accordingly, positive values indicate an advantage of 
the normally dominant hemisphere (LDT: LH; FDT: RH), and negative values an 
advantage of the normally sub-dominant hemisphere. In order to obtain indices that 
would be comparable in this respect, the indices for i) accuracy in the LDT, and ii) 
reaction times in the FDT was (RVF–LVF)/ (LVF+RVF)*100, while the indices for 
reaction times in the LDT was (LVF–RVF)/ (LVF+RVF)*100. For accuracy in the FDT, 
we determined only percent LF decisions (as LF and RF decisions added up to 100%, 
including RF decisions and was deemed redundant). These indices were subjected for 
each group separately to one sample t–tests against chance level.  
Finally, in order to establish an effect of schizotypy over and above smoking status or 
nicotine dependence on hemispheric asymmetry, we performed multiple stepwise 
regressions as follows. Group status and nicotine dependence scores were entered in the 
first step, UnEx scores, CogDis scores and IntAn scores in the second step, and the 
interaction between the schizotypy subscales and smoking status or FTND scores, 
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respectively, in the last step. Thus, three blocks of predictors were entered in nested 
blocks, meaning that each subsequent block contained all prior predictors and the 
additional predictors from the current block. Presentation of results however will only 
include the new predictors entered, for economy of presentation. The full model can be 
found in the Appendix of this dissertation (see Tables 23-24). Because all tolerance 
values were above .2 (Menard, 1995), and all independent variables were mean-
centered, multi-collinearity between the independent variables was considered 
negligible. The dependent variables were i) percent index for the LDT and ii) RT-
indices for the LDT and FDT separately. However, to account for a potentially different 
contribution of each hemisphere to decreased hemispheric asymmetry (Mohr, 
Krummenacher, et al., 2005; Sommer, et al., 2001), additional separate stepwise 
regression analyses were conducted with iii) correct word recognition in the LVF and 
RVF, iv) RTs for correct lexical decisions in the LVF and RVF, v) percent LF decisions 
and percent correct sex decisions for WF, and vi) RTs for LF decisions, RTs for RF 
decisions, and RTs for correct WF decisions. Kolmogorov–Smirnov tests for the 
smokers and non-smokers separately revealed normal distribution for all behavioural 
measures and questionnaire scores. All p-values were two-tailed and the α-level was set 
at .05, unless otherwise stated. 
 
4. Results 
Participants 
After removal of LDT data of one participant due to erroneous usage of the three 
response keys, unpaired t-tests showed that smokers and non-smokers did not differ for 
age, handedness scores, UnEx scores, CogDis scores, and IntAn scores (Table 2). 
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Average schizotypy scores across groups were lower (UnEx: 6.15 ± 4.44, CogDis: 9.20 
± 4.68, IntAn: 4.80 ± 2.94) than those reported from a representative comparison 
sample (Mason & Claridge, 2006). In smokers and non-smokers, schizotypy scores 
were unrelated (all p-values > .20), apart from significant positive correlations between 
UnEx and CogDis scores (non-smokers: r=.62, p < .01; smokers: r = 0.63, p < .01). 
FTND scores were within normal ranges (Table 2) for an unselected group of smokers 
(Fagerström et al., 1996), and were unrelated with schizotypy scores (all p-values > 
.20). 
Table 2. Demographic variables of the study population. Presented is age (in years), 
handedness scores, schizotypy scores, and Fagerström test for nicotine dependence 
scores for smokers (n = 20) and non-smokers (n = 20) separately. Results (t) of the 
unpaired t-tests (df = 37) are given together with the respective p-values (p). 
Variables Smoker 
Mean ± SD (range) 
Non-Smoker 
Mean ± SD (range) t p 
Age 22.09 ± 1.92 (19 - 28) 21.59 ± 1.09 (18 - 23) 1.03 0.31 
Handedness 11.08 ± 0.94 (9 - 12) 11.28 ± 0.72 (10 - 12) -0.76 0.45 
UnExª 6.65 ± 5.08 (0 - 16) 5.65 ± 3.75 (0 - 14) 0.71 0.48 
CogDis
b
 8.75 ± 4.93 (2 - 17) 9.65 ± 4.49 (1 - 19) -0.60 0.55 
IntAn
c
 3.95 ± 2.19 (0 - 9) 5.65 ± 3.38 (1 - 12) -1.89 0.07 
FTND
d
 1.40 ± 1.57 (0 - 5) n/a n/a n/a 
Note: ª Unusual Experiences; 
b 
Cognitive Disorganization; 
c 
Introvertive Anhedonia; 
d 
Fagerström Test for Nicotine Dependence 
  
Lateralized performance in smokers and non-smokers 
(1) LDT 
The repeated measures ANOVA on percent accuracy showed a significant main effect 
for visual field (F [1, 37] = 2.16, p < .001; partial η2 = .35) with performance being 
superior for the RVF than LVF (Table 3). The remaining comparisons (main effect for 
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group: F [1, 37] = 0.46, p = .50, partial η2 = .01; interaction between group and visual 
field: F [1, 37] = 0.67, p = .42, partial η2 = .02, Table 3) were both not significant. The 
analogue ANOVA on mean RT revealed no significant main effects (visual field: F [1, 
37] = 1.40, p = .25, partial η2 = .04; smoking group: F [1, 37] = 0.80, p = .38, partial η2 
= .02), and no significant interaction between smoking group and visual field (F [1, 37] 
= 1.00, p = .33, partial η2 = .03). Single t-tests against zero for the laterality indices 
were significant for percent accuracy, but not RT, for the whole sample (percent 
accuracy: t [38] = 4.65, p < .001; RT: t [38] = 0.88, p = .38, Table 3), smoker (percent 
accuracy: t [19] = 2.87, p = .01; RT: t [19] = 0.06, p = .95, Table 3), and non-smoker 
(percent accuracy: t [18] = 3.67, p < .01; RT: t [18] = 1.02, p = .32, Table 3), separately. 
The positive laterality indices point to a RVF advantage (and thus a LH advantage) in 
all instances.  
(2) FDT 
The repeated measures ANOVA on percentage accuracy showed a main effect for face 
type (WF, LF decisions) indicating that percent correct sex decisions for WF was higher 
than the proportion of LF decisions (F [1,38] = 222.45, p < .001, partial η2 = .85, Table 
3). The interaction between face type and group (F [1, 38] = 0.24, p = .63, partial η2 = 
.01) and the main effect for group (F [1, 38] = 2.35, p = .13, partial η2 = .06) were not 
significant. The repeated measures ANOVA on mean RT for sex decisions with face 
type (correct decisions for whole faces, LF decisions, RF decisions) as repeated measure 
(see also data analysis section) showed a significant main effect for face type (F [2,37] 
= 41.85, p < .001, partial η2 = .52). Post-hoc within-subjects contrasts showed 
comparable RTs for LF and RF decisions (F [1, 38] = 2.29, p = .14, partial η2 = .06), 
but faster responses for WF as compared to both LF (F [1, 38] = 48.42, p < .001, partial 
η2 = .56) and RF (F [1, 38] = 62.12, p < .001, partial η2 = .62) decisions (Table 3). The 
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main effect for smoking group (F [1, 38] = 0.45, p = .51, partial η2 = .01), and the 
interaction were both not significant (F [2, 37] = 0.42, p = .65, partial η2 = .01).  
Table 3. Mean (SD) lateralized task performance for the total sample (LDT
a
: n = 39, 
FDT
b
: n = 40), smoker (LDT: n = 20, FDT: n = 20) and non-smoker (LDT: n = 19; 
FDT: n = 20) separately. 
Variables All Non-smoker Smoker 
  Mean SD Mean SD Mean SD 
LDT
 
 LDT LVF
c
 %
d
 54.06 19.57 51.21 19.91 56.77 19.35 
 LDT RVF
e
 % 69.02 12.99 68.97 12.75 69.06 13.56 
 LDT NoW
f
 % 43.70 20.58 48.03 21.16 39.58 19.66 
 LDT index
g
 % 14.01 18.81 16.95 20.15 11.22 17.50 
 LDT LVF RT 680.33 182.55 714.04 198.50 648.30 164.65 
 LDT RVF RT 654.83 149.30 665.98 146.05 644.23 155.34 
 LDT NoW RT 936.55 209.41 945.00 229.60 928.51 193.97 
 LDT index RT 1.47 10.44 2.91 12.38 0.11 8.30 
FDT
 
 FDT LF
h
 % 54.38 9.72 53.00 8.54 55.75 10.81 
 FDT WF
i
 % 86.94 11.27 84.50 9.95 89.38 12.22 
 FDT LF RT 702.04 167.42 716.64 157.29 687.45 179.84 
 FDT RF
j
 RT 724.13 182.22 732.36 174.59 715.91 193.73 
 FDT WF RT 582.80 110.03 606.15 107.75 559.46 109.97 
 FDT index RT 1.40 5.95 0.84 4.83 1.96 6.98 
Note: 
a 
Lexical decision task; 
b 
Facial decision task; 
c 
Left visual field; 
d 
Percentage 
correct; 
e 
Right visual field; 
f 
Two non words displayed on either side of the screen; 
g
 
Laterality index; 
h 
Left face decisions;
 i
 Whole face decisions; 
j
 Right face decisions 
 
For the whole sample, a single t-test against chance level (50%) for percent LF 
decisions was significant (t [39] = 2.85, p < .01), but not for a single t-test against 
chance level (0) for the RT laterality index (t [39] = 1.49, p = .14, Table 3). Analogue t-
tests for the groups separately showed no significant bias for non-smokers (percent LF 
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decisions: t [19] = 1.57, p = .13; RT index: t [19] = 0.78, p = .45, Table 3), but a 
significant LF decision bias in smokers for percent LF decisions (t [19] = 2.38, p = .03; 
RT index: t [19] = 1.26, p = .22, Table 3). Percent LF decisions above 50% represent a 
LF bias (and by inference point to a RH dominance in the FDT).  
Multiple regression analyses using smoking status as a predictor variable 
Hierarchical multiple regression analyses with Group (smokers, non-smokers) entered 
in the first block (Step 1), schizotypy subscales in the second block (Step 2) and the 
interaction between group and schizotypy subscales in the third block (Step 3, see also 
data analysis section) were conducted to evaluate the variance contributions of 
schizotypy as a predictor of hemispheric asymmetry on top of smoking status. Since 
multiple comparisons were run, we will only focus on significant R²-changes (all other 
results see Table 4-7), and for economy of presentation of nested block multiple 
regression analyses we will present only the final block added in each model (for the 
full model please see Tables 23-24 in the Appendix).  
(3)  LDT 
Results showed that group status alone (Step 1) did not significantly predict variance in 
any of the outcome variables. Adding schizotypy subscale scores (Step 2) improved the 
model for the RT index, and RVF RT (Table 4). In both cases, increasing CogDis scores 
predicted a decrease in the RT-index, likely resulting from a significant increase in RVF 
RTs (Table 4). Adding the interaction terms in the third block (Step 3) did not improve 
the regression model significantly (Table 4).  
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Table 4. Beta-weights and ΔR² for the LDTa outcome variables for the whole sample 
accounting for smoking status.  
  Percentage correct RT 
Steps 
regression 
Independent 
variables LVFf RVFg Indexh LVF RVF Index 
Step 1:  Group (SM, nSMb) 0.14 0.00 -0.15 -0.18 -0.07 -0.14 
Smoking 
status ΔR² 0.02 0.00 0.02 0.03 0.01 0.02 
Step 2:  UnExc 0.17 0.18 -0.07 -0.05 -0.13 0.12 
Schizotypy CogDisd 0.16 -0.38
┼
 -0.33 0.09 0.55** -0.51* 
 IntAne -0.11 0.13 0.18 -0.02 -0.12 0.13 
 ΔR² 0.09 0.10 0.15 0.00 0.23* 0.20* 
Step 3:  Group*UnEx -0.05 0.19 0.21 -0.04 0.01 -0.05 
Interaction  Group*CogDis 0.02 -0.10 -0.10 0.18 0.05 0.20 
smoking 
status  Group*IntAn -0.04 -0.06 -0.01 0.27 0.13 0.26 
and 
schizotypy ΔR² 0.00 0.02 0.03 0.10 0.02 0.09 
 R² total 0.11 0.12 0.20 0.13 0.25 0.31
┼
 
 Adjusted R² total -0.09 -0.08 0.02 -0.06 0.08 0.16
┼
 
┼
 p≤.10; * significant at p≤.05; ** significant at p≤.01; *** significant at p≤.001 
Note: 
a
 Lexical decision task; 
b
 SM=smoker, nSM= non-smoker; 
c
 Unusual experiences; 
d
 Cognitive disorganization; 
e
 Introvertive Anhedonia; 
f 
Left visual field; 
g
 Right visual 
field;
 h
 Laterality index 
 
(4) FDT 
The comparable hierarchical multiple regression analyses for the FDT (see also 2.3) 
showed that group status alone (Step 1) did not predict variance in any of the outcome 
variables (Table 5). Adding schizotypy subscale scores (Step 2) did not improve the 
model (Table 5). Adding the interaction terms in the third block (Step 3) improved the 
overall model for WF %. This improvement resulted from a significant interaction 
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between group and IntAn scores (Table 5). Post-hoc regressions for each group 
separately including only IntAn as a predictor variable revealed that increasing IntAn-
scores predicted a decrease in WF% in non-smokers only (non-smokers: R²= .47, β= -
.69, p< .001; smokers: R²= .04, β= .21, p= .37).  
Table 5. Beta-weights and ΔR² for the FDTa outcome variables for the whole sample 
accounting for smoking status. 
┼ p≤.10; * significant at p≤.05; ** significant at p≤.01; *** significant at p≤.001 
Note: 
a
 Facial decision task; 
b
 SM=smoker, nSM= non-smoker; 
c
 Unusual experiences; 
d
 
Cognitive disorganization; 
e
 Introvertive Anhedonia; 
f 
Left face decisions; 
g
 Whole face 
decisions; 
h
 Right face decisions;
 i
 Laterality index 
 
 
  
Percentage 
correct RT 
Steps 
regression 
Independent 
variables LFf WFg LF RFh WF Indexi 
Step 1:  Group (SM, nSMb) 0.14 0.22 -0.09 -0.05 -0.22 0.10 
Smoking 
status ΔR² 0.02 0.05 0.01 0.00 0.05 0.01 
Step 2:  UnExc -0.16 -0.20 -0.17 -0.23 -0.02 -0.24 
Schizotypy CogDisd -0.06 0.18 0.44* 0.49* 0.41* 0.18 
 IntAne -0.30 -0.28
┼
 0.06 0.00 0.05 -0.15 
  ΔR² 0.13 0.10 0.14 0.15 0.16┼ 0.06 
Step 3:  Group*UnEx -0.18 -0.26 0.01 0.11 0.14 0.19 
Interaction  Group*CogDis 0.28 0.25 -0.11 -0.10 -0.07 -0.02 
smoking 
status  Group*IntAn -0.03 0.41* 0.44* 0.39* 0.18 -0.04 
and 
schizotypy ΔR² 0.05 0.19* 0.15┼ 0.13 0.04 0.03 
 R² total 0.20 0.33* 0.30
┼
 0.28 0.25 0.10 
 Adjusted R² total 0.03 0.19* 0.15
┼
 0.13 0.08 -0.10 
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Multiple regression analyses using nicotine dependence scores as a predictor variable 
(5) LDT  
The hierarchical multiple regression analysis with nicotine dependence scores (FTND) 
entered in the first block (Step 1), schizotypy subscales scores in the second block (Step 
2) and the interaction between group and schizotypy subscales scores in the third block 
(Step 3, see also data analysis section) were conducted to determine the effect of 
schizotypy on top of nicotine dependence within smokers. Again, since multiple 
comparisons were run, we will only focus on the significant R²-changes (all other 
results see Table 6). Results showed that FTND scores predicted 23.5% of the variance 
in RVF % (higher FTND scores predicted decreasing RVF %, Table 6). The addition of 
schizotypy subscale scores (Step 2) and the addition of the interaction terms (Step 3) did 
not improve the model (Table 6).  
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Table 6. Beta-weights and ΔR² for the LDTa outcome variables for smokers only 
accounting for nicotine dependence. 
  Percentage correct RT 
Steps 
regression 
Independent 
variables LVFf RVFg Indexh LVF RVF Index 
Step 1:  FTNDb -0.10 -0.48* -0.20 0.17 0.01 0.21 
Nicotine 
dependence ΔR² 0.01 0.23* 0.04 0.03 0.00 0.04 
Step 2:  UnExc 0.13 0.14 0.00 -0.08 -0.18 0.17 
Schizotypy CogDisd 0.21 -0.33 -0.40 0.22 0.59
┼
 -0.53
┼
 
 IntAne -0.13 0.01 0.12 0.30 0.05 0.46* 
  ΔR² 0.09 0.07 0.14 0.15 0.26 0.30 
Step 3:  FTND*UnEx -0.69* -0.27 0.47 0.48 0.32 0.26 
Interaction FTND*CogDis 0.05 -0.23 -0.16 -0.15 -0.15 0.06 
nicotine 
dependence  FTND*IntAn -0.26 -0.30 0.05 0.46 0.07 0.67* 
and schizotypy ΔR² 0.35 0.15 0.13 0.26 0.07 0.27┼ 
 R² total 0.44 0.45 0.31 0.44 0.33 0.61
┼
 
 
Adjusted R² 
total 0.12 0.13 -0.09 0.12 -0.07 0.38
┼
 
┼
 p≤.10; * significant at p≤.05; ** significant at p≤.01; *** significant at p≤.001 
 
Note: 
a
 Lexical decision task; 
b
 Fagerström Test for Nicotine Dependence; 
c
 Unusual 
experiences; 
d
 Cognitive disorganization; 
e
 Introvertive Anhedonia; 
f 
Left visual field; 
g
 
Right visual field;
 h
 Laterality index 
 
(6) FDT 
The comparable hierarchical multiple regression analyses for the FDT (see also 2.3) 
showed that FTND scores explained 26% of the variance in LF % (Model 1, Table 7); 
increasing FTND scores predicted an increase in LF %. The addition of schizotypy 
subscale scores (Step 2) did not improve the model. The interaction terms showed that 
the interaction between FTND scores and CogDis scores explained additional variance 
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in WF RTs. Median-splits were performed on FTND-scores and post-hoc regressions 
were conducted on WF RT and CogDis scores for the high- and low-scoring FTND 
groups separately. Increasing CogDis scores predicted slowed responding for WF in the 
low-FTND group only (Low FTND: R²= .65, β= .81, p< .01; high FTND: R²= .07, β= -
.27, p= .52). 
Table 7. Beta-weights and ΔR² for the FDTa outcome variables for smokers only 
accounting for nicotine dependence. 
  
Percentage 
correct RT   
Steps 
regression 
Independent 
variables LFf WFg LF RFh WF Indexi 
Step 1:  FTNDb 0.51* 0.36 -0.04 0.11 0.08 0.21 
Nicotine 
dependence ΔR² 0.26* 0.13 0.00 0.01 0.01 0.05 
Step 2:  UnExc -0.09 -0.33 -0.25 -0.16 0.13 -0.01 
Schizotypy CogDisd 0.06 0.27 0.31 0.34 0.31 0.11 
 IntAne -0.23 0.22 0.50* 0.41
┼
 0.24 -0.14 
 ΔR² 0.06 0.11 0.34┼ 0.28 0.28 0.02 
Step 3:  FTND*UnEx -0.44 0.09 0.27 0.02 0.09 -0.45 
Interaction FTND*CogDis 0.45 0.10 -0.60* -0.50
┼
 -0.72** 0.18 
nicotine 
dependence  FTND*IntAn 0.42 -0.14 -0.06 0.22 0.24 0.49 
and 
schizotypy ΔR² 0.19 0.03 0.21 0.21 0.40* 0.19 
 R² total 0.51 0.27 0.55 0.51 0.69* 0.26 
 Adjusted R² 
total 0.22 -0.15 0.28 0.23 0.50* -0.17 
┼
 p≤.10; * significant at p≤.05; ** significant at p≤.01; *** significant at p≤.001 
Note: 
a
 Facial decision task; 
b
 Fagerström Test for Nicotine Dependence; 
c
 Unusual 
experiences; 
d
 Cognitive disorganization; 
e
 Introvertive Anhedonia; 
f 
Left face decisions; 
g
 Whole face decisions; 
h
 Right face decisions;
 i
 Laterality index 
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5. Discussion 
A varying degree of illegal and legal drug consumption along the SSp might explain 
heterogeneous findings when investigating the link between schizotypy and 
neuropsychological performance (Archie, et al., 2007; Barnes, et al., 2006; de Leon, et 
al., 2002; Esterberg, et al., 2009; Gurpegui, et al., 2004; Jones & Fernyhough, 2009; J. 
H. Williams, Wellman, Allan, et al., 1996). In particular, it could be conjectured that 
neuropsychological impairments formerly associated with symptom dimensions are 
actually the result of drug use. We therefore investigated whether a reduced hemispheric 
asymmetry for function (language in the LH, visual face recognition in the RH) in 
schizotypy might result from nicotine consumption or an interaction between 
schizotypy and nicotine consumption. Irrespective of schizotypy and smoking status, we 
replicated the commonly observed RVF over LVF advantage for lexical decisions (e.g. 
Bourne, 2006; Mohr, Krummenacher, et al., 2005) reflecting the LH’s dominance for 
language processing. We also replicated the LF bias for composite faces (Butler & 
Harvey, 2006; Mason & Claridge, 1999; McClernon, et al., 2003) that reflects the RH 
dominance for visual face processing. When nicotine consumption and schizotypy were 
accounted for, we observed that i) nicotine consumption per se was unrelated to 
lateralized performance, ii) increasing nicotine dependence (FTND scores) seemed to 
predict a RH bias in both the LDT and FDT, and iii) CogDis seemed the only 
schizotypy dimension related to lateralized performance (increasing CogDis predicted a 
decreased LH language dominance and slowed responding for the sex of whole faces in 
individuals with low FTND scores). UnEx scores, on the other hand, were unrelated to 
lateralized task performance and elevated IntAn scores were related to a potentially 
more general visual face processing deficit.  
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Nicotine and lateralized performance 
The finding that general smoking status was unrelated to lateralized performance is in 
line with previous studies showing no difference in LDT performance between a group 
who received a DA agonist (Levodopa) and a group who received a placebo (Mohr, 
Krummenacher, et al., 2005; Mohr, et al., 2006). However, studies investigating the role 
of nicotine on task performance more directly found that transdermal nicotine patches 
(slow, constant nicotine application) provided to abstinent smokers stabilized LH 
language functions (Gentry, et al., 2000; McClernon, et al., 2003), and smoking a 
nicotine cigarette (fast, acute nicotine application) impaired lexical decisions for 
centrally presented words (Gentry, et al., 2000). McClernon et al. (2003) additionally 
observed that increasing nicotine dependence was related to improved performance in 
both hemispheres in a language memory task; unfortunately the authors did not test a 
RH-dominant task. In the present study we observed that increasing nicotine 
dependence (FTND scores) in smokers predicted decreasing word recognition 
performance in the RVF and an increasing LF decision bias (irrespective of schizotypy). 
This RH shift in hemispheric dominance as a function of nicotine dependence would 
support previous electroencephalography (McClernon, et al., 2003; Norton, et al., 1992) 
and positron emission tomography (M. Ernst, et al., 2001; Rose, et al., 2007) studies. 
Also, such a RH shift might reflect a general bias towards RH functioning with 
increasing drug dependence since higher consumption of one drug commonly predicts 
higher consumption of other drugs (Degenhardt, Hall, & Lynskey, 2001; Martinez-
Ortega, Jurado, Martinez-Gonzalez, & Gurpegui, 2006). In support of this possibility, 
the RH has been implicated in other forms of compulsive behaviours such as over-
eating (Regard & Landis, 1997; Uher & Treasure, 2005), gambling (Cilia et al., 2008; 
Regard, Knoch, Gutling, & Landis, 2003), and violent or antisocial behaviour 
II     Experiments: Nicotine, schizotypy and hemispheric asymmetry 
 
67 
 
(Mychack, Kramer, Boone, & Miller, 2001; Narayan et al., 2007). Given the structural 
and neurochemical dependence of the brain, it is not unreasonable to argue that transient 
short-term (Bachtold et al., 2001; Mohr, Michel, et al., 2005; Regard, Cook, Wieser, & 
Landis, 1994) or longer-term (Crinion & Leff, 2007; Raboyeau et al., 2008) inter-
hemispheric asymmetries might be influenced by neurochemical processes (e.g. Fink et 
al., 2008; Hausmann & Güntürkün, 2000; Mohr, Landis, et al., 2005). Accordingly we 
would predict even stronger relationships between hemispheric asymmetry and nicotine 
(or other forms of substance and non-substance) dependence when testing hemispheric 
asymmetry as a function of more severe dependencies. Nicotine dependence scores 
were relatively low in the current sample and several of our smokers had scores of zero 
that are indicative of being a “light” smoker (Etter, Duc, & Perneger, 1999).  
Schizotypy, nicotine and lateralized performance 
While our findings on nicotine dependence were promising, those relating to schizotypy 
subscales did not support our predictions.  Firstly, we found no relationship between 
UnEx scores and both hemispheric asymmetry (Kravetz, et al., 1998; Mason & 
Claridge, 1999) and nicotine dependence (Lopez, Maldonado, & Pueyo, 2001). A 
possible reason  might be our relatively low UnEx and CogDis scores (Table 2) when 
compared to those of a normative sample (Mason & Claridge, 2006); however, our 
nicotine dependence (Lopez, et al., 2001; Stavem, Røgeberg, Olsen, & Boe, 2008) and 
schizotypy scores (Nunn & Peters, 2001; Rawlings & Goldberg, 2001; Suzuki & Usher, 
2009) were comparable to previous studies. For instance, Lopez et al. (2001) reported 
elevated UnEx scores in smoking undergraduate psychology students compared to non-
smoking ones. In the current study schizotypy scores were comparable in the two 
smoking groups and were unrelated to nicotine dependence scores (Esterberg, et al., 
2007), although most authors report this link (Allan et al., 1995; Esterberg, et al., 2009). 
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Secondly, we found that increasing CogDis scores were related to a RH shift of 
function, i.e. a decreasing LH dominance for language and an increasing LF preference 
(together with slowed WF decisions). This might indicate that CogDis relates to 
impaired face recognition performance more generally and to impaired LH-language 
functions in particular. In line with our findings, a reduced LH language dominance as a 
function of CogDis has been reported previously (Claridge, et al., 1992; Kravetz, et al., 
1998; Suzuki & Usher, 2009) although independent studies would have also predicted a 
similar result for UnEx scores (Brugger, et al., 1993; Kravetz, et al., 1998; Mohr, 
Krummenacher, et al., 2005; Pizzagalli, et al., 2000; Suzuki & Usher, 2009). 
Questionnaires in several of these previous studies did not distinguish between positive 
schizotypy and CogDis (Brugger, et al., 1993; Mohr, Krummenacher, et al., 2005) and 
when schizotypy dimensions were separated, both scales related to a reduced LH 
language dominance (Kravetz, et al., 1998; Suzuki & Usher, 2009). CogDis is 
frequently considered to be a distinct dimension of positive schizotypy, but it is not yet 
known whether it has a stronger overlap with positive or negative symptoms (Kitamura, 
Okazaki, Fujinawa, Takayanagi, & Kasahara, 1998; McGorry, Bell, Dudgeon, & 
Jackson, 1998; Spitzer, 1993; Weinstein & Graves, 2001). A stronger positive 
correlation between CogDis and UnEx scores than between CogDis and IntAn scores 
seems common (Kravetz, et al., 1998; Mason, et al., 1995; Nunn & Peters, 2001; 
Rawlings & Goldberg, 2001; Tsakanikos & Reed, 2003). Moreover, a stronger 
relationship of CogDis compared to positive schizotypy, with language “impairments” 
has also been reported (Johnston, Rossell, & Gleeson, 2008; S. Moritz et al., 1999; 
Stefanis et al., 2006). Therefore, future studies will be required to disentangle the 
specific or combined role of CogDis on hemispheric asymmetry.  
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With regards to face processing, the effect of CogDis in the present study seemed rather 
general than hemisphere-specific. In past studies, positive schizotypy was related to a 
LF bias (Leonards & Mohr, 2009; Luh & Gooding, 1999) and a decreased LF bias 
(Mason & Claridge, 1999). Whether this might reflect a more general pattern of face 
processing deficits with increasing positive schizotypy has to investigated, but the 
consistent direction of regression coefficients (Table 5 and 7) and other reported forms 
of face processing difficulties in schizotypy (Laroi, D'Argembeau, Bredart, & van der 
Linden, 2007) would support a more general face processing deficit with enhanced 
CogDis. Interestingly, the decrease in WF-processing seemed particularly relevant to 
individuals with low nicotine dependence who might suffer from generally slowed 
visual face processing abilities. If this were the case, enhanced nicotine dependence 
should attenuate a relationship between CogDis and face processing. Studies 
investigating nicotine use in relation to schizotypy subscales are few. Esterberg et al. 
(2007) found that smoking related to enhanced SPQ scores (Raine, 1991) in relatives of 
patients with schizophrenia but not in controls. Further, Esterberg et al. (2009) reported 
that enhanced cognitive disorganization (again SPQ) were predictive of cigarette use in 
a sample of healthy controls. Since increasing nicotine dependence scores in our sample 
were predictive of a RH-shift of function (M. Ernst, et al., 2001; McClernon, et al., 
2003; Norton, et al., 1992; Rose, et al., 2007) it is possible to argue that increasing 
nicotine consumption might stabilize RH-functions, particularly in individuals with high 
CogDis scores. In order to test this prediction individuals with higher nicotine 
dependence would have to be tested. 
The findings relating to IntAn, a negative schizotypal feature, were unexpected since 
negative schizotypy has previously been a largely insensitive marker for hemispheric 
asymmetry (see Liouta, et al., 2008; Suzuki & Usher, 2009 for recent accounts). 
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Performance in the LDT (none of the dependent LDT measures were related to IntAn 
scores), but not in the FDT, would support this notion. In our non-smoking sample, 
increasing IntAn scores were predictive of a decrease in WF processing.  Luh and 
Gooding (1999) observed that participants endorsing high positive schizotypal features 
were left-biased for faces, but those with high social anhedonia scores lacked this LF 
bias, which suggests a bimodal distribution (i.e., either showing a strong LF or RF bias) 
(Leonards & Mohr, 2009). In two different samples, UnEx scores, but not CogDis 
scores, predicted a decreased LF bias for emotional composite faces (Mason & 
Claridge, 1999). In one of these studies, IntAn scores in women predicted a decreased 
LF bias. Importantly, none of the studies reported on WF performance (Luh & Gooding, 
1999; Mason & Claridge, 1999) and our own findings would indicate that impaired 
performance in the FDT with increasing IntAn scores reflects a more general social 
and/or facial processing impairment in non-smokers (Haxby, Hoffman, & Gobbini, 
2000; Kanwisher, McDermott, & Chun, 1997; Onitsuka et al., 2006; Pinkham, 
Hopfinger, Ruparel, & Penn, 2008), particularly given that non-smokers tended to score 
higher on IntAn as compared to smokers. 
Limitations to the study 
While we pre-selected participants for their right-handedness, right-handedness seems 
reduced in schizophrenia (Dragovic & Hammond, 2005) and schizotypy (Somers, 
Sommer, Boks, & Kahn, 2009) and, as such, this pre-selection might have compromised 
our ability to investigate a population that is truly psychosis-prone. While valid as a 
potential limitation of the current study, this pre-selection procedure is common practice 
in the study of hemispheric asymmetry in schizotypy (e.g. Mason & Claridge, 1999; 
Mohr, Krummenacher, et al., 2005; Suzuki & Usher, 2009) and generally in the study of 
hemispheric asymmetry (Bourne, 2006) since the testing of only right-handed 
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participants reduces the number of potential “confounds”, i.e. that of a reduced 
hemispheric asymmetry due to handedness. However, because of the important role of 
reduced right-handedness to both enhanced schizotypy and reduced hemispheric 
asymmetry, it only seems reasonable to suggest that future studies should investigate a 
more representative sample that is unselected for handedness (or actually select a wider 
range of hand preferences (e.g. Shaw, et al., 2001; Somers, et al., 2009).  
Another limitation was our control of nicotine consumption. For instance, our smoking 
group consisted of a group of light smokers rather than heavy smokers for whom 
nicotine influences on behaviour might have been more pronounced (Myers, Taylor, 
Moolchan, & Heishman, 2008). Some previous studies directly challenged nicotine 
availability by providing nicotine patches/nicotine cigarettes (Gentry, et al., 2000; 
McClernon, et al., 2003). Nicotine exerts differential cognitive effects depending on 
whether administration is acute or chronic (M. Ernst, et al., 2001; Jacobsen, et al., 2005; 
McClernon, et al., 2003; Rose, et al., 2007). Additionally, nicotine activates receptors in 
different brain regions depending on the amount of nicotine exposure (e.g. Kumari & 
Postma, 2005); for instance, in an EEG study higher nicotine doses seemed to result in a 
LH shift of EEG power (i.e., decreased LH α-power and increased RH β-power) 
(Norton, et al., 1992). Nicotine dependence was relatively low in our study (Esterberg, 
et al., 2007; Etter, et al., 1999), yet within normal ranges for an unselected group of 
smokers (Heatherton, et al., 1991). Future research would certainly benefit from 
comparing chronic and acute nicotine exposure as well as administering varying 
amounts of nicotine directly. 
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Summary 
In sum, we tested whether nicotine consumption might be a better predictor of 
hemispheric asymmetry than schizotypy in 40 right-handed men. We were particularly 
interested in whether attenuated hemispheric asymmetry would be more evident as a 
function of smoking status and nicotine dependence than (positive) schizotypy, or its 
interaction. Our findings partially support this idea. Increasing nicotine dependence (but 
not smoking status per se) was related to a RH shift in hemispheric function for both a 
left- and right-hemisphere dominant task. These results indicate that nicotine use is 
relevant to the study of laterality and schizotypy, and might also be pertinent to the 
study of compulsive/impulsive behaviour generally. With regards to schizotypy, CogDis 
seemed to be a more promising schizotypal dimension than UnEx in predicting 
attenuated language dominance (irrespective of smoking status). IntAn seemed to relate 
to face processing impairments more generally, particularly in non-smokers. Given our 
smokers’ relatively low nicotine dependence and schizotypy scores, future studies 
should test individuals consuming higher doses of nicotine, and control more directly 
how much (e.g., nicotine dosage), in which form (slow: patches, fast: inhalation) and 
when (time before testing) nicotine is consumed with regards to testing. Such future 
studies might help to further elucidate the role of drug use on links between behaviour 
and schizotypal symptoms as potential indicators of psychosis risk or psychosis 
protection. As a final note, most previous studies in the area reported on either a LH or 
RH dominant task (but not both). If we had only used the LDT, we would have found 
“evidence” for a reduction in LH language functions with increasing FTND scores, but 
no overall RH shift in function.  
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Cannabis, schizotypy and cognitive functioning 
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Herzig, D. A., Nutt, D. & Mohr, C. (submitted). Does cannabis use impair frontal lobe 
functioning? The role of alcohol, nicotine, and schizotypy. 
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1. Abstract 
The prevalence of cannabis use is particularly high amongst young adults and early 
onset of cannabis use is associated with an earlier onset of psychotic illnesses. However, 
most people using cannabis will not develop psychotic disorders, so other risk factors 
must exist that render individuals more vulnerable to the adverse consequences of 
cannabis use. Two potential candidates are schizotypy and polydrug (including licit 
drug) use.  In high schizotypes, cannabis and licit drug use is elevated, and they show 
similar cognitive attenuations as those suffering from psychotic illness and 
cannabis/polydrug use, e.g. in frontal lobe functioning. Therefore, attenuation of frontal 
lobe functioning may be a cognitive marker of pathology, but given the higher 
substance use rates amongst high schizotypes cannabis or licit drug use may have 
influenced previous findings along the schizophrenia spectrum. To test this idea, verbal 
short-term and working memory, cognitive flexibility, schizotypy and drug use were 
assessed in 35 pure cannabis users and 48 non-users. While pure cannabis use related to 
impairments in verbal short-term memory, working memory was influenced by alcohol 
use instead. As schizotypy seemed rather unrelated to performance in healthy controls, 
the results suggest that substance use, and licit drug use in particular, is an important 
variable to consider in future schizotypy studies. Additionally, the heterogeneity of 
findings for the specific cognitive tasks may reflect the difficulty of identifying 
consistent cognitive markers sensitive to pathological changes. Using composite scores 
of test batteries and including other potentially influential factors are proposed as 
possible solutions. 
 
Keywords: Polydrug use, licit drug use, cognition, working memory, verbal short term 
memory, cognitive flexibility, schizotypy, psychosis-proneness  
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2. Introduction 
Cannabis sativa (marijuana) is currently the most widely used non-legal substance in 
Europe (EMCDDA 2010 report). About 23 million Europeans have used cannabis in the 
last year, which corresponds to an average of 6.8 % of all 15- to 64-year-olds 
(EMCDDA, 2010 report). Additionally, an estimated 12.5 million Europeans used the 
drug in the last month prior to the interview, or 3.7 % (on average) of all 15- to 64-year-
olds. Among the European 15- to 24-year-olds, estimated average prevalence rates are 
even higher ranging from 16 % for reported last year use to 8.4 % for reported last 
month use (EMCDDA, 2010 report). In Switzerland, the rates of young cannabis users 
that meet DSM-IV criteria for cannabis dependence is also quite high (see Cascone, 
Zimmermann, Auckenthaler, & Robert-Tissot, 2011 for overview). This relatively 
elevated prevalence rate amongst young adults is concerning when considering that 
cannabis use might go along with both cognitive attenuation (Barkus & Murray, 2010; 
Fernández-Serrano, et al., 2011) and an increased risk for mental health problems, in 
particular psychosis (Arseneault et al., 2002; Casadio, et al., 2011; Schimmelmann, et 
al., 2011; van Os, et al., 2002; Zammit, et al., 2002). Yet, not all studies unequivocally 
subscribe to these disconcerting messages, and other factors may influence the adverse 
consequences associated with cannabis use [see meta-analysis by Moore et al (2007)].  
In the present study, our major focus was on the supposedly negative implications of 
cannabis use on cognitive functioning while accounting for associated licit drug use and 
individuals’ schizotypy for the following reasons. Relatively pure cannabis users are 
reported to have attenuated frontal lobe functioning, e.g. immediate and delayed 
memory and reasoning (Fried, et al., 2005), verbal short-term memory (Wagner, et al., 
2010), and mental flexibility (see also Fernández-Serrano, et al., 2011; Lundqvist, 2005 
for overview; Pope & Yurgelun-Todd, 1996). Relatively common, researchers report on 
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the use of other illicit drugs, or exclude participants who used these (Fernández-Serrano, 
et al., 2011). Less common is the control for licit drugs such as alcohol and tobacco, 
although use of both drugs is elevated in cannabis users (see also Bélanger, Akre, 
Kuntsche, Gmel, & Suris, 2011; Fernández-Serrano, et al., 2011; Pape, Rossow, & 
Storvoll, 2009). When considering licit drug use in the just mentioned studies, it is 
observed that licit substance use (e.g. nicotine and alcohol use) was occasionally (Fried, 
et al., 2005; Pope & Yurgelun-Todd, 1996), but not always (C. J. A. Morgan, et al., 
2010; Skosnik, et al., 2001) controlled for (either statistically, or by excluding 
participants who report additional drug use). Other groups asked participant to abstain 
from additional (licit and illicit) drug use before testing (Block & Ghoneim, 1993), or 
excluded participants reporting excessive alcohol use/ dependence (Pope, Gruber, 
Hudson, Huestis, & Yurgelun-Todd, 2001; Solowij et al., 2002). Alcohol, however, 
might result in cognitive attenuation much in the same way as suggested for cannabis 
involving functions such as verbal memory (Parada et al., 2011; Petros, Kerbel, 
Beckwith, Sacks, & Sarafolean, 1985; Poltavski, Marino, Guido, Kulland, & Petros, 
2011), cognitive flexibility (Guillot, Fanning, Bullock, McCloskey, & Berman, 2010; 
Lyvers & Tobias-Webb, 2010) and working memory (Crego et al., 2010; Weissenborn 
& Duka, 2003; Yücel, Lubman, Solowij, & Brewer, 2007). The same can be said for 
nicotine with negative implications on working memory (M. Ernst, et al., 2001; 
Jacobsen, et al., 2005), verbal memory (Dunne, et al., 1986; Jacobsen, et al., 2005; 
Poltavski & Petros, 2005), and cognitive flexibility (Nesic, Rusted, Duka, & Jackson, 
2011). Given the comparable implications of cannabis, alcohol, and nicotine on 
cognitive functioning, it is not possible to claim that impairments are specific to 
cannabis use.  
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In the present study, we also account for individuals’ schizotypy, a thinking style that is 
qualitatively similar, but quantitatively attenuated to the one reported from psychotic 
patients. The schizotypy approach assumes that schizophrenia(-like) symptoms exist on 
a spectrum with severest symptoms being found in patients with schizophrenia and 
mildest sub-clinical symptoms being experienced in the least affected schizotypal 
individual in the general population (Meehl, 1962). Schizotypy is typically assessed in 
the general population using self-report questionnaires (L. J. Chapman, et al., 1994; 
Launay & Slade, 1981; Mason, et al., 1995; Raine, 1991; Rust, 1988; Stefanis et al., 
2002; Venables, Wilkins, Mitchell, Raine, & Bailes, 1990) with high scores indicating 
enhanced psychosis-proneness (L. J. Chapman, et al., 1994; Gooding, et al., 2005). 
Support for the spectrum idea of schizophrenia comes from studies showing that the 
symptom dimensions proposed for patient populations can be replicated in the general 
population as revealed by a three-factor solutions consisting of positive schizotypy (e.g. 
cognitive-perceptual distortions, unusual experiences, magical thinking, paranoia etc.), 
negative schizotypy (e.g. social/physical anhedonia) and disorganization (e.g. odd 
speech and behavior, difficulties with decision-making and/or attention, etc.; Raine, 
1991, 2006). Further support for the spectrum idea comes from studies showing that 
high schizotypes yield relatively impaired frontal lobe functioning (comparable with 
patient populations) as assessed from tasks on working memory (Park & McTigue, 
1997; Pflueger, et al., 2007), verbal fluency (Tsakanikos & Claridge, 2005; Koychev et 
al., 2011), cognitive flexibility (Giraldez, et al., 1999), selective attention (Pflueger, et 
al., 2007) and verbal memory (Langdon & Coltheart, 2004; Simon, et al., 2007).  
 
In the present context, we accounted for schizotypy, and by inference the schizophrenia 
spectrum,  because individuals scoring high on schizotypy reveal an elevated substance 
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use of cannabis (Barkus & Lewis, 2008; A. S. Cohen, et al., 2011; Esterberg, et al., 
2009; Fridberg, et al., 2011; Skosnik, et al., 2001), but also of nicotine (Esterberg, et al., 
2009; Larrison, Briand, & Sereno, 1999), and alcohol (Esterberg, et al., 2009; Larrison, 
et al., 1999). This higher drug use is relevant for the schizophrenia spectrum, because 
patients as compared with controls also consume higher amounts of cannabis (Barkus & 
Murray, 2010; Zammit, et al., 2002), nicotine (de Leon, et al., 2002; Kumari & Postma, 
2005), and alcohol (Cantor-Graae, et al., 2001; Gregg, Barrowclough, & Haddock, 
2007; Mastrigt, Addington, & Addington, 2004). Given that drug use might have 
negative implications on the same cognitive functions also attenuated along the 
schizophrenia spectrum, and that more drugs are consumed along the schizophrenia 
spectrum, we cannot exclude the possibility that any influence cannabis might have on 
cognition is associated with individuals’ higher schizotypal features. The most likely 
schizotypal symptom dimensions are cognitive disorganization (Barkus & Lewis, 2008; 
A. S. Cohen, et al., 2011; Esterberg, et al., 2009) and / or positive schizotypal features 
(Compton, Chien, & Bollini, 2009; Skosnik, et al., 2001; Verdoux, Sorbara, Gindre, 
Swendsen, & van Os, 2003), with predictions for negative schizotypy being hindered by 
heterogeneous findings (Bailey & Swallow, 2004; A. S. Cohen, et al., 2011; Compton, 
Chien, et al., 2009; Mass, Bardong, Kindl, & Dahme, 2001; Skosnik, Park, Dobbs, & 
Gardner, 2008). To note, the few studies that would provide a hint on the role of 
schizotypy on the link between cannabis use and cognition did not report on a potential 
effect of licit drug use (C. J. A. Morgan, et al., 2010; Skosnik, et al., 2001), e.g. nicotine 
and alcohol use. 
The present study investigated the link between cognitive attenuation and cannabis use 
in pure cannabis users (CU) and non-using controls (nCU) accounting for the potential 
additional influence of licit drug use (alcohol, nicotine) and individuals’ schizotypal 
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features. We expected CU to reveal cognitive attenuation as compared to nCU, but also 
that any cognitive attenuation might be associated with licit drug use, likely to be a 
more important factor than schizotypy (Herzig & Mohr, in press; Herzig, et al., 2010).  
3. Method 
Participants 
Participants were recruited via advertisements distributed in the local University 
departments and venues, the University of Bristol ‘Experimental Hours’ scheme for 
course credits, and local websites (‘Gumtree’). We recruited 83 healthy native English 
speaking participants, 35 of which were CU (23 males) and 48 nCU (20 males). 
Participants either received monetary compensation for travel expenses or course credits 
for taking part. 
Screening 
Prior to study inclusion, participants were made aware that they would have to hand in a 
urine sample for drug screening, and were then asked about regular illegal substance use 
(apart from cannabis) within two weeks prior to testing.  They were also asked about 
their cannabis use habits in the past 30 days. The participants were kept unaware about 
the spectrum of drugs assessed with the urine test, which measured only THC-content. 
This was done to encourage volunteers to reveal use of other drugs before the testing, 
and verified the regularity of cannabis use as indicated by self-report. Participants were 
excluded when reporting additional illicit drug use (apart from cannabis use). CU with 
negative drug tests were classified as occasional users if it matched their self-report. If 
the self-report deviated from their urine test, their data were removed from further 
analysis. The nCU were healthy controls screened for regular nicotine use in the past 
three months. In both groups, people were excluded if they reported excessive alcohol 
II     Experiments: Cannabis, schizotypy and cognitive functioning 
81 
 
use (>50 units of alcohol/week for men, >35 units of alcohol/women), neurological, 
psychological or psychiatric history, or problems with their visual system (including 
dyslexia). 
Procedure 
Participants were firstly screened by means of the procedure outlined above. After this, 
participants had to come into the Department of Experimental Psychology for the 
testing session, which lasted about an hour. The CU were asked to abstain from 
cannabis use at least 2h prior to testing and nicotine use 30min prior to testing. All 
participants were given an information sheet before signing the consent form which 
informed them about the aims and procedure of the experiment. Afterwards, they 
handed in a urine test and then the testing session started. Subjects were firstly given the 
questionnaires on detailed drug use and schizotypy, and then performed the frontal lobe 
tasks outlined below
1
. The order of these tasks was randomized to avoid habituation- 
and/or fatigue effects. Finally, participants were debriefed and reimbursed for their time. 
Questionnaires 
(1) Schizotypy 
The Oxford-Liverpool Inventory of Feelings and Experiences (O-LIFE; Mason & 
Claridge, 2006; Mason, et al., 1995) is a self-report instrument containing 159 
questions. Positive schizotypy is assessed by 30 items pertaining to Unusual 
Experiences (UnEx, maximum score 30, including items such as ‘Are your thoughts 
sometimes so strong that you can almost hear them?’), negative schizotypy is assessed 
by 27 items pertaining to Introvertive Anhedonia (IntAn, maximum score 27, including 
items such as ‘Do you prefer watching television to going out with people?’), and 
                                                 
1
 We also assessed laterality with tachistoscopic lexical and facial decision tasks. For economy of 
presentation, these findings will be presented elsewhere, but data and findings from these tasks can be 
requested from the corresponding author. 
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Cognitive Disorganization is assessed by 24 items (CogDis, maximum score 24, 
including items such as ‘Are you easily confused if too much happens at the same 
time?‘). Finally, 23 items assess Impulsive Nonconformity (ImpNC, maximum score 
23), which does not represent a schizotypy dimension (Mason, et al., 1995), but will be 
accounted for in the present study because of the strong link between impulsivity and 
addiction (Crews & Boettiger, 2009).  Normative values can be found in Mason et al. 
(2006; 1995). 
(2) Drug questions 
Participants were asked to fill in drug use information, e.g. their alcohol, nicotine, 
cocaine, cannabis and amphetamine use. The questions were taken from the national 
household  survey on drug abuse(United States Department of Health and Human 
Services, 1998),  which asks detailed data of respondents’ prior drug use, with 
assessment of lifetime, past year and past month drug use assessed. Additionally, it taps 
into the DSM-IV criteria for drug dependence in the past 12 months by asking about 
e.g. time spent to obtain, use, or recover from the drug, tolerance (marked increase in 
amount; marked decrease in effect), substance taken in larger amount and for longer 
period than intended, persistent desire or repeated unsuccessful attempt to quit, and 
important social, occupational, or recreational activities given up or reduced due to drug 
use. Additionally, it enquires about psychological and physical problems caused by the 
drug in question (e.g. withdrawal symptoms such as depression). For each of these 
symptoms indicated in the past 12 months, participants received 1 point (maximum 
score 7), and higher values indicate higher substance dependence.  
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Behavioural measures 
(3) Frontal lobe functioning2 
i. Trail making task (TMT) 
The TMT is used to test executive functioning. It was originally part of the Army 
Individual Test Battery (1944), and was incorporated into the Halstead–Reitan Battery 
(Reitan & Wolfson, 1985). In the Trail making test A, participants have to draw a line 
on numbered circles in chronological order (1 to 25), as fast as possible. On TMT B 
participants are presented with circles containing numbers and letters, and are instructed 
to draw a line in chronological order from 1 to 13, and A to L, but to switch back and 
forth between numbers and letters. Therefore, participants have to draw a line from 1 to 
A, from A to 2, from 2 to B etc. The reaction time of both tasks is recorded, and an 
index subtracting RT’s of TMT-A from RT’s of TMT-B results in an estimate of 
cognitive flexibility (Lezak, 1995) adjusted for individual differences in motor 
functioning and visual search strategies (Reitan & Wolfson, 1985). Norm values are 
available from Tombaugh (2004). 
ii. Verbal short term memory (Story-recall/logical memory) 
Verbal short term memory was tested with a subtest of the revised version of the 
Wechsler adult intelligence scale (Wechsler, 1987). We asked participants to 
immediately repeat a 60 words story that was read to them by the experimenter, and 
recall as many details as possible. The story details were given in units. For each 
correctly recalled unit the participant received 1 point. Half a point was given if 
information was paraphrased despite the wording being slightly different. For instance, 
if the sentence was: “The Officers, / touched by the woman’s story, / had a collection / 
                                                 
2
 We measured a computerised Go NoGo task as well. Due to an overall ceiling performance, we omitted 
this task from all further analysis. Detailed information on this task can, however, be requested from the 
first author. 
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for her.”, and participants literally repeated “touched by the woman’s story” as a unit, 
they would receive 1 point. If they paraphrased the unit, e.g. by saying “felt sorry for 
the woman”, they would receive half a point. A total of 23 possible points could be 
acquired. Normative data for young adults and University samples can be found in 
Bowden et al. (1999) and Ivison (1993), respectively. 
iii. Verbal working memory (2-back task) 
Comparable to previous published reports (Owen, et al., 2005; Schoofs, et al., 2008), 
participants saw 64 digits, (ranging from 1 – 9), sequentially presented, in the middle of 
the computer screen (white on black background, font Arial, size 16). Participants were 
instructed to press a given response key when the current digit (n) was identical to the 
digit n-2 (target trials). In all non-target trials, participants had to press another response 
key. Half the participants responded with the left SHIFT-key for target trials and the 
right SHIFT-key for non-target trial. Response key allocation was reversed for the other 
half of participants.  
A third of the trials (n = 20) were target trials, and the remaining trials were non-target 
trials [n = 44 (e.g. Schoofs, et al., 2008)]. To increase task difficulty intrusion trials 
were added, ensuring that participants were not able to restart memorizing after each 
successful identification of a target, as sometimes targets occurred twice in a row. Each 
stimulus was presented for 2 seconds, with an inter-stimulus interval of 500ms (Barch, 
Sheline, Csernansky, & Snyder, 2003). Presentation of the stimuli was continuous, and 
if participants did not respond within this time, the next digit was presented and the 
response was counted as an omission. No feedback was given to participants about their 
performance. All participants performed 16 practice trials. We measured the percentage 
of the correctly identified targets, as well as mean RTs for target trials (e.g. Jonides et 
al., 1997; Schoofs, et al., 2008).  
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Data analysis 
To determine if cannabis use affects frontal lobe functioning, we conducted separate 
univariate ANOVAs with group (CU, nCU) as between-subjects factor on the 
percentage of correct responses [(amount of correctly identified target stimuli 
*100)/total of targets] and RT in the 2-back task, the TMT-index (TMT B scores – TMT 
A scores) and the percentage of correctly identified units in the story recall task 
[(amount of correctly identified units *100)/total of units)].  
 
In order to establish an effect of drug use and schizotypy on frontal lobe functioning, we 
firstly investigated the demographic characteristics of our population, and found that the 
sex distribution differed between the drug groups (see result section for details). We 
then correlated age and handedness with the outcome measures to determine the 
relevance of these control variables for the regression model (see result section for 
details). Since neither age nor handedness significantly correlated with frontal lobe 
functioning, we performed hierarchical regressions as follows. Sex was entered in the 
first step, drug dependence (nicotine, alcohol and cannabis) was entered in the second 
step, and schizotypy (UnEx scores, CogDis scores IntAn scores, Imp scores) in the third 
step. Thus, three blocks of predictors were entered in nested blocks, meaning that each 
subsequent block contained all prior predictors and the additional predictors from the 
current block. Presentation of results however will only include the new predictors 
entered, for economy of presentation. The full model can be found in the Appendix of 
this dissertation (see Table 25). Because all tolerance values were above .2 (Menard, 
1995), and all independent variables were mean-centered, multi-collinearity between the 
independent variables was considered negligible. The dependent variables were: i) 
percentage correctly identified targets and mean RT for correctly identified targets and 
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non-targets in the 2-back task; ii) TMT-index and iii) percentage of correctly recalled 
units in the story recall task. 
 
Kolmogorov–Smirnov tests for the groups separately revealed normal distribution for 
all behavioral measures. All p-values were two-tailed and the α-level was set at .05.  
 
4. Results 
Participants 
Of the 83 healthy native English speaking controls, 35 pure cannabis-using participants 
were identified, six occasional users (17%) with negative THC-urine tests, 11 regular 
users (31%) and 18 (51%) frequent users, the latter two groups with positive urine tests 
for THC-content. Frequent use was defined as using cannabis at least four times per 
week, regular use as using cannabis between once and three times per week, and 
occasional use was defined as using cannabis less than once/week, but within the past 
three months. Within the CU group, 13 people were educated to college level (37%), 
one to secondary school (3%), and 21 to University degrees (60%). Of the 48 people in 
the control group, there were 12 people with finished college degrees (25%) and 36 with 
University degrees (75%). A chi-square test indicated that the two groups did not differ 
from each other in terms of highest finished education level [Χ2(df = 2) = 3.03, p = .22]. 
However, there were significantly more males (n = 23) in the cannabis using group as 
compared to the non-using group [n = 20; Χ2(df = 1) = 4.69, p = .03]. 
As can be seen from Table 8, participants did not differ in age and handedness. 
However, CU as compared to nCU scored higher on UnEx (as a trend) and ImpNC, 
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cigarettes per week, joints per week, nicotine dependence, alcohol dependence, and 
cannabis dependence. 
Table 8. Demographical and drug use statistics for the total sample as well as CU and 
nCU, separately. Values were compared between groups using independent t-tests. We 
report the statistical results in this table (t-values, df = 81; p-values). Significant group 
differences are highlighted in bold. 
 All (N=83) Cannabis 
users (N=35) 
Controls (N=48)  
Variables Mean SD Mean SD Mean SD t p 
Age 22.02 4.54 22.51 5.63 21.67 3.56 0.84 0.40 
Handedness 11.36 0.90 11.49 0.85 11.27 0.94 1.07 0.29 
UnEx
 a
 6.36 4.92 7.63 6.04 5.44 3.71 1.90 0.06 
CogDis
 b
 10.61 5.28 10.46 5.75 10.73 4.97 -0.23 0.82 
IntAn
 c
 4.54 3.67 4.26 3.53 4.75 3.78 -0.60 0.55 
ImpNC
 d
 9.06 3.70 9.97 4.11 8.40 3.25 1.95 0.05 
Cigarettes/week 10.40 22.16 24.66 28.67 0.00 0.00 5.09 0.00 
Joints/week 4.70 9.59 11.14 12.16 0.00 0.00 5.42 0.00 
Nicotine 
dependence 0.87 1.55 1.94 1.86 0.08 0.45 5.78 0.00 
Cannabis 
dependence 1.25 1.94 2.97 1.95 0.00 0.00 9.03 0.00 
Alcohol 
dependence 1.72 1.67 2.29 1.84 1.31 1.42 2.72 0.01 
a 
Unusual experiences; 
b 
Cognitive Disorganisation; 
c 
Introvertive Anhedonia; 
d 
Impulse 
Non-conformity; 
 
Frontal lobe functioning 
The separate univariate ANOVAs with cannabis use (CU, nCU) as between subject 
factor on the outcome measures in the frontal lobe tasks revealed that CU performed 
significantly worse in the story recall task and slightly worse on the working memory 
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task as compared to nCU (Table 9). The results for the remaining tasks were not 
significant (Table 9). 
Table 9. Descriptives and values from the multivariate ANOVA. Significant values are 
highlighted in bold, trends in grey. 
 All (N=83) CU (N=35) nCU (N=48)    
Variables Mean SD Mean SD Mean SD F(1,81) p Partial eta
2
 
2-back % 
target correct 
88.61 10.86 86.00 13.49 90.52 8.07 3.62 0.06 0.04 
2-back mean 
RT 
821.90 188.30 822.57 164.00 821.42 205.92 0.00 0.98 <0.01 
TMT
 a
 index 23.65 15.30 23.77 13.58 23.56 16.58 0.00 0.95 <0.01 
Story recall 
% correct  
62.44 14.40 55.90 14.78 67.21 12.19 14.55 <0.01 0.15 
a 
Trail making task;  
 
Regression 
Correlations between scale scores revealed that neither age nor handedness related to 
frontal lobe functioning (all p-values > .10), and therefore these variables will not be 
considered further in the analyses. However, due to the significantly higher proportion 
of males in the CU group, sex will be entered as a control variable. 
As can be seen from Table 10, sex significantly predicted verbal short-term memory 
performance. Post-hoc independent t-tests revealed that women were significantly better 
than men in the story recall task [women: m = 66.63%, SD = 12.08, men: m = 58.54%, 
SD = 15.39; t(81) = -2.65, p = .01]. Entering drugs in the second step predicted 
significant amounts of variance in the outcome measures. Here, alcohol dependence 
predicted lower working memory performance, and cannabis predicted reduced verbal 
short-term memory on top of sex. Entering schizotypy in the third step predicted 
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additional variance on top of the drug variables and sex only in story recall (see Table 
10). Here, higher ImpNC values predicted better story recall. 
Table 10. Regression assessing the effect of sex (step 1), drug dependence (nicotine, 
alcohol and cannabis dependence; step 2), and schizotypy (Unusual Experiences, 
Cognitive Disorganisation, Introvertive Anhedonia and Impulse Non-conformity; step 
3) on frontal lobe functioning.  
Outcome 
variables 
Step Significant 
predictor 
β-value Total 
R² 
ΔR² F for 
ΔR² 
2-back % target 
correct 
2 Alcohol 
-0.24* 0.14** 0.14** 4.25** 
2-back mean RT 1 Sex 
-0.21† 0.04† 0.04† 3.61† 
 2 Alcohol 
0.39*** 0.18** 0.13** 4.19** 
Story recall % 
correct 
1 Sex 
0.28** 0.08**  0.08**  7.02** 
 2 Cannabis 
-0.37** 0.28*** 0.20*** 7.22*** 
 3 CogDis
a
 
-0.21* 0.39* 0.11* 3.34* 
 3 ImpNC
 b
 
0.36** SAA* SAA SAA 
† p≤.10; * significant at p≤.05; ** significant at p≤.01; *** significant at p≤.001  
 
a 
Cognitive disorganization; 
b
 Impulsive Non-Conformity; 
c 
Same as above 
 
5. Discussion 
Cannabis is one of the most frequently used substances amongst European youth, and 
its use has been associated with negative implications such as cognitive attenuation 
(Barkus & Murray, 2010; Fernández-Serrano, et al., 2011) and an elevated risk for 
psychosis (Arseneault, et al., 2002; Casadio, et al., 2011; Schimmelmann, et al., 2011; 
van Os, et al., 2002; Zammit, et al., 2002). However, the relationship is not as clear-cut 
II     Experiments: Cannabis, schizotypy and cognitive functioning 
90 
 
as some authors have pointed out. For instance, in patients with schizophrenia using 
cannabis, cognitive functions seem superior to non-using patients (Rabin, et al., 2011). 
Also, most individuals using cannabis will never develop a psychotic illness (e.g. 
Andreasson, et al., 1987; Arseneault, et al., 2002; Hall & Degenhardt, 2000; 
Schimmelmann, et al., 2011; van Os, et al., 2002; Zammit, et al., 2002; Zammit et al., 
2008). Additionally, cannabis is rarely used alone, being usually associated with alcohol 
and nicotine use, but these have rarely been taken into account in the triadic 
investigation of cannabis use, cognition, and psychosis (-risk). To investigate whether 
cannabis use hampers cognitive performance, or whether cognitive attenuation is better 
explained by associated licit drug use and psychotic-like features (schizotypy), we here 
investigated CU and nCU on cognitive functions commonly associated with the frontal 
lobe, accounting also for alcohol and nicotine use, as well as individuals’ self-reported 
schizotypal features. The main findings from this study were that i) CU as compared to 
nCU performed worse on story recall and slightly worse on the 2-back task, but not on 
the TMT, ii) regression analysis showed that enhanced alcohol use predicted impaired 
working memory deficits, whereas enhanced cannabis use predicted decreased verbal 
short-term memory, and iii) none of the schizotypy subscales explained any additional 
variance in frontal lobe functioning (apart from ImpNC and CogDis for story recall), iv) 
CU scored higher than nCU on positive schizotypy (as a trend), ImpNC and drug use 
other than cannabis. The implications of these findings are discussed below. 
The role of cannabis use 
Our results showed that the implications of cannabis use are rather negative than 
positive (or neutral) because our CU performed worse than nCU on tasks measuring 
verbal short term memory, and showed a reduced performance in verbal memory (story 
recall) with increasing cannabis use. This is in line with previous studies (Fernández-
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Serrano, et al., 2011; Ranganathan & D’Souza, 2006; Wagner, et al., 2010). Our results 
also showed that these relatively negative cognitive implications were not further 
enhanced with individuals’ self-reported schizotypy. However, story recall (verbal 
memory) was the only task that was affected by cannabis use, whereas relative impaired 
performance on another cognitive task (working memory as assessed with the 2back-
task) was related to enhanced alcohol use instead. Previous studies have indicated that 
cannabis use should have a negative impact on working memory performance (see 
Ranganathan & D’Souza, 2006 for overview) and mental flexibility (see also 
Fernández-Serrano, et al., 2011; Lundqvist, 2005 for overview) as well. Our findings 
suggest that these previous findings on cannabis were potentially confounded by 
concomitant alcohol use (see Fernández-Serrano, et al., 2011 for overview; Zeigler et 
al., 2005).  
 
Despite some evidence that cannabis use is still associated with cognitive impairments 
after adjusting for alcohol use (Medina, Hanson, et al., 2007), independent studies 
(Schimmelmann, et al., 2011) report that cannabis users tend to consume higher 
amounts of other drugs as well. This additional drug use, because it is frequently not 
assessed, might have led to misleading conclusions about the effect of cannabis use on 
cognitive functioning. Particularly licit drug use like alcohol seems to be a relevant 
confound. For instance, whereas in some studies alcohol use is either statistically 
controlled for (Fried, et al., 2005; Pope & Yurgelun-Todd, 1996), or subjects with 
alcohol abuse are excluded from participating (Wagner, et al., 2010), other studies do 
not do this (Skosnik, et al., 2001). Worse, alcohol and cannabis are thought to exert 
comparable effects on cognition, i.e. cognitive attenuation in verbal memory (Parada, et 
al., 2011; Petros, et al., 1985; Poltavski, et al., 2011), cognitive flexibility (Guillot, et 
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al., 2010; Lyvers & Tobias-Webb, 2010) and working memory (Crego, et al., 2010; 
Weissenborn & Duka, 2003; Yücel, et al., 2007). Therefore, future studies should aim to 
include this variable as potential confound when investigating the effects of cannabis 
use on cognition. 
The role of schizotypy 
Of additional significance was the observation that schizotypy did not explain variance 
in most cognitive tasks beyond what was already explained by drug use. We do not 
think that this finding can be explained by deviant features of our sample, because we 
replicated many previous observations that CU as compared to nCU scored slightly 
higher on measures of positive schizotypy (e.g. A. S. Cohen, et al., 2011; Compton, 
Chien, et al., 2009; Fridberg, et al., 2011; Skosnik, et al., 2008; Skosnik, et al., 2001; 
Verdoux, et al., 2003) and measures of impulsivity (e.g. ImpNC; Chamberlain & 
Sahakian, 2007; Crews & Boettiger, 2009; Koob & Volkow, 2010; Verdejo-García, 
Lawrence, & Clark, 2008) reflecting the populations’ representativeness, at least in 
these regards. The lack of the schizotypy measures to be importantly related to frontal 
lobe functioning would indicate that impairments in frontal lobe functioning like 
working memory (Park & McTigue, 1997; Pflueger, et al., 2007), verbal fluency (Kopp, 
Wolff, Hruska, & Reischies, 2002; Laurent et al., 2000; Tsakanikos & Claridge, 2005; 
Voglmaier et al., 2005; Voglmaier, Seidman, Salisbury, & McCarley, 1997), cognitive 
flexibility (Blanchard et al., 2010; Diforio, et al., 2000; Giraldez, et al., 1999; Laurent, 
et al., 2000; Voglmaier, et al., 1997), and verbal memory (Langdon & Coltheart, 2004; 
Simon, et al., 2007) may not be due to individuals’ schizotypal symptoms but result at 
least partially from co-morbid drug use.  
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When trying to follow up this argument, unfortunately the above mentioned studies did 
not report on drug use (Blanchard, et al., 2010; Diforio, et al., 2000; Giraldez, et al., 
1999; Langdon & Coltheart, 2004; Park & McTigue, 1997; Simon, et al., 2007; 
Tsakanikos & Claridge, 2005), or only screen for substance use history without 
specifying the substances controlled for (Kopp, et al., 2002; Laurent, et al., 2000; 
Pflueger, et al., 2007; Voglmaier, et al., 2005; Voglmaier, et al., 1997). It is thus 
possible that substances (e.g. illicit as well as licit) influenced the relationship between 
schizotypal symptoms and the frontal/executive functions assessed in these experiments 
(e.g. Herzig & Mohr, in press; Herzig, et al., 2010). In particular, our results would 
suggest that cannabis may be more relevant than schizotypy for the cognitive 
attenuations in verbal short-term memory, and alcohol to be more relevant than 
schizotypy for the cognitive attenuations in working memory performance. 
 
The specific effects of cannabis use on story recall, but not the 2-back or trail making 
task may also suggest that not all cognitive functions are equally sensitive to cannabis 
related attenuations. Even though many studies observe CU to show impairments 
compared to nCU on tasks measuring working memory (see Ranganathan & D’Souza, 
2006 for overview) and mental flexibility (see also Fernández-Serrano, et al., 2011; 
Lundqvist, 2005 for overview), this may not always be the case [working memory 
(Grant, Chamberlain, Schreiber, & Odlaug, 2012), cognitive flexibility (Solowij, et al., 
2002)]. Due to this lack of specificity many researchers use set scores / composite 
scores of test batteries (see Barrantes-Vidal et al., 2003; Brewer et al., 2006 for 
overview), or look at changes in the correlations between different cognitive markers as 
indicators of pathological processes (Cadenhead & Braff, 2002). These approaches may 
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be useful tools to consider in subsequent studies on the link between cannabis, cognition 
and psychosis. 
 
Additionally, different meta-analyses draw inconsistent conclusions about which 
cognitive functions qualify as cognitive markers, or endophenotypes for pathological 
changes. Not only are findings in cannabis users inconsistent, but also along the 
schizophrenia spectrum. For instance, studies report consistent verbal memory 
impairments in psychosis (Heinrichs, 2004; Mesholam-Gately, Giuliano, Goff, Faraone, 
& Seidman, 2009) and cannabis use (see also Crean, Crane, & Mason, 2011; Solowij & 
Michie, 2007 for overview), whereas others find cognitive flexibility to be impaired in 
relatives (Sitskoorn, Aleman, Ebisch, Appels, & Kahn, 2004) or psychosis patients 
(Mesholam-Gately, et al., 2009), or consistent working memory impairments in both 
patient populations and cannabis users (Crean, et al., 2011; Mesholam-Gately, et al., 
2009; Solowij & Michie, 2007). One problem when investigating this triad of cannabis, 
cognition and psychotic-like thinking is the complexity of the relationship between 
these factors and others influencing it. For instance, many factors such as genetic 
predisposition (Ho, Wassink, Ziebell, & Andreasen, 2011), IQ (Pope et al., 2003) and 
neurochemical peculiarities such as dopamine receptor availability (Bossong et al., 
2009; Kuepper et al., 2010) may influence the effect cannabis exerts on cognitive 
functions. These factors are also relevant for the link between psychosis and drug use, 
e.g. genetic predisposition (Caspi et al., 2005; Estrada et al., 2011), IQ (Khandaker, 
Barnett, White, & Jones, 2011; Leeson, Barnes, Hutton, Ron, & Joyce, 2009 for 
overview; Matheson & Langdon, 2008), and neurochemical peculiarities such as 
dopamine receptor availability (see Kuepper, et al., 2010 for overview). However, it is 
impossible to account for all putatively influential variables, and hence additional 
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studies need to be conducted to replicate the importance of drug use in schizotypy 
research, be it clinical, experimental and/or epidemiological studies. 
 
Study limitations and future research 
While it may be close to impossible to find a Western sample of cannabis users that 
does not also use alcohol, the co-use of nicotine seems even more unavoidable. 
Cannabis is mostly used in combination with nicotine, a procedure known as ‘mulling’ 
(Bélanger, et al., 2011). Cannabis use might predict future nicotine use (Suris, 
Berchtold, Akre, Belanger, & Michaud, 2010), and those who also consume nicotine 
without cannabis might show lower educational attainment than those who only use 
nicotine in combination with cannabis (Suris, Akre, Berchtold, Jeannin, & Michaud, 
2007). To what extent this differential influence of nicotine on cognitive functioning 
might relate to the direct neurochemical influences of nicotine and cannabis, or to 
indirect socio-educational mechanisms remains to be seen. For instance, higher 
intelligence seems to be a protective factor from the negative impact of 
psychopathology and/or drug use (Zammit, Lewis, Dalman, & Allebeck, 2010). What 
can be conjectured is that nicotine itself might have important influences on cognitive 
functioning, that might either worsen the implications of cannabis (Suris, et al., 2007), 
or potentially counteract them (Adler, et al., 1993; see Heishman, Kleykamp, & 
Singleton, 2010 for overview; Kumari & Postma, 2005; Zabala, et al., 2009). We would 
therefore suggest that future studies should elucidate the role of nicotine and cannabis 
more directly.  
 
Gender imbalance is frequent in studies similar to ours, and we found an unequal 
distribution of females and males in the two groups (CU, nCU), which could have 
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affected the group differences on story recall. Typically, females perform better on 
verbal short-term memory tasks than males (see Kaushanskaya, Marian, & Yoo, 2011 
for recent summary of relevant studies), a finding also observed in the present study. 
Since the nCU group consisted of more females than the CU, it could be argued that this 
could alternatively explain the worse story recall in CU. However, since cannabis use 
related to worse story recall performance on top of sex in the regression analysis, we 
deem it unlikely that the group differences are solely due to effects associated with the 
unequal sex distribution. Nevertheless, future studies on drug use and cognition should 
aim to control for sex differences. 
 
A final limitation also frequently mentioned is the sample size. Obviously, a larger 
sample would always be advisable. Yet, it has turned out to be a true challenge to recruit 
pure CU. A potential reason could be firstly, that these individuals are either extremely 
difficult to motivate, or secondly, that pure users of drugs are rather difficult to find. 
The latter could be due to the recent trend, with many designer drugs being available on 
the market. Yet, if sample descriptions of the last 30 years are considered, it is also 
obvious that many studies inferred on the influence of cannabis use on cognition and 
mental health risk without necessarily ensuring that individuals not also used other legal 
and illegal drugs. We thus face the future challenge to disentangle what impact a 
specific drug, or even synergetic drug effects (Perez-Reyes, Hicks, Bumberry, Robert 
Jeffcoat, & Cook, 1988; Ramaekers et al., 2011; Ronen et al., 2010) might have on 
cognition and mental health.  
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Conclusion 
While pure cannabis use seems associated with adverse effects on frontal lobe 
functioning, other risk factors such as alcohol and nicotine use may also contribute to 
this. Schizotypy, on the other hand, did not seem to consistently relate to attenuated 
frontal lobe functioning on top of drug dependence. The results suggest that it is 
important to control for substance use when assessing the effect of schizotypal 
symptoms and/or cannabis use on cognition. Moreover, heterogeneity of cannabis-
related attenuations of specific frontal lobe functions may be avoided by calculating set-
scores reflecting more generalized versus specific deficits in future studies, and 
controlling for additional factors potentially influencing the relationship between 
cannabis, cognition and psychosis (-risk). 
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D. Study 3: Mephedrone / Polydrug use 
 
Running title 
 Mephedrone, polydrug use and cognition 
 
 
Reference 
Herzig, D. A., Brooks, R., Mohr, C. (submitted). The cocktail (party) phenomenon: 
Inferring about individual drug effects on cognitive functioning in polydrug 
using mephedrone users before and after clubbing. 
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1. Abstract  
Mephedrone has been recently made illegal in the UK, but little is known about its 
impact on cognitive functions. Filling this gap was the first aim of this study. 
Additionally, chronic drug use (including mephedrone) and personality features such as 
schizotypal thinking have been associated with cognitive attenuations, but the 
relationship between drug use, schizotypy and cognitive functioning is not well 
explored. Investigating this relationship was the second aim of this study. Volunteers (n 
= 26) performed cognitive measures twice (verbal learning, verbal fluency and 
cognitive flexibility), i.e. before (pre-clubbing) and after (post-clubbing) a clubbing 
experience. All filled in self-report questionnaires detailing demographic information, 
drug use, schizotypal symptoms (O-LIFE), depression, and premorbid IQ. Results 
showed that i) 10 volunteers had used mephedrone (post-clubbing, assessed via self-
report), ii) mephedrone users performed worse than controls pre-clubbing, and 
deteriorated post-clubbing, iii) other pre-clubbing drug use (cannabis, amphetamine) 
predicted attenuation in cognitive functioning, iv) Post-clubbing, depression scores 
predicted attenuation in cognitive functioning, and v) schizotypy was largely unrelated 
to cognitive functioning, apart from a negative relationship between cognitive 
disorganisation and verbal fluency pre- clubbing. These results suggest that polydrug 
use and subjectively experienced depressive symptoms negatively affect cognitive 
functioning. The finding on cognitive disorganisation supports independent notions that 
this schizotypy dimension in the general population might be the most relevant to a 
pathological cognitive profile reported along the psychosis dimension.  
 
Keywords: New-wave drugs, cognition, psychosis spectrum, substance dependence, 
cathinone  
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2. Introduction 
Drugs are feared to threaten our mental health facilitating politics that criminalise their 
distribution and use (Nutt, King, & Phillips, 2010). While we increasingly know about 
the clinical, cognitive, and physical implications when individuals use “conventional” 
licit and illicit psychoactive substances (e.g. heroine, cocaine, nicotine; Fernandez-
Serrano, Perez-Garcia, Rio-Valle, & Verdejo-Garcia, 2010; Fernández-Serrano, et al., 
2011; Nutt, et al., 2010), we are yet to accumulate a comparable knowledge on so called 
“new wave” designer drugs. New wave designer drugs encompass a range of modern 
psychoactive substances, which have been both specifically marketed and synthesized 
for the aim of providing an intoxicating high. Since they are new, legislations have not 
yet been established, making the use of many of these substances officially legal and 
therefore attractive. The most popular of these drugs are based on the substance 
“cathinone”, a compound found in the khat plant (see Schifano, et al., 2010 for 
overview). One derivate of cathinone is a substance widely known as “mephedrone”, 
which is also known as 4-MMC, MMCat, Meow/Miaow Miaow, Bubbles, Meph, Rush, 
Drone, Plant Feeder etc., and which has been relatively popular in the clubbing scene in 
recent years (Winstock et al., 2011).  
Cathinone substances have a chemical structure similar to amphetamine (Dal Cason, 
Young, & Glennon, 1997; Hoffman & Al'Absi, 2010), a similarity that is also reflected 
in the observation that they seem to mimic the physiological and psychological actions 
of amphetamines (Kalix, 1992; Schifano, et al., 2010). For instance, both cathinones 
and amphetamines prevent the uptake and stimulate the presynaptic release of 
dopamine, serotonin and noradrenalin (see Kalix, 1992 for overview). Importantly, 
similarly to amphetamines, high doses of mephedrone can induce hallucinations 
(ACMD, 2010; James, et al., 2010; Vardakou, et al., 2011). To assess the physiological 
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and psychological effects of cathinones, Brenneisen et al. (1990) investigated the effects 
of intravenous administration of cathinone in human participants and discovered that the 
drug markedly increased heart rate and blood pressure in comparison to placebo. 
Furthermore, participants reported an increased sense of euphoria and sociability, which 
is comparable to independent reports on the psychological effects of mephedrone 
(Morris, 2010). Reports such as these certainly facilitated a fierce debate on the 
potential risks and harmfulness of mephedrone prior to the prime minister elections in 
the UK in 2010, and its use was recently made illegal in the UK (see Vardakou, et al., 
2011 for overview; Winstock, et al., 2011) and other European countries (EMCDDA, 
2010). 
Despite some scientific explorations on the physiological and psychological effects of 
cathinones (ACMD, 2010; Brenneisen, et al., 1990; James, et al., 2010; Morris, 2010; 
Vardakou, et al., 2011), studies on the cognitive effects of these substances are 
surprisingly sparse (Hoffman & Al'Absi, 2010), and to our knowledge have only 
recently started to be investigated. For instance, impairments in working memory and 
cognitive flexibility have been reported as a function of khat use (Colzato, Ruiz, van 
den Wildenberg, & Hommel, 2011). Given the similarities between amphetamines and 
cathinones in chemical structure (Dal Cason, et al., 1997) and subjective reports 
(ACMD, 2010; Brenneisen, et al., 1990; James, et al., 2010; Morris, 2010; Vardakou, et 
al., 2011), it seems justified to expect cathinone use to result in similar cognitive 
peculiarities to those reported after amphetamine use. If this reasoning is indeed 
considered feasible, we can infer from previous experimental research into the cognitive 
harms of amphetamines (see Fernández-Serrano, et al., 2011; Kalechstein, et al., 2007 
for overview) that mephedrone (and other derivates of cathinones) might negatively 
affect various aspects of cognition such as working memory (Curran & Travill, 1997), 
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verbal fluency (Hanson & Luciana, 2004), cognitive flexibility (King, et al., 2010), 
verbal learning (Gonzalez, et al., 2004; Laws & Kokkalis, 2007; McCardle, et al., 2004; 
Parrott & Lasky, 1998), and mood (Curran & Travill, 1997; Parrott & Lasky, 1998). 
Given that these predictions are based on inferences from research on amphetamines, 
we here aimed to test more directly whether cognitive impairments reported from 
amphetamine use might also be observed for mephedrone use, or other drug use more 
broadly.  
While the question on cognitive impairments as a function of drug use seems 
straightforward, it misses out on the equally important question on who would be most 
prone to use such drugs in the first place, or who might have a higher risk of 
experiencing harmful consequences from drug consumption. Knowing about these 
influential factors should indeed be of interest to clinicians and society more broadly, 
because early detection might help reduce negative long-term consequences for mental 
health (Bird, et al., 2010; Larsen, et al., 2011; M. Marshall & Rathbone, 2006). One 
factor associated with enhanced drug use is schizotypy (see Barkus & Murray, 2010 for 
overview), a personality construct that has also been associated with an enhanced risk 
for psychiatric conditions (L. J. Chapman, et al., 1994; Gooding, et al., 2005).  
Schizotypy is thought to describe subjective experiences in the general population that 
are reminiscent of those reported from  patients with schizophrenia, but in a milder form 
(Meehl, 1962). Such similarities are not only evident on the phenomenological level, 
but are also found for cognitive functions. In more detail, cognitive impairments that are 
common in patients with psychosis are also found along the psychosis dimension, 
although less severe, such as in individuals with a schizotypal personality disorder [see 
Reichenberg & Harvey (2007) for overview], and individuals from the general 
population scoring relatively high on self-report schizotypy questionnaires (Burch, 
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Hemsley, & Joseph, 2004; Krabbendam, et al., 2005; Laurent et al., 2001; Poreh, Ross, 
& Whitman, 1995; Vollema & Postma, 2002). Most important to the present study, 
cognitive functions relying on the frontal lobes such as cognitive flexibility (Blanchard, 
et al., 2010; Diforio, et al., 2000; Laurent, et al., 2000; Voglmaier, et al., 1997), working 
memory (Kopp, et al., 2002; Park & McTigue, 1997; Voglmaier, et al., 2005; 
Voglmaier, et al., 1997) and verbal fluency (Laurent, et al., 2000; Tsakanikos & 
Claridge, 2005; Koychev et al., 2011) seem attenuated along the psychosis spectrum 
including schizotypy (see also Reichenberg & Harvey, 2007 for overview).  
A potential problem of the above described study lines is that only few investigated 
cognition, drug use and schizotypy simultaneously, i.e. studies either investigated the 
influence of a particular drug on cognition, the link between drug use and schizotypy, or 
the relationship between schizotypy and cognitive functioning. Yet, in the latter case, 
individuals with elevated schizotypy are also likely to be subject to relative enhanced 
polydrug use, without this drug consumption being accounted for in most scientific 
reports. We found 16 studies investigating the link between schizotypy and cognitive 
functioning; nine of them did not report drug use (Burch, Hemsley, Corr, & Gwyer, 
2006; Dinn, Harris, Aycicegi, Greene, & Andover, 2002; Giraldez, Caro, Rodrigo, 
Pineiro, & Gonzalez, 1999; Kerns & Becker, 2008; Laws, Kondel, Clarke, & Nillo, 
2011; Lenzenweger & Korfine, 1994; Park, Holzman, & Lenzenweger, 1995; Schmidt-
Hansen & Honey, 2009; Tsakanikos & Claridge, 2005), and the others varied in their 
drug control criteria (Daneluzzo, Bustini, Stratta, Casacchia, & Rossi, 1998; 
Kaczorowski, Barrantes-Vidal, & Kwapil, 2009; Kim, Oh, Hong, & Choi, 2011; 
Koychev et al., 2011; Matheson & Langdon, 2008; Poreh, et al., 1995; Suhr, 1997). It is 
thus possible that substances (e.g. illicit as well as licit substances) influenced the 
relationship between schizotypal symptoms and the cognitive functions assessed 
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(Herzig & Mohr, in press; Herzig, et al., 2010). As will be shown in the following, the 
present study took this reasoning into account.  
We investigated the potential role of current mephedrone use (but also of other common 
drugs) on cognitive functioning, and how this relationship might be influenced by 
individuals’ schizotypy. In particular, we adopted a “natural” design in which a group of 
participants was tested twice, before (pre-clubbing) and after (post-clubbing) their 
clubbing experience. Because mephedrone was a preferred clubbing drug at the time of 
testing, we expected that some participants would consume new wave designer drugs 
such as mephedrone. This experimental design not only allowed to account for changes 
of cognitive functioning over the course of a clubbing experience (short-term) but also 
whether individuals using mephedrone have a more severe overall drug history 
(polydrug use) potentially implying that their cognitive functioning is already relatively 
impaired at the pre-clubbing stage (long-term effects).  
Given the similarity between the physiological and emotional effects of cathinones and 
amphetamines, we predict that mephedrone users as compared to non-users should 
show relatively impaired cognitive functioning already reported from amphetamine 
users (cognitive flexibility, verbal learning and verbal fluency). Moreover, we 
considered the possibility that drug use rather than schizotypy would be the dominant 
predictor of these relatively impaired cognitive functions (Herzig & Mohr, in press; 
Herzig, et al., 2010). Because of the reported links between various drugs of abuse, 
mood and sleep patterns on cognition we also controlled for possible influential 
variables such as depression (Curran & Travill, 1997; Davison & Parrott, 1997; Deykin, 
Levy, & Wells, 1987; MacInnes, Handley, & Harding, 2001) and sleep (Carhart-Harris, 
Nutt, Munafo, & Wilson, 2008; Curran & Travill, 1997). By accounting for these 
variables a ‘purer’ measure of the effects of drug use on cognition is expected to derive. 
II     Experiments: Mephedrone, polydrug use and cognition 
106 
 
3. Methods 
Participants 
Participants were recruited using a combination of snowballing sample method and 
advertisements, distributed at local businesses and university departments in the Bristol 
area. It was made explicitly clear that only members of the clubbing community were 
eligible to take part in the study, although no mention was made of drug use. 
Participants were excluded if they were not educated to at least degree level, and/or 
reported on major psychiatric illness or chronic health problems. Furthermore, 
participants were excluded if they were currently taking psychoactive medication (such 
as antidepressants, analgesics or neuroleptics), and/or had suffered from any form of 
organic head injury according to self-report. No pressure was placed on participants to 
consume psychoactive drugs at any point during the research, and no reimbursement 
was given for participants’ time. Instead, they were entered into a prize draw to win 
£100 worth of vouchers to spend in a Bristol based business enterprise. We were able to 
recruit 26 native English speakers who were willing to participant shortly before and 
after their clubbing experience. Of these 26 participants, 10 reported having used 
mephedrone at the post-clubbing session.  
The study was approved by the ethics committee of the University of Bristol, 
Department of Experimental Psychology. 
Procedure 
Participants completed a total of two experimental sessions, lasting approximately an 
hour each. The pre-clubbing session took place (mostly) on the Friday, in a quiet 
laboratory in the Department of Experimental Psychology, University of Bristol. This 
session acted as a baseline for measuring participants’ cognitive performance when 
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abstinent from current psychoactive drugs (baseline cognitive functioning). Drug use 
information was not collected during this session, rendering the experimenter blind to 
participants’ drug history. During this session participants completed all of the cognitive 
tasks and questionnaires (details are given below). Following completion of these tasks 
participants were instructed to engage in their usual clubbing experience. It is important 
to note that participants were not aware that the study was assessing the link between 
mephedrone use and cognition, therefore preventing to stimulate participants’ 
motivation to consume drugs to be eligible for this study. The post-clubbing session was 
arranged approximately 48 hours after the night that they went clubbing (e.g. if they 
went clubbing on Friday the next testing session would be on Sunday). Participants 
were considered mephedrone users if they reported mephedrone use in the 48 hours 
between the pre-clubbing and post-clubbing testing session. The post-clubbing testing 
session involved exactly the same cognitive measures and tests that were completed in 
session 1. Considering the likely poly-drug use of clubbers, participants also filled out 
additional questionnaires that measured their current and past psychoactive drug use 
(including any drugs taken in the period between testing sessions).  
Tasks 
(1) Cognitive tests3 
iv. Premorbid verbal intelligence: The national adult reading scale (NART) 
To ensure groups were matched on IQ, participants completed the NART at the 
beginning of the pre-clubbing session. The NART is designed to provide a measure of 
verbal IQ, through the visual presentation of a list containing 50 irregular words, which 
the participant is required to pronounce in serial order (H. E. Nelson, 1982). The NART 
                                                 
3
 We measured a computerised Go NoGo task as well. Due to an overall ceiling performance, we omitted 
this task from all further analysis. Detailed information on this task can be requested from the first author.  
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is a widely used and reliable test that takes advantage of the correlation between reading 
ability and intelligence in the normal population (Wiens, Bryan, & Crossen, 1993). The 
greater the number of correctly pronounced words the higher a participant’s verbal IQ. 
Normative values for the English version in healthy adults can be found in Crawford et 
al. (1989). 
v. Verbal learning and memory:  The Rey Auditory verbal memory task (RAVLT)  
The RAVLT (e.g. Spreen & Strauss, 1998) is an easy to administer task assessing verbal 
learning as well as immediate and delayed recall. A series of 15 nouns are read aloud to 
the participant (separated by one second intervals) for five consecutive trails. Each trial 
is followed by an immediate free recall test. We assessed the number of correctly 
recalled words over the five trails (maximum 75). Finally, after a delay of 25 minutes, 
participants are again asked to recall the original word list (delayed recall). We 
calculated percentages of the correctly recalled words for both immediate and delayed 
recall. Pre-clubbing and post-clubbing, participants received alternative versions with 
the order of the two versions having been counterbalanced between participants. 
Normative values for both versions can be found in Badcock et al. (2011). 
vi. Verbal fluency (COWAT) 
The COWAT (= Controlled Word Association Task) was originally developed by 
Bechtold, Benton et al. (1962), and is a measure of left frontal lobe functioning 
(Newman, Trivedi, Bendlin, Ries, & Johnson, 2007; A. G. Wood, Saling, Abbott, & 
Jackson, 2001). It tests participants’ ability to produce as many words as they can that 
begin with pre-determined sequentially presented letters (in this study: F, A and S) or 
categories (in this study: animals, vegetables and fruit) within a minute. In the present 
study, only letters were presented. We assessed the number of correctly generated words 
across all three letters. Proper nouns and changing of suffixes and prefixes were not 
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included (for example ‘See’ would be correct but subsequently saying ‘seeing’ would 
not). The test has been found to have reasonable test-retest reliability (Ruff, Light, 
Parker, & Levin, 1996), and updated normative data can be found in Ruff et al. (1996). 
vii. Trail making task (TMT) 
The TMT is used to test cognitive flexibility. It was originally part of the Army 
Individual Test Battery (1944), and was incorporated into the Halstead–Reitan Battery 
(Reitan & Wolfson, 1985). In the TMT participants are presented with a sheet of paper, 
filled with circles. These circles are either filled with numbers (TMT-A), or with 
numbers and letters (TMT-B). In version A, participants have to draw a line from circle 
1 to circle 25 in chronological order, as fast as possible. In TMT B participants have to 
draw a line in chronological order from 1 to 13, and A to L, but to switch back and forth 
between numbers and letters. Therefore, participants draw a line from 1 to A, from A to 
2, from 2 to B etc. The reaction time (RT) of both tasks are recorded, and an index 
subtracting RT’s of TMT A from RT’s of TMT B results in an estimate of cognitive 
flexibility (Lezak, 1995) adjusted for individual differences in motor functioning and 
visual search strategies (Reitan & Wolfson, 1985). Norm values are available from 
Tombaugh (2004). 
Questionnaires 
(2) The Becks Depression Inventory (BDI) 
The BDI (Beck, Erbaugh, Ward, Mock, & Mendelsohn, 1961) is a 21 item 
questionnaire designed to measure depressive symptoms. Each item comprises a 4 
choice statement differing in the extent of depressive loading. For example (0) I don’t 
have thoughts of killing myself, (1) I have thoughts of killing myself but I would not 
carry them out, (2) I would like to kill myself, (3) I would kill myself if I had the 
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chance. Each of the 4 choice statements provides a score that gauges how depressed the 
person feels from 0 to 3. The total depression score is the sum of the scores of each of 
the 21 items. Scores between 0–9 indicate that a person is not depressed, 10–18 
indicates mild-moderate depression, 19–29 indicates moderate-severe depression and 
30–63 indicates severe depression (Beck, et al., 1961; Sotiropoulos et al., 2008). In this 
experiment, we asked participants to answer the questionnaire by referring to how they 
generally felt in the past two weeks (pre-clubbing) and to how they feel currently (post-
clubbing). 
(3) The Oxford-Liverpool Inventory of Feelings and Experiences (O-LIFE; short 
version) 
The short O-LIFE questionnaire (Mason, et al., 2005) is a validated 43-item self-report 
questionnaire assessing schizotypy in terms of four dimensions. Positive schizotypy is 
assessed by 12 items pertaining to Unusual Experiences (UnEx, maximum score 12, 
including items such as ‘Are your thoughts sometimes so strong that you can almost 
hear them?’), negative schizotypy is assessed by 10 items pertaining to Introvertive 
Anhedonia (IntAn, maximum score 10, including items such as ‘Do you prefer 
watching television to going out with people?’), and Cognitive Disorganization is 
assessed by 11 items (CogDis, maximum score 11, including items such as ‘Are you 
easily confused if too much happens at the same time?‘). Finally, 10 items assess 
Impulsive Nonconformity (Imp, maximum score 10), which does not represent a 
schizotypy dimension (Mason, et al., 1995), but will be accounted for in the present 
study because of the significant link between impulsivity and addiction (Crews & 
Boettiger, 2009). For each item, participants have to indicate whether the statement is 
true or false. The number of positive responses (some items are reversely formulated) is 
summed so that higher scores indicate higher schizotypy. Normative values can be 
II     Experiments: Mephedrone, polydrug use and cognition 
111 
 
found in Mason et al. (2005) and the scale has shown good internal consistency as well 
as high correlations with the original O-Life questionnaire (Mason, et al., 1995; Mason, 
et al., 2005). 
(4) Drug use and sleep patterns 
On the post-clubbing testing session participant were asked to fill in the drug 
questionnaires of the national household survey on drug abuse (United States 
Department of Health and Human Services, 1998). The national household survey on 
drug abuse (NHSDA) gives detailed data of respondents’ prior drug use, and an adapted 
version was administered to assess use of nicotine, alcohol, cannabis, mephedrone, 
amphetamine, cocaine, ketamine and benzodiazepine use during the clubbing 
experience (amount used), and in the past 30 days (times used). Additionally, 
participants indicated their total amount of average hours of sleep, as well as how much 
they slept between the pre- and the post-clubbing experience (total amount of hours).  
Data analysis Mephedrone use vs. Control 
In a first set of analysis, in which we focused on recent mephedrone use, we calculated 
separate 2 x 2 mixed sample ANOVAs with day (pre-clubbing, post-clubbing) as the 
related samples factor and drug use group (mephedrone, control) as the independent 
samples factor on the total % correct responses in the RAVLT (measuring verbal 
learning) as well as total amount correct items named in the COWAT (measuring verbal 
fluency). In the TMT (measuring cognitive flexibility) an index (TMT B –TMT A) was 
calculated and used as an outcome measure, with higher values indicating reduced 
cognitive flexibility. Post-hoc tests were performed using paired samples tests. Effect 
sizes are reported for all ANOVA results.  
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In order to establish if schizotypy is explaining an additional amount of variance on top 
of drug use and demographic / control variables, we firstly explored which variables are 
relevant to the regression models. We correlated age, BDI scores, hours of sleep 
(average amount and total sum of hours between pre- and post-clubbing), NART-scores, 
drug use variables and schizotypy sub-scale scores with the outcome measures of the 
cognitive tasks. For regression analyses, we only kept variables that were significantly 
related to at least one outcome measure. Subsequently, two separate regression models 
were run, corresponding to the two times of assessment (see result section for details). 
Blocks of predictors were entered into the regression model, with the first one 
containing control variables (if none of these correlated with the outcome measures, this 
step was omitted), the subsequent step including drug use information, and the final step 
containing schizotypy measures. These blocks were entered in nested blocks, meaning 
that each subsequent block contained all prior predictors and the additional predictors 
from the current block. Presentation of results however will only include significant 
predictors as in Fridberg et al. (2011), for economy of presentation. The full model will 
be presented, however, in the Appendix of this dissertation (see Tables 26-27). Because 
all tolerance values were above .2 (Menard, 1995), and all independent variables were 
mean-centered, multi-collinearity between the independent variables was considered 
negligible. The dependent variables were i) total percentage correctly recalled items in 
the RAVLT, for immediate and delayed recall, ii) the total amount of correctly named 
items in the verbal fluency task, and iii) TMT index scores.  
Kolmogorov–Smirnov tests for the groups separately revealed normal 
distribution for all behavioral measures, NART, BDI and schizotypy scores. All p-
values were two-tailed and the α-level was set at .05.  
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4. Results 
Participants and self-report questionnaires 
As is evident from Table 11, mephedrone users used more amphetamine, mephedrone, 
and nicotine as compared to the control group in the past 30 days, as well as more 
mephedrone and alcohol during the clubbing experience. Furthermore, mephedrone 
users as compared to controls scored higher on BDI scores, CogDis and ImpNC. A 
mixed-samples ANOVA with BDI scores (pre-clubbing, post-clubbing) as the repeated 
measures, and group (mephedrone, control) as the between subjects factor indicated that 
there was a significant effect of day of testing [F(1,24)=6.69, p=.02, partial η2= .22], 
with BDI scores being generally higher post-clubbing than pre-clubbing (see Table 11). 
There also was a significant interaction between group * day of testing [F(1,24)=17.83, 
p<.001, partial η2= .43]. Post-hoc paired samples t-tests split by group revealed that this 
rise in BDI scores was only significant in the mephedrone using group [t(9)=-3.70, 
p<.01], but not in the control group [t(15)= 1.50, p=.16; see Table 11]. All other 
measures did not differ between groups (Table 11). 
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Table 11. T-test values and descriptives for demographic variables, average sleep and 
total hours sleep between test sessions, BDI scores, schizotypy scores, and substance 
use in mephedrone users (n = 10 participants) and non-mephedrone using controls (n = 
16 participants). Significant values are highlighted in bold. 
  Total   Mephedrone 
(N=10) 
Control 
(N=16) 
T-test statistics 
Variable Mean SD Mean SD Mean SD t(24) p 
Age 23.42 5.54 21.40 0.84 24.69 6.80 -1.91 0.07 
Verbal IQ 32.96 5.44 33.60 5.42 32.56 5.59 0.47 0.65 
Average hours sleep  7.58 1.03 7.60 1.06 7.56 1.03 0.09 0.93 
Total hours sleep between 
sessions 
19.35 4.99 19.80 4.10 19.06 5.58 0.36 0.72 
BDI
a
 pre
b
 8.15 7.25 11.90 5.53 5.81 7.36 2.24 0.03 
BDI post
c
 8.77 7.63 14.50 5.70 5.19 6.48 3.73 0.00 
UnEx
d
 3.35 2.71 4.60 2.41 2.56 2.66 1.97 0.06 
CogDis
e
 5.15 3.46 6.80 3.26 4.13 3.26 2.03 0.05 
IntAn
f
 1.73 1.80 2.00 1.89 1.56 1.79 0.59 0.56 
ImpNC
g
 3.42 2.48 5.30 1.57 2.25 2.24 3.76 0.00 
Amphetamine
 
past 30 days 0.19 0.49 0.50 0.71 0.00 0.00 2.24 0.05 
Mephedrone past 30 days 0.62 1.10 1.60 1.26 0.00 0.00 4.00 0.00 
Nicotine past 30 days 12.77 14.33 22.00 13.17 7.00 12.08 2.98 0.01 
Cannabis past 30 days 2.31 4.35 4.80 6.12 0.75 1.53 2.05 0.07 
Alcohol past 30 days 9.62 6.54 9.20 5.29 9.88 7.37 -0.25 0.80 
Mephedrone between test 
sessions 
0.54 0.76 1.40 0.52 0.00 0.00 8.57 0.00 
Cannabis between test 
sessions 
0.27 1.00 0.70 1.57 0.00 0.00 1.41 0.19 
Alcohol between test sessions 16.08 7.03 20.50 7.75 13.31 5.02 2.88 0.01 
Age of first use: Amphetamine 18.75 1.86 19.00 1.66 18.00 2.65 0.79 0.45 
Age of first use: Mephedrone n/a n/a 20.67 0.50 n/a n/a n/a n/a 
Age of first use: Nicotine 16.00 3.12 15.38 1.19 16.63 4.31 -0.79 0.44 
Age of first use: Cannabis 17.56 4.06 16.60 1.78 18.75 5.75 -1.12 0.28 
Age of first use: Alcohol 14.85 1.93 14.70 1.57 14.94 2.17 -0.30 0.77 
Note: 
a Beck’s Depression Inventory; b Pre-clubbing experience; c Post-clubbing 
experience; 
d 
Unusual Experiences; 
e
 Cognitive Disorganisation; 
f 
Introvertive 
Anhedonia;
g
 Impulse Non-conformity; 
 
Results in the behavioural tasks 
(1) RAVLT  
For the immediate recall measure, we found that mephedrone users performed worse 
than controls (F(1,24) = 10.43, p < .01, partial η2= .30; see Table 12). The interaction 
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between group and day (F(1,24)= .85, p= .37, partial η2 = .03) and the effect of day 
(F(1,24) = 1.99, p = .17, partial η2= .08; see Table 12) were both not significant. For the 
delayed recall measure, we found that mephedrone users performed significantly worse 
than controls (F(1,24) = 12.33, p < .01, partial η2= .34; see Table 12). Whereas the 
effect of day (F(1,24) = .73, p = .40, partial η2 = .03; see Table 12) was not significant, 
the analysis revealed a significant interaction between group and day (F(1,24) = 7.72, p 
= .01, partial η2 = .24). Post-hoc paired samples t-tests split by group revealed that in 
the control group there was no difference in scores between pre- and post clubbing 
[t(15) = -1.30, p = .21]. However, the mephedrone group showed a significant decrease 
in delayed recall performance between pre- and post-clubbing [t(9) = 4.33, p < .01; see 
Table 12]. 
Table 12. Means and standard deviations (SD) of task performance for the total sample 
and the two groups separately. 
 All Mephedrone Control 
Variables Mean SD Mean SD Mean SD 
RAVLT
a
 % Immediate 
b 
pre
c
 
79.85 10.07 74.50 11.37 83.19 7.78 
RAVLT % Immediate 
post
 d
 
78.27 9.09 71.30 8.60 82.63 6.38 
RAVLT % Delayed
 e
 
pre 
82.81 17.03 74.60 19.39 87.94 13.60 
RAVLT % Delayed 
post 
82.27 19.27 66.00 19.18 92.44 10.54 
COWAT
f
 pre 45.88 9.09 42.40 10.29 48.06 7.81 
COWAT post 44.69 10.20 38.20 8.70 48.75 9.07 
TMT
 g
 index pre 16.49 9.39 14.61 5.80 17.66 11.10 
TMT index post 15.62 7.41 14.92 5.81 16.06 8.41 
Note: 
a 
Rey Auditory verbal memory task; 
b 
Immediate Recall; 
c
 Pre-clubbing; 
d 
Post-
clubbing; 
e 
Delayed Recall; 
f
 Verbal Fluency Task; 
g 
Trail Making Task;  
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(2) COWAT 
There was a significant main effect for group (F(1,24) = 5.32, p = .03, partial η2= .18), 
with mephedrone users performing significantly worse than controls (see Table 12). 
Additionally, there was a significant effect of day (F(1,24) = 6.77, p = .02, partial η2= 
.22; see Table 12), and interaction between group and day (F(1,24) = 13.11, p < .01, 
partial η2 = .35). Post-hoc paired samples t-tests split by group revealed that in the 
mephedrone group values significantly decreased from pre- to post-clubbing [t(9) = 
5.00, p < .01; see Table 12), whereas there was no day difference in the control group 
[t(15) = -.74, p = .47; see Table 12). 
(3) TMT 
There were no significant findings (group: F(1,24) = .39 p = .54, partial η2 = .02; day: 
F(1,24) = .60, p = .45, partial η2 = .02, interaction between group * day: F(1,24) = 1.31, 
p = .26, partial η2 =.05; see Table 12). 
Regressions: Severity of drug use and schizotypy as predictors of performance 
To further investigate the possibility that schizotypy may be relevant to cognitive 
functioning on top of drug use, multivariate step-wise regressions were conducted. 
Exploratory correlation analyses (Table 13) showed that pre-clubbing amphetamine, 
mephedrone and cannabis use, as well as CogDis scores correlated with cognitive 
functioning. Therefore, for the pre-clubbing session amphetamine, mephedrone and 
cannabis use in the past 30 days was entered in the first step, and CogDis scores in the 
second step.  
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Table 13. Correlations between potential predictor variables and outcome measures 
pre- clubbing. Significant values are highlighted in bold. 
Variables 
RAVLT
h
 % 
Immediate 
i 
pre 
RAVLT % 
Delayed
 j
 
pre 
TMT
 k
 
index pre 
COWAT
l
 
pre 
Age 0.30 0.04 0.23 0.24 
NART
a
 0.15 0.08 -0.22 0.35† 
BDI
b
 pre
c
 -0.27 -0.26 -0.08 -0.34† 
Average sleep 0.05 0.29 -0.02 -0.16 
UnEx
d
 -0.22 -0.25 0.03 -0.25 
CogDis
e
 -0.47* -0.13 0.04 -0.65*** 
IntAn
f
 0.14 0.21 -0.13 0.17 
ImpNC
g
 -0.17 -0.17 0.09 -0.37† 
Amphetamine
 
 past 30 days -.49* -0.52** -0.21 -0.30 
Mephedrone past 30 days -.48* -0.18 0.01 -0.29 
Nicotine past 30 days -0.21 -0.31 -0.18 0.04 
Cannabis past 30 days -0.63*** -0.34† 0.02 -0.39* 
Alcohol past 30 days 0.20 -0.07 -0.12 0.28 
†
p≤.10; * significant at p≤.05; ** significant at p≤.01; *** significant at p≤.001  
 
Note: ; 
 a
 National Adult Reading Test; 
b 
Beck’s Depression Inventory; c Pre-clubbing 
experience; 
d
 Unusual Experiences; 
e
 Cognitive Disorganization; 
f
 Introvertive 
Anhedonia; 
g
 Impulsive Non-conformity; 
h
 Rey Auditory verbal memory task; 
i 
Immediate Recall; 
j 
Delayed Recall; 
k 
Trail Making Task; 
l
 Verbal Fluency Task; 
 
For the post-clubbing session (Table 14) BDI scores, total hours of sleep between test 
sessions, mephedrone use and schizotypy scores (UnEx, CogDis and ImpNC scores) 
were correlated with at least one of the outcome measures. Therefore, BDI scores post-
clubbing and total hours of sleep between test sessions were entered in the first step, 
mephedrone use between test sessions in the second, and schizotypy subscales (UnEx, 
CogDis and ImpNC) in the third step. 
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Table 14. Correlations between potential predictor variables and outcome measures 
post-clubbing. Significant values are highlighted in bold. 
Variables 
RAVLT
 h
 % 
Immediate
i 
post 
RAVLT % 
Delayed
 j
 post 
TMT
 k
 
index post 
COWA
T
l
 post 
Age 0.32 0.04 0.07 0.36† 
NART
 a
 0.24 -0.02 -0.32 0.30 
BDI
 b
 post
c
 -0.49* -0.55** 0.02 -0.44* 
Total hours sleep 
between test sessions 
-0.36† -0.22 0.13 -0.39* 
UnEx
 d
 -0.31 -0.54** 0.09 -0.23 
CogDis
 e
 -0.52** -0.47* 0.15 -0.59** 
IntAn
 f
 -0.23 0.05 0.03 0.19 
ImpNC
 g
 -0.40* -0.47* 0.10 -0.40* 
Alcohol between test 
sessions 
0.02 -0.22 -0.06 -0.08 
Cannabis between 
test sessions 
-0.26 -0.35† -0.29 -0.29 
Mephedrone between 
test sessions 
-0.58** -0.52** 0.00 -0.43* 
†
p≤.10; * significant at p≤.05; ** significant at p≤.01; *** significant at p≤.001  
 
Note: ; 
 a
 National Adult Reading Test; 
b 
Beck’s Depression Inventory; c Post-clubbing; d 
Unusual Experiences; 
e
 Cognitive Disorganization; 
f
 Introvertive Anhedonia; 
g
 
Impulsive Non-conformity; 
h
 Rey Auditory verbal memory task; 
i 
Immediate Recall; 
j
 
Delayed Recall; 
k 
Trail Making Task;
 l
 Verbal Fluency Task; 
 
The results from the regression on the pre-clubbing session are displayed in Table 15. 
We found that immediate recall in the RAVLT was reduced with increasing cannabis 
use and delayed recall in the RAVLT was reduced with increasing amphetamine use. 
Additionally, increasing CogDis scores related to a decreasing number of words 
produced in the COWAT.  
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Table 15. Regression analysis assessing the effect of cannabis, mephedrone and 
amphetamine use (step 1) and CogDis (step 2) on cognitive functioning at the pre-
clubbing session. Only significant ΔR²-values and their corresponding coefficients (β-
values) are reported. 
Outcome 
variables 
Step Significant 
predictor 
β-value Total R² ΔR² F for ΔR² 
RAVLT
 a
 % 
immediate 
b
 
1 Cannabis -0.60* 0.48** 0.48** 6.85** 
  1 Amphetamines -0.33† SAA SAA SAA 
RAVLT % 
delayed 
c
 
1 Amphetamines -0.53* 0.35* .035* 3.99* 
COWAT
 d
 2 CogDis
 e
 -0.58** 0.45** 0.26** 9.76** 
† p≤.10; * significant at p≤.05; ** significant at p≤.01; *** significant at p≤.001  
Note: 
a 
Rey Auditory verbal memory task; 
b 
Immediate Recall; 
c
 Delayed Recall; 
d
 
Verbal Fluency Task; 
e
 Cognitive Disorganisation; 
 
The results from the regression on post-clubbing session are presented in Table 16. 
Results indicate that increasing BDI scores predicted lower RAVTL performance 
(immediate and delayed recall) as well as less words produced in the COWAT. 
Additionally, a higher amount of hours slept between test-sessions related to lower 
immediate recall performance in the RAVTL and less words produced in the COWAT. 
Adding drugs or schizotypy in later steps did not explain additional variance in 
cognitive functioning.  
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Table 16. Regression assessing the effect of total hours of sleep between test sessions 
and depression (Beck´s Depression Inventory/BDI; step 1), mephedrone use between 
test sessions (step 2), and schizotypy (Unusual Experiences, Cognitive Disorganisation, 
and Impulse Non-conformity; step 3) on cognitive functioning post-clubbing. Only 
significant ΔR²-values and their corresponding coefficients (β-values) are reported. 
Outcome 
variables 
Step Significant predictor β-value Total R² ΔR² F for ΔR² 
RAVLT %
 a
 
immediate 
b
 
1 BDI
 e
 post
 f
  -0.55** 0.42** 0.42** 8.45** 
 
1 Total hours of sleep 
between test sessions  
-0.43* SAA
 g
 SAA SAA 
RAVLT
 
 % 
delayed 
c
 1 BDI post -0.59** 0.39** 0.39** 7.40** 
COWAT
 d
 
1 BDI post -0.50** 0.39** 0.39** 7.49** 
 
1 Total hours of sleep 
between test sessions 
-0.46* SAA SAA SAA 
* significant at p≤.05; ** significant at p≤.01;  
 
Note: 
a 
Rey Auditory verbal memory task; 
b 
Immediate Recall; 
c
 Delayed Recall; 
d
 
Verbal Fluency Task; 
e
 Beck’s Depression Inventory;  f Post- clubbing; g Same as above; 
 
5. Discussion 
Drug policies are aimed to prevent harm to people by making access to these drugs 
more difficult. To avoid the problem of the illegality of drugs, new drugs are frequently 
developed that are little or not yet regulated. Among those drugs are popular new wave 
designer drugs such as mephedrone. These provide “legal highs” without knowing 
much about their harmfulness or factors that might predict it. We here investigated 
whether mephedrone use might have a negative impact on cognitive functioning, and 
whether any such relationship might be influenced by individuals’ schizotypal features. 
We tested cognitive functions that were formerly associated with amphetamine use and 
elevated schizotypy, i.e. cognitive flexibility, verbal learning and verbal fluency. 
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Importantly, we were able to recruit volunteers in a “natural” setting, i.e. before (pre-
clubbing) and after (post-clubbing) a clubbing experience during which drugs such as 
mephedrone are commonly consumed. The advantage of this design consists in the 
assessment of i) participants’ baseline functioning (i.e. the cognitive level at which 
individuals with different drug histories entered the study), and ii) how the drug use of 
the clubbing experience affected their cognitive performance (i.e. short-term effects). 
The main findings of the present study were that i) mephedrone users performed worse 
than controls at baseline and their performance decreased pre- to post-clubbing in tasks 
measuring cognitive functioning, ii) cannabis and amphetamine use related to decreased 
cognitive performance in the pre-clubbing session, whereas mephedrone did not, iii) 
depression rather than drug use or schizotypy was the most consistent predictor of 
cognitive attenuations in the post-clubbing session, and iv) schizotypy did not explain 
variance in cognitive functioning (apart from CogDis in the pre-clubbing session) when 
controlling for drug use. These findings will be discussed in the following sections. 
 
We argued that the cognitive consequences of mephedrone use should mirror those of 
amphetamine use, because studies reported on physiological, chemical and 
psychological similarities between the consequences of amphetamine (such as ecstasy) 
and cathinone use (ACMD, 2010; Brenneisen, et al., 1990; Dal Cason, et al., 1997; 
Hoffman & Al'Absi, 2010; James, et al., 2010; Kalix, 1992; Morris, 2010; Schifano, et 
al., 2010; Vardakou, et al., 2011).  
For our pre-clubbing session, we already observed that mephedrone users performed 
worse than the control group for immediate and delayed verbal recall, and verbal 
fluency. Our group results also showed that performance in all but the TMT task 
became worse over the pre-clubbing to post-clubbing session in our mephedrone users 
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as compared to controls. If we would have only performed these group comparisons, we 
would have concluded that recent mephedrone use negatively affects cognitive 
functioning. We have, however, obtained more detailed information on other drug use 
as well, and this additional drug use was important to cognitive functioning.   
 
When taking additional drug use into consideration, we firstly found that mephedrone 
users as compared to controls had consumed more amphetamines and nicotine in the 30 
days prior to testing. Secondly, when looking at the individual contribution of drug use 
(regression analysis) on cognitive functioning, we found that enhanced cannabis and 
amphetamine use was related to memory impairments, whereas mephedrone use was 
not. These latter results are in line with studies on the cognitive effects of amphetamines 
(see Gouzoulis-Mayfrank & Daumann, 2009; Hoshi et al., 2007; Kuypers & Ramaekers, 
2005; M. J. Morgan, 2000; G. Rogers et al., 2009 for overview), cathinones (Colzato, et 
al., 2011), and cannabis (Fernández-Serrano, et al., 2011) indicating impairments in 
verbal recall, verbal learning and/or fluency as a function of these drugs’ consumption. 
Our findings and the previous literature would thus suggest that mephedrone 
consumption does not necessarily exert a negative impact on cognitive functioning by 
itself. Instead, mephedrone users are likely those individuals who are prone consuming 
or having consumed other drugs before. It might be this polydrug use that makes these 
individuals more vulnerable to the observed attenuations in the cognitive tasks. In line 
with this rational, it seems difficult to find pure users of any one substance alone 
(Fernández-Serrano, et al., 2011), and our sample has been no exception.  
 
The implication of polydrug use when trying to understand the influence of a particular 
drug on cognition is thus far-reaching. For instance, those who have a risk for negative 
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implications of drug use on mental health are likely polydrug users (Bondi, Drake, & 
Grant, 1998; Hakansson, Schlyter, & Berglund, 2011). Findings from 
psychopharmacological studies who have pre-selected their participants according to 
drug naivety might thus not provide very representative results for a clinically relevant 
population. Moreover, when only use of one particular drug is targeted (see Fernández-
Serrano, et al., 2011 for overview), we might neglect and miss out on the influence of 
other drugs on the relationship we are interested in. Based on these considerations, we 
here conjecture that it might be impossible to infer about the impact of a single drug on 
cognition in a research context as the present one. Instead, we should take polydrug use 
more thoroughly into account, as former polydrug use might also explain long-term 
effects on cognitive functioning in substance users.  
 
Polydrug use and not only single drug use might also be relevant for cognition and 
mood in the short-term, as was found here when considering post-clubbing performance 
and mood. In the regression analysis, we explored additional factors that could 
influence cognitive measures post-clubbing more thoroughly. Strikingly, we found that 
higher BDI scores and prolonged sleep (rather than drug use or schizotypy) predicted a 
relative drop in cognitive performance. While not our a priori focus, the role of 
depression is worthwhile considering. To start with, our mephedrone users as compared 
to controls showed higher BDI scores both pre-clubbing and post-clubbing. Moreover, 
schizotypy scores showed no additional influence on cognitive functioning post-
clubbing, and the influence of actual drug use seemed to become marginal when BDI 
scores were considered. We thus conjecture that depression might be a major confound 
in previous schizotypy and drug studies that targeted cognitive functions, because 
depression levels are commonly not assessed (e.g. Herzig, et al., 2010; Skosnik, et al., 
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2001). The same can be said for studies testing non-clinical populations (and thus non-
clinical depression) on the influence of particular drugs, where potentially relevant 
depression ratings have not been reported in relatively pure cannabis users (Fried, et al., 
2005), alcohol users (Ratti, Bo, Giardini, & Soragna, 2002) or psychostimulant users 
(Bolla et al., 2003). Depression rates are, however, relatively elevated in e.g. 
amphetamine users (M. J. Morgan, 2000; G. Rogers, et al., 2009 for overview), alcohol 
users (Weitzman, 2004) or cannabis users (Hayatbakhsh et al., 2007; Patton et al., 
2002). Consequently, if depression is a major confound in studies such as the present 
one, we would expect that depression influences cognitive functioning directly (primary 
influence) or indirectly (secondary influence through e.g. loss of motivation), much as 
we have originally expected this to be the case for drug use and / or schizotypy.  
 
Studies that tested the link between depression and cognitive functioning indeed report 
that clinical depression in young adults is accompanied by relatively impaired cognitive 
functioning including those we tested here (see Castaneda, Tuulio-Henriksson, 
Marttunen, Suvisaari, & Lönnqvist, 2008 for overview). Even in healthy subjects, 
negative mood can lead to reduced brain activity during verbal (not spatial) working 
memory tasks (Aoki et al., 2011). Finally, the mood-behavior model (Gendolla, 2000) 
predicts that negative mood results in disengagement and little resource mobilization 
when facing difficult tasks, as demands would be perceived as being too high 
(Silvestrini & Gendolla, 2009). Given that negative mood is frequently a characteristic 
of depression, it is possible that task performance decreases the more individuals are 
depressed, due to decreased motivation (Engelmann, Damaraju, Padmala, & Pessoa, 
2009; Locke & Braver, 2008).  
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Another possibility, though not necessarily independent of motivational factors, could 
be that the clubbing experience (including the drug consumption) resulted in 
neurochemical changes related to depression via serotonergic pathways, or more 
specifically through an attenuation of serotonergic functioning (Bhagwagar et al., 2006; 
Meyer et al., 2004; Meyer et al., 2003). Serotonin is a neurotransmitter, importantly 
linked to depression, to amphetamine use (see Walstab, Rappold, & Niesler, 2010 for 
overview), and the interaction between depression and amphetamine use (see Darke, 
Kaye, McKetin, & Duflou, 2008 for overview; McCardle, et al., 2004; M. J. Morgan, 
2000; G. Rogers, et al., 2009). In all cases, a reduction in serotonin availability seems to 
have negative consequences. For instance, taking amphetamines such as ecstasy is 
related to a drop in mood, observable about two days after its consumption (Curran & 
Travill, 1997; Parrott & Lasky, 1998), presumably via reductions in serotonin-receptor 
density and binding [McCann et al. (1998; 2008)]. These changes in serotonin 
functioning have also been related to verbal memory performance (Reneman et al., 
2001). Interestingly, serotonin receptor functioning has been implicated in the 
rewarding effects of THC as well (Maldonado, Berrendero, Ozaita, & Robledo, 2011), 
and some studies suggest that the effect of amphetamine and cannabis on memory 
functions is accumulative when consumed in parallel (see Mohamed, Hamida, Cassel, 
de Vasconcelos, & Jones, 2011 for overview). Taken together, these findings suggest 
that amphetamine and cannabis use may have altered susceptibility to mood-related 
cognitive attenuations, either via motivational factors, neurochemical modulations, or 
both.  
 
To summarize, drug use was a consistent predictor of task performance in the long-term 
(pre-clubbing), and may have induced mood-related attenuations in cognitive 
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functioning in the short-term (post-clubbing). Schizotypy, on the other hand, was 
largely irrelevant to cognitive functioning on top of (poly-)drug use. The only 
significant schizotypy finding was that enhanced CogDis scores related to reduced 
verbal fluency. If we consider this single significant finding to be meaningful, the 
question arises whether some schizotypy dimensions are pathologically more relevant 
than others. Indeed, several researchers have indicated that CogDis is related to 
perceiving unusual experiences as unpleasant (Schofield & Claridge, 2007), or related 
to cognitive attenuations and poor emotional processing (Kerns & Becker, 2008). A 
problem is certainly the lack of consideration of disorganised symptoms in studies that 
found attenuated cognitive functioning relating to positive symptoms (Hoshi, Scoales, 
Mason, & Kamboj, 2011; Laws, et al., 2011; Lenzenweger & Korfine, 1994), and that 
most of the psychometric tools used in these studies do not distinguish between the two 
symptom dimensions (L. J. Chapman, et al., 1976; L. J. Chapman, et al., 1978; Eckblad 
& Chapman, 1983; Eysenck & Eysenck, 1975; Peters, Joseph, & Garety, 1999; 
Winterstein, et al., 2011).  
If cognitive disorganisation is considered to be a separate symptom dimension, it seems 
more relevant to cognitive performance than the positive symptom dimension. For 
instance, in a study by Rawlings and Goldberg (2001) performance in a continuous 
performance task was affected by higher cognitive disorganization, but not as 
consistently by other schizotypy dimensions. Similar conclusions on the role of 
symptom dimensions have also been drawn from studies in other schizotypal samples 
(Bejaoui & Pedinielli, 2010; Chan et al., 2011; Steffen Moritz, Andresen, Naber, 
Krausz, & Probsthein, 1999) and in patients with schizophrenia (Kebir et al., 2008; 
Lucas et al., 2004). With regard to schizotypy, positive symptoms have even been 
associated with performance benefits in creativity tasks (Batey & Furnham, 2008; 
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Mohr, Graves, Gianotti, Pizzagalli, & Brugger, 2001; B. Nelson & Rawlings, 2010). It 
might be the case that only scoring high on positive schizotypy relates to a well-adapted 
cognitive profile, while high scores in CogDis alone and/or in combination with high 
scores in positive schizotypy might yield the most disadvantageous cognitive profile 
(Schofield & Claridge, 2007). Our results would support this notion.  
Study limitations and implications 
Our study population consisted of volunteers who were willing to come to the 
laboratory twice, shortly before and after a clubbing night. Moreover, testing had to be 
completed within two months. These study constraints reduced the number of possible 
participants, and by inference the overall sample size. Given our naturalistic designs, we 
nevertheless argue that our results are informative (Fernández-Serrano, et al., 2011), and 
stress that we could retain a considerable number of participants despite their clubbing 
activity, and decreased mood. These volunteers committed themselves to be tested twice 
around their clubbing experience, turning this sample and the measurements into a 
valuable data pool. Only with this naturalistic design were we able to assess the long-
term (pre-clubbing) and short-term (post-clubbing) effects of drug use as it might occur 
in everyday situations. We do suggest that the current study, its design and results 
revealed important new findings that should be followed up in future studies, including 
laboratory ones (the role of depression, changes in results due to the emotional 
consequences of the clubbing / drug experience not observable in laboratory tests of 
drug exposure, the problem of poly-drug use).  
Illicit drug use and depression are associated, but so are licit drugs. For instance, alcohol 
negatively influences mood, and the accumulation of this effect could be related to the 
depression rate increase seen in mephedrone users as well. According to recent meta-
II     Experiments: Mephedrone, polydrug use and cognition 
128 
 
analyses, alcohol increases the risk for depression (Boden & Fergusson, 2011), is 
related to impairments in memory and verbal fluency (see Fernández-Serrano, et al., 
2011 for overview; Manning et al., 2008; Wendt & Risberg, 2001; Zeigler, et al., 2005), 
and hangovers are usually associated with low mood (Howland et al., 2010). Moreover, 
alcohol seems to affect serotonin-receptor functioning, similarly to amphetamines 
(McHugh, Hofmann, Asnaani, Sawyer, & Otto, 2010; Vengeliene, Bilbao, Molander, & 
Spanagel, 2008). Given that alcohol has been used more frequently between test 
sessions in our sample, we assume important interaction effects with alcohol.  
It is also possible that the effects of mephedrone become more pronounced in chronic 
users, or those that use the drug at a high frequency, as in our sample use was relatively 
low (about 1.5 times/month). Additionally, it could have been advantageous to test the 
effects of mephedrone use in a sample of less educated subjects. IQ may have the 
potential to protect from adverse situations in e.g. psychiatric illnesses (MacCabe & 
Murray, 2004; Moore, et al., 2007; Sørensen et al., 2010) or substance use (Pope, et al., 
2003; Zammit, et al., 2010). However, in our sample most participants were students, or 
educated to at least degree level. Therefore, more variance in subjects’ educational 
level/IQ could be informative in subsequent studies. 
Conclusion 
We set out to investigate the effects of mephedrone use on cognition, and elucidate the 
relationship between drug use, schizotypal symptoms and cognitive functioning. Results 
showed that even before clubbing mephedrone users performed worse than non-users on 
cognitive tasks. In mephedrone users but not in controls, performance in verbal learning 
and fluency decreased over the clubbing experience. Additional analysis on the use of 
other drugs and psychological factors, however, indicated that the changes in cognitive 
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functioning were likely due to prior polydrug use (amphetamine, cannabis and alcohol 
use in particular), and related psychological consequences (enhanced depression rates). 
Schizotypal traits were rather unrelated to cognitive performance, apart from CogDis. 
This schizotypy subscale may therefore represent a pathologically more relevant 
symptom dimension. The present study shows that polydrug use should be considered in 
future studies on drug effects on cognition, as well as relevant associated psychological 
concepts (depression, schizotypy). Given the political interest in preventing the 
population from harmful drug effects, knowing when and who is really under an 
elevated risk is warranted, also because a more regulated drug policy has been called for 
from various professional domains (Bennett & Holloway, 2010; Nutt, et al., 2010).  
 
II     Experiments: Mephedrone, polydrug use and cognition 
130 
 
6. Acknowledgements 
We would like to thank Birgit Whitman for aid with ethical issues, and Prof. David Nutt 
for his valuable advice.  
II     Experiments: Compensatory behaviours, schizotypy and hemispheric asymmetry 
131 
 
E. Study 4: Compensatory behaviours 
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1. Abstract 
Relative cognitive impairments are common along the schizophrenia spectrum 
reflecting potential psychopathological markers. Yet stress, a vulnerability marker in 
schizophrenia (including its spectrum), is likewise related to cognitive impairments. We 
investigated whether one such cognitive marker (attenuated functional hemispheric 
asymmetry) during stressful life periods might be linked to individuals’ schizotypal 
features or rather to individuals’ stress-related experiences and behaviours. Fifty-eight 
students performed a left (lateralized lexical decisions) and right (sex decisions on 
composite faces) hemisphere dominant task. In order to account for individual 
differences in stress sensitivity, we separated participants into groups of high or low 
cognitive reserve according to their average current marks. In addition, participants 
filled in questionnaires on schizotypy (short O-LIFE), perceived stress, stress response, 
and a newly adapted questionnaire that enquired about potential stress compensation 
behaviour (elevated substance use). The most important finding was that enhanced 
substance use and cognitive disorganisation contributed to a right and left hemisphere 
shift in language dominance, respectively. We discuss that i) former reports on right 
hemisphere shifts in language dominance with positive schizotypy might be explained 
by an associated higher substance use and ii) cognitive disorganisation relates to 
unstable cognitive functioning that depend on individuals life circumstances, 
contributing to published reports on inconsistent laterality – schizotypy relationships.  
 
 
Keywords: Stress, drug dependence, schizophrenia spectrum, cognitive reserve, 
hemispheric asymmetry 
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2. Introduction 
Relative cognitive impairments are common in patients with psychosis as well as in less 
severely affected individuals along the schizophrenia spectrum. This includes 
individuals with a schizotypal personality disorder [see Reichenberg & Harvey (2007) 
for overview], and those scoring high on schizotypy questionnaires (Burch, et al., 2004; 
Krabbendam, et al., 2005; Laurent, et al., 2001; Poreh, et al., 1995). For instance, higher 
cognitive functions that rely on the frontal lobes (e.g. working memory, fluency) seem 
impaired along the schizophrenia spectrum, including schizotypy (Laurent, et al., 2001; 
Reichenberg & Harvey, 2007; Tsakanikos & Claridge, 2005). Supporting the likely 
brain correlates of such behavioural findings, the frontal lobes have long been discussed 
as a target area of psychopathology along the schizophrenia spectrum (Buchsbaum, et 
al., 2002).  
Most relevant to the present study are those reports that link common patterns of 
functional hemispheric asymmetry to intact frontal and temporal lobe functioning 
(Rossell, Bullmore, Williams, & David, 2001). In particular, the common hemispheric 
asymmetry pattern seems to be disrupted along the schizophrenia spectrum with 
reduced left hemisphere dominance for language or a reduced right hemisphere 
dominance for face processing reported from patients with schizophrenia (Bleich-
Cohen, et al., 2009; Kucharska-Pietura, et al., 2002; Mitchell & Crow, 2005; Phillips & 
David, 1997; Sommer, et al., 2001) and healthy individuals with elevated self-reported 
schizotypy (Broks, 1984; Brugger, et al., 1993; Løberg, et al., 2006; Mason & Claridge, 
1999; Mohr, Krummenacher, et al., 2005; Suzuki & Usher, 2009). It is considered that 
cognitive impairments (such as those specified here) might be a reflection of the illness, 
or even be a marker of the schizophrenia spectrum (Crow, 2000; Noguchi, et al., 2008).  
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In addition to above, the stress response system seems to be implicated along the 
schizophrenia spectrum as well. Firstly, the hypothalamic-pituitary-adrenal (HPA) axis, 
one of the primary neural systems triggered by stress exposure, may be hyperactive in 
psychotic patients (Walker, Mittal, & Tessner, 2008). Secondly, increases in the stress-
hormone cortisol can elevate psychotic symptoms in patients with schizophrenia [see 
Walker et al. (1997; 2008) for overview]. Drugs that increase cortisol serum levels 
induced mild psychotic symptoms and perceptual disturbances in healthy individuals 
(D'Souza et al., 2006). Thirdly, an elevated stress response has also been found in 
schizotypy (Soliman et al., 2008; see van Winkel, Stefanis, & Myin-Germeys, 2008 for 
overview), which may explain why individuals scoring high on positive schizotypy 
show sensitivity to threatening (stressful) stimuli (Fisher et al., 2004).  
 
Stress has not only been linked to the schizophrenia spectrum, but also to the cognitive 
functions associated with it. For instance, cortisol administration disrupts verbal 
memory functions (Newcomer et al., 1999). Naturalistic stressors such as exam stress 
cause increased cortisol levels in some (Lucini, Norbiato, Clerici, & Pagani, 2002; 
Morgan III, Rasmusson, Pietrzak, Coric, & Southwick, 2009) though not all studies 
(Vedhara, Hyde, Gilchrist, Tytherleigh, & Plummer, 2000). Naturalistic stressors 
associate with shifts in hemispheric functioning such that relatively greater left frontal 
EEG-activity during low examination stress, shifts to relatively greater right frontal 
activity during high examination stress [see also Gruzelier and Phelan (1991)]. This 
shift is associated with increasing health complaints [(Lewis, Weekes, and Wang 
(2007)].  
Given these cross-links between the schizophrenia spectrum, stress, and cognition, we 
investigated whether shifts in hemispheric asymmetry would be influenced by elevated 
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stress rather than by participants’ self-reported psychotic and psychotic-like thinking 
(Broks, 1984; Brugger, et al., 1993; Løberg, et al., 2006; Mason & Claridge, 1999; 
Mohr, Krummenacher, et al., 2005; Suzuki & Usher, 2009).  We also accounted for 
individual differences in stress responses and evaluations by asking about stress-related 
behaviours / experiences and cognitive reserve for the following reasons. Stress-related 
behaviours and experiences such as smoking (Finkelstein, Kubzansky, & Goodman, 
2006) and drug use (Goeders, 2003) have been found to increase in times of elevated 
stress including periods before / during exams (Kassel, Stroud, & Paronis, 2003; Ng & 
Jeffery, 2003; Steptoe, Wardle, Pollard, Canaan, & Davies, 1996; Umberson, Liu, & 
Reczek, 2008) because they might have stress-alleviating properties (henceforth referred 
to as compensatory behaviours). Such compensatory behaviours may influence 
cognition [e.g. Scarmeas and Stern (2003)], and seem to occur more frequently along 
the schizophrenia spectrum (Cantwell et al., 1999; Kavanagh, McGrath, Saunders, 
Dore, & Clark, 2002; Regier et al., 1990). Cognitive reserve (also referred to as 
cognitive resilience, and sometimes linked to IQ), can be understood as an efficient 
dynamism with which the brain balances out threatening situations and challenges in 
order to maintain efficient cognitive functioning (Katzman et al., 1989; Stern, 2002). 
Cognitive reserve may protect from adverse situations in  psychiatric illnesses 
(MacCabe & Murray, 2004; Moore, et al., 2007; Sørensen, et al., 2010) including post-
traumatic stress disorder (see Buckley, Blanchard, & Neill, 2000 for overview).  
 
In the present study, we investigated whether uncommon patterns of hemispheric 
asymmetry might relate to an abnormal or overactive stress response rather than to 
individuals’ self-reported schizotypy. We assessed whether reduced hemispheric 
asymmetry in a left (lateralized lexical decisions) and right (sex decisions in visual 
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composite faces) hemisphere dominant task is affected by individuals’ experienced 
stress / compensatory behaviours and cognitive reserve rather than by their self-reported 
schizotypy. If stress is a more important predictor of hemispheric asymmetry than 
schizotypy, we expect that higher stress levels and higher stress-related compensatory 
behaviours will relate to a reduced hemispheric asymmetry for function, in particular in 
those with less cognitive reserve (relatively lower marks).  
 
3. Methods 
Participants 
This native English speaking student sample (n = 58, n = 16 males) reported normal or 
corrected to normal vision, and was right-handed according to a standardized 
handedness questionnaire [Oldfield (1971), scoring criteria see also Kita, de Condappa 
and Mohr (2007)]. The sample consisted of MSc students (n = 29) and BSc students at 
the University of Bristol. Their mean age (years, ±SD) was 20.33 (±2.35). Participants 
took part to obtain course credit or were recruited via a local internet advertising 
system. The study was approved by the local ethics committee. All participants 
provided written informed consent prior to participation. As indicated by self-report, 
none of the participants reported a previous history of psychiatric or neurological illness 
(Mohr, et al., 2006).  
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Self-report questionnaires 
(1) Perceived stress scale  
This 14-item scale (S. Cohen, Kamarck, & Mermelstein, 1983) measures global levels 
of perceived stress tapping into the key components of perceived stress, namely how 
uncontrollable, unpredictable and overloading (Averill, 1973; Houston, 1972; Monat, 
Averill, & Lazarus, 1972; Schulz, Kirschbaum, Prüßner, & Hellhammer, 1998) 
respondents found their lives in the past month. Participants answer on a 5-point Likert 
scale ranging from ‘never’, ‘almost never’, ‘sometimes’, ‘fairly often’ and ‘very often’. 
After coding all items so that higher scores indicate higher perceived stress levels, 
scores range from 0 to 56. The perceived stress scale has adequate internal validity, 
construct validity and test-retest-reliability (S. Cohen, et al., 1983; Ramirez & 
Hernandez, 2007). Normative values can be found in Ramirez & Hernandez (2007). 
(2) Stress response inventory 
This 39-item stress response inventory (Koh, Park, Kim, & Cho, 2001) measures 
emotional, somatic, cognitive, and behavioural stress responses  tapping into different 
stress-response domains such as tension (6 statements), aggression (4 statements), 
somatisation (3 statements), anger (6 statements), depression (8 statements), fatigue (5 
statements) and frustration (7 statements). People indicate how much each statement 
applied to them in the past month on a 5-point Likert scale with the response options 
being ’Not at all’ (scored ‘0’), ’Somewhat’ (scored ‘1’), ’Moderately’ (scored ‘2’),’Very 
much’ (scored ‘3’), or ’Absolutely’ (scored ‘4’). After coding all items so that higher 
scores indicate a higher stress response, scores range from 0 to 156. The stress response 
inventory is considered to have adequate internal consistency and test-retest reliability, 
and normative values for different populations can be found in Koh et al. (2001). 
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(3) Short O-LIFE 
The short O-LIFE questionnaire (Mason, et al., 2005) is a validated 43-item self-report 
questionnaire assessing schizotypy in terms of four dimensions. Positive schizotypy is 
assessed by 12 items pertaining to Unusual Experiences (UnEx, maximum score 12,), 
negative schizotypy is assessed by 10 items pertaining to Introvertive Anhedonia 
(IntAn, maximum score 10), and Cognitive Disorganization is assessed by 11 items 
(CogDis, maximum score 11). Finally, 10 items assess Impulsive Nonconformity (Imp, 
maximum score 10), which does not represent a schizotypy dimension (Mason, et al., 
1995), but will be accounted for in the present study because of the strong link between 
impulsivity and addiction (Crews & Boettiger, 2009). For each item, participants have 
to indicate whether the statement is true or false. The number of positive responses 
(some items are reversely formulated) is summed so that higher scores indicate higher 
schizotypy. Normative values can be found in Mason et al. (2005) and the scale has 
shown good internal consistency as well as high correlations with the original O-LIFE 
questionnaire (Mason, et al., 1995; Mason, et al., 2005). 
(4) Compensatory behaviours 
This adapted questionnaire (see Appendix, part A) is based on Ogden et al.’s (1997) 
‘Exercise Dependence Questionnaire’, and is aimed to assess the severity or extent of 
substance based compensatory behaviours (henceforth referred to as substance-CB, 16 
items). To avoid stigmatization, reduce associations with clinically relevant dependence, 
ethical concerns and socially desirable answers, we did not ask for drug use or drug 
addiction, but focussed on the need, or habit to consume a given substance (see the 
questionnaire instructions in Appendix, part A). Nevertheless, the items assess a variety 
of life-domains commonly affected by clinically relevant dependency, such as 
‘interference with social / family life’ (3 statements), ‘withdrawal symptoms’ (3 
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statements), ‘insight into problem’ (2 statements), ‘positive reward’ (3 statements), ‘loss 
of control’ (2 statements) and behaviour salience (3 statements). On a 5-point Likert 
scale, individuals indicate how often they think each statement applied to them in the 
past month, with response options being ‘Never’ (scored ‘0’), ‘Sometimes’ (scored ‘1’), 
‘Often’ (scored ‘2’), ‘Nearly always’ (scored ‘3’) and ‘Always’(scored ‘4’). Thus, 
scores range from 0 to 64 with a higher score indicating a higher ‘dependence’ on 
substance-CB.  
(5) Cognitive reserve 
To estimate cognitive reserve, participants indicated their current average mark. 
Answers were provided in percentages (0-100% scale), where 50% is a pass, 70% – 
100% (for taught components and dissertations, respectively) is a first or distinction. 
Higher scores indicate higher marks and by inference higher cognitive reserve. The link 
between higher marks and higher IQ/cognitive reserve is well established (see Buckley, 
et al., 2000 for overview; Spinath, Harald Freudenthaler, & Neubauer, 2010; Stern, 
2002). 
Hemi-field studies 
4
 
We assessed hemispheric asymmetry with two lateralized lexical and facial decision 
tasks used before (Herzig, et al., 2010). Details can be found in this reference, whereas 
we will only briefly describe the tasks here.  
(6) Lateralized Lexical Decision Task (LDT) 
The stimulus material consisted of 24 abstract words and 72 pronounceable non-words. 
The stimuli consisted of four- and five-letter words and were matched for 
                                                 
4
 We also assessed verbal and figural fluency performance. For economy of presentation, these findings 
will be presented elsewhere. Data and findings from the fluency tasks can also be requested from the 
corresponding author. 
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neighbourhood and CELEX frequency (Coltheart, 1981). Each word was matched with 
a non-word of the same length. The remaining non-words were matched to result in an 
additional set of non-word pairs. There were 72 trials with three 24-trial conditions 
(word left/non-word right, non-word left/word right, and non-word/non-word as the 
control condition). Participants were instructed to indicate whether they saw a 
meaningful English word on the left or right, or did not see a meaningful English word 
at all by pressing the shift key ipsilateral to the word with the index finger, or space bar 
with both thumbs if they did not see a meaningful string of letters on the screen.  Prior 
to the experimental task each participant undertook a practice block consisting of 10 
trials with words and non-words not used in the experimental trial.  The order of the 
stimuli was randomized within blocks and between participants, and trials were doubled 
according to suggestions by Hunter & Brysbaert (2008), resulting in a total of 144 trials. 
We assessed the number of correct lexical decisions and the mean reaction times for 
correct lexical decisions for the left (LVF) and right (RVF) visual field separately.  
(7) Lateralized Facial Decision Task (FDT) 
Participants were presented with emotionally neutral facial stimuli against a grey 
background on the computer screen. In the control condition, 20 whole faces (=WF, 10 
male, 10 female) were presented. From these, 20 sexually dimorphic composite faces 
were constructed with an equal number of female and male half-faces appearing in each 
visual field. These composite faces were also presented mirror-reversed resulting in 40 
composite faces. Participants were instructed to press one of the two shift keys to 
indicate the sex of the picture. The allocation of face sex to the two shift keys was 
counterbalanced between participants. Prior to the test trials participants were presented 
with a practice block of 10 trials consisting of two whole faces and eight composite 
faces that were not included in the experimental trials. The order of stimuli was 
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randomized within blocks and between participants, and trials were doubled according 
to suggestions by Hunter and Brysbaert (2008), resulting in 120 trials in total. We 
assessed the number and response time of facial decisions towards the left visual field 
(LF decisions) and right visual field (RF decisions).  
Data cleaning and analysis 
We excluded individual response latencies that were faster than 2xSD from the 
individual means of the different conditions in the LDT and FDT. To test for differences 
in performance as a function of cognitive reserve, we split the whole group into a group 
of high and low cognitive reserve at the median current average mark. Using these 
measures we calculated separate 2x2 mixed-samples ANOVAs with visual field (LVF, 
RVF) as the repeated factor and cognitive reserve (high, low) as the independent factor 
on i) mean reaction times of correct responses (LVF/RVF in the LDT), and ii) percent 
correct responses (LVF/RVF in the LDT). For the FDT (see Herzig, et al., 2010 for 
detailed rational), we performed a mixed-samples ANOVA on percent correct (WF) and 
percent LF decisions (composite faces) as repeated measure and the cognitive reserve 
group as between-subject measure. In addition (see Herzig, et al., 2010 for detailed 
rational), we performed a mixed-samples ANOVA on mean reaction time for sex 
decisions with face type (correct decisions for WF, LF decisions, RF decisions) as a 
repeated measure and the cognitive reserve group as a between-subject measure. Post-
hoc tests correcting for multiple comparisons were performed using Tukey HSD tests. 
Effect sizes (partial η2) are reported for all ANOVA results.  
 
We also tested whether, within each cognitive reserve group, the tasks resulted in 
lateralized performance at all (Herzig, et al., 2010; Mason & Claridge, 1999; Mohr, et 
al., 2006) using conventional laterality indices (J. C. Marshall, et al., 1975) by 
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subtracting inferior performance from superior performance, and dividing this 
difference by its sum. Accordingly, positive values indicated an advantage of the 
normally dominant hemisphere (LDT: left hemisphere/LH; FDT: right hemisphere/RH), 
and negative values an advantage of the normally sub-dominant hemisphere. In order to 
obtain indices that would be comparable in this respect, the index for i) accuracy in the 
LDT, and ii) reaction times in the FDT was [(RVF–LVF)/ (LVF+RVF)]*100, while the 
index for reaction times in the LDT was [(LVF–RVF)/ (LVF+RVF)]*100. For accuracy 
in the FDT, we needed only the percentage of LF decisions (as LF and RF decisions 
added up to 100%). These indices were calculated for each cognitive reserve group 
separately, with one sample t–tests against chance level (zero for both LDT indices and 
the FDT RT index, 50% for the FDT LF percentage index).  
 
To establish an effect of schizotypy over and above age, cognitive reserve (average 
mark), substance-CB and stress (perceived stress scale, stress response inventory) on 
hemispheric asymmetry, we performed hierarchical regressions as follows. Age was 
entered in the first step (Amirkhan & Auyeung, 2007; Brallier, Palm, & Gilbert, 2007; 
see also Tables 21 and 22), cognitive reserve (average mark) was entered in the second 
step, substance-CB in the third step, stress measures (perceived stress scale, stress 
response inventory) in the fourth step, and schizotypy (UnEx scores, CogDis scores 
IntAn scores, Imp scores) in the fifth step. Thus, five blocks of predictors were entered 
in nested blocks, meaning that each subsequent block contained all prior predictors and 
additional predictors from the current block. In line with Fridberg et al. (2011), the 
presentation of results will be restricted to significant ΔR²-values and their 
corresponding significant coefficients. The full model can be found in the Appendix of 
this dissertation (see Table 28). We considered multi-collinearity between independent 
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variables negligible, because all tolerance values were above .2 (Menard, 1995), and all 
independent variables were mean-centered. Separate regression analyses were applied to 
the same dependent variables included in the ANOVAs described above (see also 
Herzig, et al., 2010). Kolmogorov–Smirnov tests for the groups separately revealed 
normal distribution for all behavioural measures and questionnaire scores. All p-values 
were two-tailed and the α-level was set at .05.  
 
4. Results 
Participants and self-report questionnaires 
Most participants did not report any particularly stressful previous life events (n = 44). 
Self-report measures were compared to previous normative samples via calculations of 
Cohen’s d (1992) with values of ± 0.2 / ± 0.5 / ± 0.8 being indicative of a small / 
medium / large effect size, respectively (see Table 17). These comparisons showed that 
the present sample was largely comparable with normative samples, apart from CogDis 
scores and perceived stress scale scores that were elevated and IntAn scores and stress 
response inventory scores that were reduced in our as compared to the normative 
sample  (see Table 17).  
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Table 17. Means, SDs and effect sizes (Cohen’s d), comparing the normative sample 
values with our sample.  
  Norm values Our sample 
Questionnaire Published norms by m SD N m SD Cohen's d 
O-LIFE: UnEx
a
 Mason et al., 2005 3.35 2.92 2072 3.67 1.89 -0.11 
O-LIFE: 
CogDis
b
 
Mason et al., 2005 4.42 2.90 2094 6.16 2.55 -0.60 
O-LIFE: IntAn
c
 Mason et al., 2005 2.46 2.01 2073 1.40 1.41 0.53 
O-LIFE: Imp
d
 Mason et al., 2005 2.60 1.99 2098 2.78 1.52 -0.09 
PSS
e
 Ramirez & 
Hernandez (2007) 
21.90 7.03 365 28.21 8.00 -0.88 
SRI
f
 Koh et al. (2001) 68.50 23.40 215 41.96 20.79 1.16 
Note: 
a 
Unusual experiences; 
b 
Cognitive Disorganisation; 
c 
Introvertive Anhedonia; 
d 
Impulse Non-conformity; 
e 
Perceived Stress Scale; 
f 
Stress Response Inventory; 
 
Regarding the cognitive reserve groups, the median-split (median of 65%) on the 
average mark (in percent) resulted in 31 students (23 women) belonging to the high 
cognitive reserve group (marks ≥ 65%, range 65%-80%, m = 68.55, SD = 4.12), and 27 
students (19 women) belonging to the low cognitive reserve group (marks < 65%, range 
40%-64%, m = 56.44, SD = 6.70). Separate t-tests on age, schizotypy scores, substance-
CB scores, perceived stress scale scores, and stress response inventory scores with 
cognitive reserve group as a between-subject measure showed that the high as compared 
to low cognitive reserve group was older, and had lower CogDis scores (Table 18). 
None of the other group comparisons were significant (Table 18).  
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Table 18. Means and SD for age and self-report questionnaire scores for the whole 
sample, and for the two cognitive reserve groups separately. The results of the t-tests 
are presented.  
 Total 
(N = 58) 
 High  
(N = 31) 
  Low 
(N = 27) 
    
Dependent 
variable 
Mean SD Mean SD Mean SD t(1, 56) p 
Age 20.33 2.35 20.97 2.87 19.59 1.25 2.42 0.02 
UnEx
a
 3.67 1.89 3.26 1.71 4.15 1.99 -1.83 0.07 
CogDis
b
 6.16 2.55 5.55 2.59 6.85 2.35 -1.99 0.05 
IntAn
c
 1.40 1.41 1.42 1.29 1.37 1.57 0.13 0.90 
Imp
d
 2.78 1.52 2.71 1.47 2.85 1.61 -0.35 0.73 
SCB
e
 12.38 8.60 11.61 7.41 13.26 9.87 -0.72 0.47 
PSS
f
 28.21 8.00 27.52 7.31 29.00 8.80 -0.70 0.49 
SRI
g
 41.96 20.79 39.19 18.34 45.13 23.23 -1.09 0.28 
Note: 
a 
Unusual experiences; 
b 
Cognitive Disorganisation; 
c 
Introvertive Anhedonia; 
d 
Impulse Non-conformity; 
e 
Substance-based compensatory behaviours; 
f 
Perceived 
Stress Scale; 
g 
Stress Response Inventory; 
 
Correlations between self-report questionnaire scores 
The correlations between schizotypy measures showed positive correlations between 
UnEx, Imp and CogDis scores, but no correlations with IntAn scores (Table 19). The 
stress response inventory scores were positively correlated with perceived stress scale 
scores (Table 19). Correlations between schizotypy and stress-relevant measures 
showed that increasing UnEx scores, CogDis scores, and Imp scores all related to 
increasing perceived stress scale scores and stress response inventory scores. Substance-
CB scores were positively correlated with CogDis scores (Table 19). An inverse 
relationship between the extent of schizotypal traits and IQ is sometimes reported [e.g. 
(Matheson & Langdon, 2008; Noguchi, et al., 2008)], even though IQ is generally 
believed to be spared in schizotypy (Raine, 2006). In this sample none of the 
correlations between schizotypy and average mark were significant (Table 19). 
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Table 19. Pearson correlations between scale scores.  
 UnEx CogDis IntAn Imp SCB PSS SRI Average 
Mark 
UnEx
a
 1.00 0.37** -0.02 0.36** 0.18 0.32* 0.42*** -0.18 
CogDis
b
 0.37** 1.00 0.02 0.44*** 0.46*** 0.45*** 0.56*** -0.22† 
IntAn
c
 -0.02 0.02 1.00 0.24† -0.01 0.05 0.01 0.23† 
Imp
d
 0.36** 0.44*** 0.24† 1.00 0.13 0.33* 0.36** -0.08 
SCB
e
 0.18 0.46*** -0.01 0.13 1.00 0.19 0.24† -0.14 
PSS
f
 0.32* 0.45*** 0.05 0.33* 0.19 1.00 0.69*** -0.20 
SRI
g
 0.42*** 0.56*** 0.01 0.36** 0.24† 0.69*** 1.00 -0.23† 
Average 
mark 
-0.18 -0.22† 0.23† -0.08 -0.14 -0.20 -0.23† 1.00 
†p≤.10; * significant at p≤.05; ** significant at p≤.01; *** significant at p≤.001 
Note: 
a 
Unusual experiences; 
b 
Cognitive Disorganisation; 
c 
Introvertive Anhedonia; 
d 
Impulse Non-conformity; 
e 
Substance-based compensatory behaviours; 
f 
Perceived 
Stress Scale; 
g 
Stress Response Inventory; 
 
 
Hemispheric asymmetry tasks 
(1) LDT 
The ANOVA on accuracy showed that performance was superior for RVF as compared 
to LVF presentations (F(1,56) = 16.97, p < .001, partial η2 = .23; see Table 20). The 
interaction between group and visual field (F(1,56) = .27, p = .60, partial η2 < .01) and 
the main effect of group (F(1,56) = 1.21, p = .28,  partial η2 =.02; see Table 20) yielded 
no significant result. The ANOVA on reaction times showed no significant result, 
neither for the main effect visual field (F(1,56) = .08, p = .78, partial η2 < .01), nor the 
main effect group (F(1,56) = .14, p = .71, partial η2 < .01), nor the interaction visual 
field * group (F(1,56) = 1.84, p = .18, partial η2 = .03].  
 
The comparisons against chance level for the laterality indices were significant for 
percent accuracy (t [57] = 3.66, p < .001), but not for reaction times (t [57] = .12, p = 
.91). The difference remained stable when calculated for the cognitive reserve groups 
separately (high cognitive reserve group: accuracy: t [30] = 2.62, p = .01; reaction time: 
II     Experiments: Compensatory behaviours, schizotypy and hemispheric asymmetry 
147 
 
t [30] = -.70 p = .49); low cognitive reserve group: accuracy: t [26] = 2.52, p = .02; 
reaction time: t [26] = .99, p = .33; Table 20). The positive laterality indices point to a 
RVF (LH) advantage in the LDT.  
 
(2) FDT 
The ANOVA on percentage of sex decisions showed a main effect for face type with 
sex decisions for WF being more accurate than the proportion of LF decisions (F [1,56] 
= 443.85, p < .001, partial η2 = .89, Table 20). The interaction between face type and 
group (F [1, 56] = 1.76, p = .19, partial η2 = .03) and the main effect for group (F [1, 
56] = 3.43, p = .07, partial η2 = .06) were not significant. The ANOVA on reaction 
times showed a significant main effect for face type (F [2,112] = 76.63, p < .001, partial 
η2 = .58), due to slower responses for both RF-decisions (p < .001) and LF decisions (p 
< .001) as compared to WF decisions (Table 20). However, participants were equally 
fast for LF and RF decisions (p = .15). The main effect for cognitive reserve (F [1, 56] = 
.20, p = .66, partial η2 < .01), and the interaction between cognitive reserve and visual 
field were both not significant (F [2, 112] = .45, p = .61, partial η2 = .01). The 
comparisons against chance level for the laterality indices showed a significant finding 
for percent LF decisions (t [57] = 6.95, p < .001; see Table 20) as well as the reaction 
time index (t [57] = 2.79, p = .01). The analogue comparisons for the cognitive reserve 
groups separately were significant for the high (t [30] = 6.94, p < .001) and low (t [26] = 
3.23, p < .01) group on percent LF decisions, but only for the high group (t [30] = 2.39, 
p = .02, low group: t [26] = 1.46, p = .16, Table 20) on the reaction time index. Percent 
LF decisions above 50% represent a LF (RH) bias.  
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Table 20. Mean and SD of lateralized task performance for the total sample and the 
two groups separately. 
  All (N=58) High (N=31) Low (N=27) 
  Mean SD Mean SD Mean SD 
LDT
a
 LDT 
LVF
c
 %
d
 
62.14 20.99 64.85 21.28 59.03 20.60 
 LDT 
RVF
e
 % 
74.43 15.87 75.67 14.60 72.99 17.38 
 LDT 
NoW
f
 % 
72.05 10.56 73.19 10.63 70.76 10.52 
 LDT 
index
g
 % 
10.34 21.52 9.50 20.18 11.30 23.32 
 LDT LVF 
RT 
695.71 108.57 691.93 92.85 700.05 125.93 
 LDT 
RVF RT 
693.24 102.81 705.59 104.76 679.06 100.58 
 LDT 
NoW RT 
834.16 133.27 843.38 118.29 823.57 150.25 
 LDT 
index RT 
0.10 6.74 -0.88 6.96 1.23 6.41 
FDT
b
 FDT LF
h
 
% 
59.03 9.89 61.37 9.12 56.34 10.22 
 FDT WF
i
 
% 
90.82 7.03 91.29 6.98 90.28 7.18 
 FDT LF 
RT 
678.82 124.37 683.47 132.41 673.49 116.74 
 FDT RF
j
 
RT 
702.28 145.31 713.25 155.59 689.69 134.35 
 FDT WF 
RT 
597.47 98.74 601.31 104.21 593.05 93.84 
 FDT 
index RT 
1.47 4.01 1.86 4.34 1.02 3.64 
Note: 
a 
Lexical decision task; 
b 
Facial decision task; 
c 
Left visual field; 
d 
Percentage 
correct; 
e 
Right visual field; 
f 
Two non words displayed on either side of the screen;  
g
 Laterality index; 
h 
Left face decisions;
 i
 Whole face decisions; 
j
 Right face decisions 
 
Regressions: Severity of compensatory behaviours, stress and schizotypy as predictors 
of performance in the LDT and FDT 
(3) LDT 
Neither age nor cognitive reserve significantly predicted variance in the LDT (see Table 
21). Compensatory behaviours explained a significant amount of variance in the LDT 
outcome variables, with increasing substance-CB scores predicting an increase in LVF 
% and a decrease in the index % (Table 21, see also Herzig et al., 2010). Adding the two 
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stress scores in the fourth step only helped to explain variance in the reaction times for 
correct lexical decisions in the RVF. More specifically, faster RVF reaction times were 
predicted by increasing perceived stress scale scores (Table 21). Schizotypy explained a 
significant amount of variance in the reaction time index only with higher CogDis 
scores enhancing the typical LH-dominant response pattern (see Table 21).  
 
Table 21. Beta-weights and ΔR² for the LDT outcome variables for the whole sample, 
assessing the effect of schizotypy (step 5) on LDT performance on top of age (step 1), 
cognitive reserve (step 2), compensatory behaviours (step 3) and stress (step 4). Only 
significant ΔR²-values and their corresponding significant coefficients (β-values) are 
reported. 
Outcome 
variables 
Step Significant 
predictor 
β-value Total R²  ΔR²  F for ΔR²  
LVF
a 
%
b
 3 SCB
d
 0.39** 0.18** 0.14** 9.20** 
Index
c
 3 SCB -0.29* 0.10* 0.08* 4.80* 
RVF RT 4 PSS
e
 -0.38* 0.14* 0.13* 3.97* 
RT Index 5 CogDis
f
 0.39* 0.28* 0.21* 3.45* 
* significant at p≤.05; ** significant at p≤.01; *** significant at p≤.001  
 
Note: 
a 
Left visual field; 
b 
Percentage correct; 
c 
Laterality index; 
d 
Substance-based 
compensatory behaviours; 
e 
Perceived Stress Scale; 
f 
Cognitive Disorganisation;  
 
(4) FDT 
As Table 22 indicates, only age and stress predicted an additional significant amount of 
variance on top of the other variables in the FDT RT index. More specifically, 
increasing age predicted a reduction in the typical RH bias for face processing. The 
stress measures predicted variance in the FDT RT index in opposite directions: Whereas 
perceived stress predicted a stabilization of the RH face processing bias, the stress 
response predicted a decrease in RH bias (see Table 22). 
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Table 22. Beta-weights and ΔR² for the FDT outcome variables for the whole sample, 
assessing the effect of schizotypy (step 5) on FDT performance on top of age (step 1), 
cognitive reserve (step 2), compensatory behaviours (step 3) and stress (step 4). Only 
significant ΔR²-values and their corresponding significant coefficients (β-values) are 
reported.
 
Outcome 
variable Step 
Significant 
predictor β-value 
Total 
R²  ΔR²  F for ΔR²  
RT index
a
 1 Age -0.26* 0.07* 0.07* 4.20* 
 4 PSS
b
 0.39* 0.21* 0.13* 4.19* 
 4 SRI
c
 -0.52** SAA
d
 SAA SAA 
* significant at p≤.05; ** significant at p≤.01; *** significant at p≤.001 
 
Note: 
a 
Laterality index; 
b 
Perceived Stress Scale; 
c 
Stress Response Inventory; 
 d 
Same 
value as above; 
 
5. Discussion 
Relative cognitive impairments along the schizophrenia spectrum might be associated 
with stress rather than those processes related to the symptoms of the schizophrenia 
spectrum. To test this idea, we measured functional hemispheric asymmetry in a student 
population varying in schizotypal thoughts around their end of year exam period. We 
assessed hemispheric asymmetry, because its attenuation has been related to enhanced 
psychotic (clinical populations) or psychotic-like (schizotypal) thinking styles (Broks, 
1984; Brugger, et al., 1993; Mason & Claridge, 1999; Reichenberg & Harvey, 2007; 
Suzuki & Usher, 2009). To account for individual differences in perceived and 
experienced stress (Dallman, 2010; Ensel & Lin, 2004; Finkelstein, et al., 2006; 
Goeders, 2003; Krause, Goldenhar, Liang, Jay, & Maeda, 1993; Scarmeas & Stern, 
2003), we  assessed perceived stress and stress response (S. Cohen, et al., 1983; Koh, et 
al., 2001), stress-related compensatory behaviours (substance use), and potential 
cognitive reserve. If stress is a more important predictor of hemispheric asymmetry than 
schizotypy, we expected higher stress levels and higher stress-related compensatory 
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behaviours, in particular in those with less cognitive reserve (relative lower marks), 
relate to reduced hemispheric asymmetry for function.  
Our data supported these predictions only partially, i.e. enhanced substance-CB 
contributed to a reduced LH dominance for language (see also Herzig, et al., 2010) but 
enhanced perceived stress was associated with increased hemispheric asymmetry. We 
did not find any consistent changes in performance due to cognitive reserve or the stress 
response. Regarding schizotypy, increasing CogDis scores were associated with 
enhanced LH language dominance. Before discussing the relevance of these findings, 
we would like to point out that we tested a seemingly representative population because 
we firstly observed the commonly reported LH bias in the LDT and the RH bias in the 
FDT (Brugger, et al., 1993; Mason & Claridge, 1999; Regard, Landis, & Graves, 1985) 
and secondly, that self-report measures were largely comparable to normative values, 
apart from some scores that were relatively higher in our sample for the perceived stress 
scale and CogDis subscale and relatively lower for the stress response inventory and 
IntAn subscale. 
Hemispheric asymmetry and its’ relation to substance-CB 
A major finding was that increased substance-CB related to a reduced LH language 
dominance supporting previous notions that drug use relates to a cognitive profile 
resembling the one seen along the schizophrenia spectrum, namely an attenuated 
hemispheric asymmetry pattern (Bleich-Cohen, et al., 2009; Broks, 1984; Brugger, et 
al., 1993; Kucharska-Pietura, et al., 2002; Løberg, et al., 2006; Mason & Claridge, 
1999; Mitchell & Crow, 2005; Mohr, Krummenacher, et al., 2005; Phillips & David, 
1997; Sommer, et al., 2001; Suzuki & Usher, 2009). Thus, an attenuated hemispheric 
asymmetry seems not only related to enhanced nicotine dependence in healthy 
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populations (Hahn, Pogun, & Güntürkün, 2010; Herzig, et al., 2010) and patients with 
schizophrenia (Hahn, et al., 2011), but might relate to a generally enhanced drug use. 
Indeed, participants in these latter nicotine studies are likely to have consumed other 
drugs (e.g. licit and illicit) as well (Degenhardt, et al., 2001; Martinez-Ortega, et al., 
2006), stressing the possibility that the present RH shift in language processing with 
increasing substance-CB is not restricted to a particular substance (Herzig, et al., 2010). 
Enhanced substance-CB as a potential indicator of a “pathological” profile would also 
be supported by the observation that elevated substance-CB predicted more cognitive 
disorganisation. This schizotypy subscale was also linked with lower cognitive reserve 
and higher perceived stress in the present and independent samples (Cuesta & Peralta, 
1995; Ventura, Thames, Wood, Guzik, & Hellemann, 2010; Walker, et al., 2008) and 
with deteriorating mental health in the long-term (Goulding & Ödéhn, 2009; Schofield 
& Claridge, 2007).  
As a final note, we found the relationship between attenuated hemispheric asymmetry 
and enhanced substance dependence only for the LDT [but see (Herzig et al., 2010)], 
potentially because language is the cognitive function that most reliably yields 
lateralized findings in healthy populations (Hugdahl & Westerhausen, 2010; Resnick, 
Lazar, Gur, & Gur, 1994).  
Hemispheric asymmetry and its’ relation to stress 
Perceived stress was associated with a LH shift in the LDT and FDT, whereas the stress 
response predicted a reduction in RH face processing for one outcome variable only. 
Such a LH-shift, in particular for the more reliable LH language functions, may point to 
a favourable cognitive profile with enhanced perceived stress. Some authors argue that 
stress is advantageous for general survival (see Lupien, Maheu, Tu, Fiocco, & 
Schramek, 2007 for overview) or performance abilities (Lewis, Nikolova, Chang, & 
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Weekes, 2008; McEwen & Sapolsky, 1995; Yerkes & Dodson, 1908). Supporting 
different, opposing conclusions for results on substance-CB above, and stress-measures 
here, these two measures were not related with each other. By inference, perceived 
stress may be related to a relatively “healthy” pattern of brain functioning while the 
need to engage in substance-CB during times of enhanced stress (exams) may be linked 
to a relatively “unhealthy” pattern of brain functioning (Herzig, et al., 2010). 
Hemispheric asymmetry and its’ relation to schizotypy 
Increasing CogDis scores were associated with an increase in LH language dominance 
for the RT measure. This result is contrary to our initial prediction and might thus be 
spurious. Caution is also warranted when considering that CogDis relates to poor verbal 
abilities (Chan, et al., 2011; Cuesta & Peralta, 1995; Lucas, et al., 2004; Stefanis, et al., 
2006). Taking into account that high CogDis is indicative of a rather disadvantageous 
cognitive profile (see above), that it was related to elevated stress perception and drug 
use, we are hesitant to conclude that CogDis favours the most common and by 
inference, “normal” cognitive profile. We would like to speculate instead, that CogDis 
may be particularly sensitive to environmental changes, based on the following 
reasoning. Previous findings investigating the link between CogDis and language 
laterality have been inconsistent in the literature. A reduction in language laterality is 
most consistently reported from samples taken from the general population (Mason & 
Claridge, 1999; Suzuki & Usher, 2009). Inconsistent findings on the relationship 
between CogDis and language laterality, on the other hand, emerge frequently for 
student samples, be it decreases in LH processing (Herzig, et al., 2010; Kravetz, et al., 
1998), increases in LH processing (Liouta, et al., 2008 and this study), or no differences 
between hemispheres (Nunn & Peters, 2001). Purportedly, as compared to the 
individuals from the general population, students have unique features not observed in 
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the general population that predispose them to fluctuations in laterality patterns, such as 
during confined periods of exam stress. We are unaware of any published report linking 
CogDis, stress and laterality but do know that stress is associated with psychotic-like 
symptoms [e.g. (H. Lee & Schepp, 2009; van Os, et al., 2009; Walker & Diforio, 1997; 
Walker, et al., 2008)]. It may be the case that relatively elevated CogDis might turn 
exam periods into particularly stressful situations. We actually found that higher 
CogDis was associated with higher perceived stress. This enhanced stress may elevate 
revision time in students high on CogDis exposing them to more verbal stimuli and 
consequently increase LH language laterality (Marcel, Katz, & Smith, 1974; Rutherford, 
2006; Wey, Cook, Landis, Regard, & Graves, 1993). On the other hand, during periods 
of low exam stress, low revision time, and lower exposure to verbal material, CogDis 
might have related to the expected hemispheric asymmetry pattern, i.e. a reduced LH 
language dominance. The present argumentation is admittedly highly conjectural but 
constructive enough to trigger future studies in which participants’ situational variables 
are accounted for.  
The influence of drug use on the link between schizotypy and cognition 
Substance-use is elevated along the schizophrenia spectrum for a large variety of drugs, 
such as i) tobacco use in schizotypy (Esterberg, et al., 2009; J. H. Williams, Wellman, 
Allan, et al., 1996) and patients with schizophrenia (de Leon, et al., 2002), ii) cannabis 
in schizotypy (Barkus, et al., 2006; Skosnik, et al., 2001; J. H. Williams, Wellman, & 
Rawlins, 1996) and schizophrenia (Archie, et al., 2007; Moore, et al., 2007), iii) 
amphetamines/stimulants in schizotypy (Curran & Morgan, 2000) and schizophrenia 
(Barkus & Murray, 2010), and iv) caffeine in schizotypy (Jones & Fernyhough, 2009) 
and schizophrenia (Gurpegui, et al., 2004). In our present study, it was not schizotypy 
but substance use that associated with a reduced LH language dominance, indicating 
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that substance use might be the major determinant to measures of cognitive functioning. 
The present study and its design are unsuited to infer which variable (schizotypy, 
substance use, or yet unspecified variables) is the most likely to cause a reduced LH 
language dominance. Reports on legal or illegal substance are still uncommon in the 
schizotypy literature when investigating the effects of psychotic (-like) thinking on 
hemispheric asymmetry (Broks, 1984; Brugger, et al., 1993; Mason & Claridge, 1999; 
Mohr, Krummenacher, et al., 2005; Suzuki & Usher, 2009), despite the recent evidence 
that the extent of substance use is important in this regard (Hahn, et al., 2011; Hahn, et 
al., 2010; Herzig, et al., 2010). The necessity to control for substance use is not 
exclusive to the study of hemispheric asymmetry but is relevant to cognitive functions 
more broadly (Rodriguez-Jimenez et al., 2010). Only by taking the influence of 
substance use on cognitive functions in schizotypy studies more seriously will we find 
out whether our focus on schizotypal symptoms has been overvalued.  
Limitations  
While we have aimed to control and account for important variables to test our 
study question, we are aware of short-comings and improvements, such as i) the pre-
selection of right-handed participants, ii) inferring cognitive reserve from the current 
mark, iii) assessing substance-CB without knowing anything about the substance(s), iv) 
unbalanced sex distribution. Concerning the first point, we pre-selected participants for 
their right-handedness as is common in experiments on hemispheric asymmetry in 
general (Bourne, 2006) and on schizotypy in particular (e.g. Mason & Claridge, 1999; 
Mohr, Krummenacher, et al., 2005; Suzuki & Usher, 2009) and general hemispheric 
asymmetry (Bourne, 2006). However, if we acknowledge reduced right-handedness in 
schizophrenia (Dragovic & Hammond, 2005) and schizotypy (H. L. Chapman, 
Grimshaw, & Nicholls, 2011; Somers, et al., 2009), we are likely to exclude relevant 
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participants. Future studies should investigate a more representative sample that 
encompasses a wider range of hand preferences (e.g. Shaw, et al., 2001; Somers, et al., 
2009). Concerning the second point, we tested a highly performing student group 
because all had to have three As (in A-level exams) when admitted to the local 
Psychology course. Using participants from a wider educational background might yield 
more systematic relationships between task performance and study performance (i.e. 
marks) than the one observed here. Concerning the third point, the substance-CB 
questionnaire did not ask about specific substances that could nevertheless have yielded 
different effects on hemispheric asymmetry. For instance, some of the substances might 
have stress-alleviating properties (e.g. anxiolytic medication), having counteracted 
otherwise detrimental effects of stress on cognition. The advantage of the present 
questionnaire is its lowered risk of socially desirable responding. Moreover, as argued 
above, results from the questionnaire replicated previous findings on specific drugs such 
as nicotine. Concerning the fourth point, studies on laterality and schizotypy frequently 
observed effects in male populations only (see Hausmann & Güntürkün, 2000 for 
overview; McGlone, 1980), hence we cannot exclude stronger and more consistent 
findings if we had excluded female participants. However, due to unequal sex 
distribution in the current sample we could not further account for this factor.  
Conclusions 
We here aimed to disentangle whether stress and stress-related behaviours or 
schizotypal symptoms influence reduced hemispheric asymmetry for function as 
formerly reported along the schizophrenia spectrum. Results from two lateralized tasks 
(LDT, FDT) were not fully supportive of either perspective, but revealed that stress, 
stress-related behaviour and schizotypal symptoms contributed differently to cognitive 
performance. Most importantly, our findings indicated that i) a RH shift in language 
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dominance might be explained by enhanced substance dependence, and less so by 
individuals’ schizotypal features, ii) perceived stress related to a LH shift, and iii) 
inconsistent findings on laterality and schizotypy might be population and context 
dependent.  
In practical terms, the implications of these results are that future studies assessing the 
link between schizotypy and cognition should control for legal and illegal substance 
use, in which participants’ life situations are measured (stressful life situation or not) 
and whether students or non-students of various educational backgrounds are targeted. 
We also argue that the current implications are not only relevant to studies on 
hemispheric asymmetry, but to cognition more generally and on frontal lobe functioning 
more particularly (Buchsbaum, et al., 2002; Laurent, et al., 2001; Reichenberg & 
Harvey, 2007; Tsakanikos & Claridge, 2005). 
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III. General discussion 
A. Interpretations of findings 
The presented four studies support the original notion of the current thesis that cognitive 
attenuations formerly linked to schizotypal symptoms might be significantly associated 
with enhanced drug consumption. The notion that drugs can influence cognition is 
known (see section I. C. 2.), as is the observation that drug use is elevated in schizotypal 
populations (see section I. C. 1.). Despite these different streams of research, studies on 
the relationship between schizotypy and cognition have shown little efforts so far to 
consider both legal and illegal drug use. In Table 30 (see Appendix), we listed studies 
that investigated schizotypy and cognition, including the information if and how they 
controlled for licit (nicotine, alcohol) and illicit substance use (e.g. via assessment, 
exclusion, statistically controlling for drug use). As Table 30 shows, the majority of 
studies did not report controlling for drug use. Sixty-seven percent (%) of the findings 
are reported without considering drug use, whereas the remaining ones vary in the 
criteria applied (see Table 30 in Appendix), potentially contributing additional noise to 
the analysis. For instance, in the 33% of findings where drug use is taken into account 
(either by reporting on it, excluding participants with a drug use history, or statistically 
controlling for it), the majority (72%) report decreased performance as a function of 
schizotypy, followed by 28% reporting no effect of schizotypy on cognition. A 
relatively elevated performance as function of schizotypy is not shown in this group of 
findings. For findings where participants’ drug use is not reported, 11% show an 
improved performance due to relatively elevated schizotypy, 30% report no effect of 
schizotypy, and the majority (59%) find relatively impaired cognitive performance as a 
function of elevated schizotypy.  
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It is therefore possible that the lack of adequately assessing drug use (e.g. via 
questionnaires, interviews, drug test) and responding accordingly (e.g. excluding drug 
using individuals, statistically controlling for drug use), or the diversity in methods used 
(e.g. according to DSM-criteria, self-report or drug tests, see Table 30 in Appendix) 
explains why results on the effects of schizotypal symptoms, in particular on 
hemispheric asymmetry and frontal lobe functioning, are frequently heterogeneous 
between studies (Giraldez, et al., 1999; Park & McTigue, 1997; Laws, et al., 2008; 
Liouta, et al., 2008; Spitznagel & Suhr, 2002). As detailed in sections I. C.1. and I. C.2., 
drug use affects those cognitive functions that are also thought to be affected along the 
schizophrenia spectrum with the use of such drugs being elevated in high schizotypes as 
well. This is also true for licit drugs like alcohol, which is rarely asked for in studies on 
schizotypy (see also Table 30 in Appendix). Since alcohol rather than schizotypy 
emerged as an important predictor for cognitive attenuations in our studies, alcohol 
potentially relates to cognitive attenuations formerly associated with schizotypal 
symptoms. In the next paragraph we will try to lend further support to this idea by 
elaborating on the effect of alcohol on frontal lobe functioning and hemispheric 
asymmetry, functions reported to be attenuated along the schizophrenia spectrum (see 
also section I. B. 1. and I. B. 2.). 
1. Alcohol 
Alcohol and schizophrenia spectrum 
It could be the case that alcohol played a role in previous studies assessing cognition 
along the schizophrenia spectrum, because independent studies reported on an elevated 
use in schizophrenia and other psychotic disorders [(Cantor-Graae, et al., 2001; Gregg, 
et al., 2007; Mastrigt, et al., 2004; Sevy et al., 2001), but see (Brown, Birtwistle, Roe, & 
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Thompson, 1999; Roick et al., 2007)]. A relative enhanced alcohol consumption can 
also be observed when studies are accounted for that assess populations along the 
schizophrenia spectrum, i.e. schizotypal individuals (Kwapil, 1996). Some studies also 
reported alcohol use to relate to schizotypal symptoms, e.g.lower negative and higher 
positive schizotypy as a function of alcohol use (Barrantes-Vidal, Lewandowski, & 
Kwapil, 2010; Nunn, Rizza & Peters, 2001), lower positive schizotypy (Larrison, et al., 
1999) or higher positive, negative and disorganized schizotypy as a function of alcohol 
(Esterberg, et al., 2009). These findings stress the relevance of this substance along the 
schizophrenia spectrum, particularly when assessing cognitive functions along the 
schizophrenia spectrum. Given that the effect of alcohol on cognitive functioning has 
emerged as important in the present doctoral thesis over the course of testing, in the 
following we account in more detail on previous experiments investigating the influence 
of alcohol on cognition, in particular those that have been tested in the present studies 
(see also section I. B. 1. and I. B. 2.). 
Alcohol and frontal lobe functioning 
Enhanced alcohol use is related to impairments in memory and verbal fluency (see 
Fernández-Serrano, et al., 2011 for overview; Manning, et al., 2008; Wendt & Risberg, 
2001; Zeigler, et al., 2005). In the case of acute alcohol intoxication, studies showed 
impairments in prose recall (Parada, et al., 2011; Petros, et al., 1985; Poltavski, et al., 
2011) or working memory impairments in populations frequently exposed to high doses 
of alcohol (Parada, et al., 2011; Parada et al., 2012; Parker, Birnbaum, & Noble, 1976). 
Additionally, verbal fluency (Wendt & Risberg, 2001), and cognitive flexibility or set 
shifting (Trail making and WCST) attenuations have been reported with increasing 
doses of alcohol (Guillot, et al., 2010; Lyvers & Tobias-Webb, 2010). These functional 
impairments are probably due to alterations in brain structure and activation in alcohol 
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using individuals. For instance, brain imaging studies reported on brain volume deficits 
and activity levels in prefrontal areas of alcoholics (see Zahr, Pitel, Chanraud, & 
Sullivan, 2010 for overview). Additionally, increased left frontal and right cerebellar 
activation was reported in alcoholics when they performed a verbal working memory 
task (Desmond et al., 2003). The increased activation seemed to support the theory that 
more effort is needed in this population to compensate for functional impairments. 
Alcohol and hemispheric asymmetry 
The literature on functional hemispheric asymmetry in alcohol use is sparse. However, 
there are some studies suggesting a reduction of hemispheric asymmetry as a function 
of alcohol. For instance, an older study investigating lateralization effects of alcohol 
(Kostandov, Arsumanov, Genkina, Restchikova, & Shostakovich, 1982) revealed 
performance decreases in the left visual field (right hemisphere) as a function of acute 
ethanol administration. Another experiment found deficits in a lateralized emotional 
word recognition task in alcoholics (Hutner & OscarBerman, 1996) suggesting a 
decrease in right hemisphere bias as well. Additionally, others studies point to a 
decrease in left hemisphere functioning as a function of alcohol, e.g. a decreased left 
hemisphere bias under acute ethanol influence as compared to placebo in occasional 
social drinkers (Leone & McCourt, 2009). Anatomical and brain imaging studies also 
reported a reduced left hippocampal volume in alcohol users as compared to non-using 
controls (Medina, Schweinsburg, Cohen-Zion, Nagel, & Tapert, 2007), and this effect 
increased with higher alcohol use. EEG-studies showed that in alcohol dependent 
subjects the left anterior frontal activation was reduced relative to the right when 
compared to non-dependent control subjects (Hayden et al., 2006). Taken together, the 
findings suggest that the harmful effects of alcohol use may be associated with a 
reduction in typical hemispheric asymmetry for function and brain anatomy.  
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Given our initial working hypothesis of attenuated cognitive performance as a function 
of schizotypal symptoms (see section I. B.), we would here conjecture that elevated 
alcohol use (see section III. A. 1.) could serve as an alternative explanation for 
attenuations in laterality patterns and frontal lobe functioning.  
2. Polydrug use 
Legal (e.g. alcohol) as well as illegal drug use affect cognitive functioning, but if this 
relates to the specific substances used, or whether or not it is the amount of drugs 
consumed simultaneously (polydrug use) we will elucidate here.  Many studies have 
shown that cannabis users (Barkus, et al., 2006; Pape, et al., 2009) or ecstasy/MDMA 
users (Brecht, Huang, Evans, & Hser, 2008; Scholey et al., 2004) are frequently not 
pure users of this particular substance, but consume a multitude of substances (see also 
Fernández-Serrano, et al., 2011). We now elaborate in how far this polydrug use is 
related to the schizophrenia spectrum, and how it may influence cognitive functioning. 
Polydrug use and the schizophrenia spectrum 
 Patients with schizophrenia show elevated consumption of a variety of drugs as 
compared to the general population, e.g. amphetamines, alcohol, nicotine etc. (Barkus & 
Murray, 2010; Degenhardt & Hall, 2001; Regier, et al., 1990). In high-risk samples, this 
elevated drug use as compared to the general population also corresponds to increased 
symptom severity (Miller et al., 2001). In the general population, users of several illicit 
drugs also score higher on measures of schizotypy than those only consuming one illicit 
drug (e.g. cannabis), or only legal drugs (van Dam, Earleywine, & DiGiacomo, 2008).  
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Polydrug use and cognitive functioning 
Polydrug use affects the cognitive functions that have been of major relevance to the 
present doctoral thesis (see section I. B. 1. and I. B. 2.). Polydrug users have frequently 
been shown to exhibit more functional frontal lobe attenuations as compared to those 
only using one drug and/or non-users (see Fernández-Serrano, et al., 2011; Mohamed, et 
al., 2011 for overview). For instance, memory functions and learning (Gouzoulis-
Mayfrank et al., 2000), or semantic word fluency (de Sola LLopis et al., 2008) are 
impaired in polydrug users as compared to uni-drug users or non-using controls. As is 
also evident from section I. C. 2., certain substances influence hemispheric asymmetry, 
but how polydrug use relates to functional hemispheric asymmetry remains to be 
investigated. The scarcity of studies on the relationship between polydrug use 
(including licit and illicit drugs) and cognition, and the relevance of these studies to 
cognitive functioning along the schizophrenia spectrum reflects the lack of knowledge 
we have in this domain. Our results would provide some initial indications that different 
drugs might affect different cognitions, but also that some might have synergetic 
influences. Obviously, these findings and conjectures are based on findings from 
healthy student populations. Whether our conjectures and observations might also have 
clinical relevance will be discussed just below.  
B. General Conclusions 
Our results indicated that drug use is mainly responsible for cognitive attenuations 
formerly ascribed to schizotypal symptoms. The question is whether or not the findings 
would extend to all populations along the schizophrenia spectrum, including at-risk 
populations and patients with schizophrenia. If this would be the case, cognitive 
impairments in patients with schizophrenia may not be illness-related per se, but may be 
importantly influenced by enhanced drug use as seen along the schizophrenia spectrum 
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as well. While this effect of drug use on cognition has to our knowledge not been tested 
systematically in e.g. patients with schizophrenia before, we will review cognitive 
functions and their relation to drug use in individuals at the ‘high’ end of the 
schizophrenia spectrum (e.g. in schizotypal personality disorder, or patients with 
schizophrenia) in the following paragraphs.  
In individuals with schizotypal personality disorder or schizophrenia, cognitive 
functioning is affected when compared to healthy controls across a variety of cognitive 
domains (Mesholam-Gately, et al., 2009; R. E. Nielsen, 2011; Siever et al., 2002), even 
in those not taking illicit drugs (Cadenhead, Perry, Shafer, & Braff, 1999; Coulston, 
Perdices, & Tennant, 2007; McClure et al., 2007; R. E. Nielsen, 2011). Moreover, the 
influence of drugs seems to be different in patients with schizophrenia than in drug 
users from the general population in terms of cognitive functioning (e.g. Jockers-
Scherubl et al., 2007). For instance, cannabis using patients with schizophrenia 
outperform non-using patients on a variety of cognitive functions (see Rabin, et al., 
2011 for overview), whereas chronic cannabis users in the general population normally 
yield cognitive attenuations when compared to non-cannabis using individuals (see 
section I. C. 2. b). It could be argued that this performance superiority is only reported 
amongst specific classes of drugs, e.g. cannabis. However, in schizophrenia this 
cognitive performance superiority is by no means specific to cannabis, and extends to 
polydrug using patients with schizophrenia as compared to non-using ones as well 
(Coulston, et al., 2007). Medication in patients with schizophrenia does not seem to 
relate to cognitive functioning in this population (see R. E. Nielsen, 2011 for meta-
analysis), even though there may be adverse interaction between substance use and 
medication response (A. I. Green et al., 2004). 
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This indicates that the influence of drug use on the relationship between schizophrenia 
symptoms and cognition may be different for healthy versus mentally ill individuals. If 
cognitive dysfunctions are related to symptoms in schizophrenia, but not schizotypy 
after controlling for drug use, cognitive attenuations may not be reliable risk markers of 
pathology before illness-onset (see also discussion study 2). However, future studies 
should try to elucidate the relationship between drugs, cognition and symptoms in 
patient populations to shed light on this issue.  
As a final remark, concerning is the fact that substance abuse in patients is associated 
with higher rates of hospitalization and relapse (Cantor-Graae, et al., 2001; Mueser, 
Bellack, & Blanchard, 1992; Swofford, Kasckow, Scheller-Gilkey, & Inderbitzin, 
1996). As a result, independent of which factors will be revealed as the most predictive 
for pathological changes in future studies, treatments or interventions for both illegal 
and legal drug use along the schizophrenia spectrum could be useful to facilitate 
amelioration or recovery from symptomatology (see also Hahn, et al., 2011; Kerfoot et 
al., 2011).  
 
C. Alternative explanations 
Due to several studies being conducted in parallel, we were mostly unable to take 
ongoing results (e.g. emerging relevant factors) for subsequent studies into account. 
Therefore, we elucidate some alternative explanations to our findings by discussing the 
relevance of factors emerging from our studies that have not systematically been 
accounted for, such as depression and its relationship to drug use, psychotic disorders 
and cognitive functioning. Additionally, we will try to cover IQ as potential explanation 
for the multitude of null-results in most of the drug group comparisons on cognitive 
outcome measures (contrary to previous research). 
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1. Depression 
Depression and drug use 
Recent debates in the UK have revolved around which objective means are useful to 
assess harmfulness of drug use on e.g. mood disorders due to the users’ lifestyle or drug 
use itself (Nutt, et al., 2010). The effect of drug use on mood may be interesting when 
cognitive functions as those outlined in this project are assessed. For instance, various 
studies confirm that depression and substance use frequently co-occur (see Swendsen & 
Merikangas, 2000 for overview). Furthermore, certain studies even suggest that drug 
use (e.g. cannabis) follows the development of depression in adolescents (Libby, Orton, 
Stover, & Riggs, 2005). In independent studies investigating the influence of particular 
drugs, potentially relevant depression ratings are frequently not reported such as in 
relatively pure cannabis users (Fried, et al., 2005; Skosnik, et al., 2001), nicotine 
smokers (Herzig, et al., 2010), alcohol users (Ratti, et al., 2002) or psychostimulant 
users (Bolla, et al., 2003). Depression rates are, however, relatively elevated in drug 
users including amphetamine users (M. J. Morgan, 2000; G. Rogers, et al., 2009 for 
overview), alcohol dependent individuals (Conner, Pinquart, & Gamble, 2009; 
Davidson, 1995), smokers  (Breslau, Kilbey, & Andreski, 1991; Klungsøyr, Nygård, 
Sørensen, & Sandanger, 2006) or cannabis users (Hayatbakhsh, et al., 2007; Patton, et 
al., 2002). We and others cannot exclude the possibility that depression rates could 
partially explain the effects of drug use on cognitive functioning known to be attenuated 
along the schizophrenia spectrum. This argument will be elaborated upon in the 
following section, by looking at the relationship between depression and cognition. 
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Depression and cognitive functioning 
Studies that tested the link between depression and frontal lobe functioning report that 
clinical depression in young adults is accompanied by relative dysfunctional frontal lobe 
functions including those we tested here (see Castaneda, et al., 2008 for overview). 
Even in healthy subjects, negative mood can lead to reduced prefrontal lobe activity 
during verbal (not spatial) working memory tasks (Aoki, et al., 2011). Additionally, 
there is some evidence for a right hemisphere deficit in depressed patients as well. For 
instance, depressed patients show longer RTs in the right hemisphere in a divided visual 
field task (Liotti, Sava, Rizzolatti, & Caffarra, 1991). This decreasing right hemisphere 
processing advantage in depressed patients is also found in verbal dichotic listening 
tasks (Pine et al., 2000), verbal divided field studies (Min & Oh, 1992) or face 
processing tasks (Heller, Etienne, & Miller, 1995).  
Overall, the above mentioned studies point to the possibility of depression being a more 
robust predictor of cognitive attenuations than drugs. To what extent this link between 
depression and cognition is relevant for individuals along the schizophrenia spectrum is 
elaborated on now.   
 The link between depression and the schizophrenia spectrum  
There is substantial overlap between depression and psychotic experiences (Hartley, 
Haddock, & Barrowclough, 2012). Some authors argue that depression and 
schizophrenia often co-occur, with depression symptoms appearing on average four 
years before admission with schizophrenia (Häfner et al., 2005). Even in healthy 
individuals from the general population schizotypal traits correlate considerably with 
measures of depression/anxiety (Wolfradt & Straube, 1998), and in adolescence 
depression and anxiety (amongst other factors) modulate the expression of positive 
schizotypal symptoms (Debbané, Van der Linden, & Eliez, 2008). Taken together, these 
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findings suggest that depression may be an important variable to consider in future 
research on drug use, schizotypy and cognition.  
2. IQ 
The majority of participants tested in our studies were students recruited from the 
University of Bristol. If we assume that marks are indicators of intellectual capacities 
(Lagerström, Bremme, Eneroth, & Janson, 1991; Rindermann & Neubauer, 2004; 
Spinath, et al., 2010), our population is characterised by a high IQ as students are 
preselected according to their high marks before they are granted access to this 
University. As also discussed in detail in study 4, IQ is linked to cognitive reserve, an 
efficient dynamism with which the brain balances out threatening situations and 
challenges to maintain efficient cognitive functioning (Katzman, et al., 1989; Stern, 
2002). As a result, these high functioning subjects may have been affected differently 
by drug use and schizotypal symptoms than those with lower intellectual capacity. This 
argument we will outline in the following sections by looking at the relationship 
between IQ and the schizophrenia spectrum, and between IQ and cognitive functioning.   
IQ and schizophrenia spectrum 
Intelligence seems diminished in patients with schizophrenia and schizophrenia 
spectrum disorders as compared to healthy controls (see Khandaker, et al., 2011; see 
Leeson, et al., 2009 for overview). Even in psychometrically defined schizotypy, 
symptoms seem to relate to intelligence (Matheson & Langdon, 2008; Noguchi, et al., 
2008) with higher IQ generally relating to lower schizotypal symptoms. Intelligence 
may protect from adverse situations in psychiatric illnesses, a finding replicated by 
several studies (MacCabe & Murray, 2004; Moore, et al., 2007; Sørensen, et al., 2010).  
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IQ and cognitive functioning 
IQ, or general intelligence, has been frequently linked to cognitive functioning, in 
particular frontal lobe functioning (Garcia-Molina, Tirapu-Ustarroz, Luna-Lario, 
Ibanez, & Duque, 2010). For instance, higher IQ frequently relates to better 
performance on tasks measuring frontal lobe functions such as verbal memory, working 
memory, verbal fluency, and cognitive flexibility (Colom, Abad, Rebollo, & Chun Shih, 
2005; J. R. Gray, Chabris, & Braver, 2003; Roca et al., 2010). However, evidence 
regarding intelligence and hemispheric asymmetry is sparse, and laterality dependent 
effects of intelligence can only be inferred. Generally, increased laterality for language 
goes along with better performance in verbal functions (potentially related to verbal IQ), 
e.g. reading proficiency (Marcel, et al., 1974; Rutherford, 2006; Wey, et al., 1993). 
Additionally, handedness can be used to infer about hemispheric asymmetry (Crow, 
2000; Crow, Crow, Done, & Leask, 1998), with increasing handedness scores usually 
relating to a more pronounced hemispheric asymmetry. As such, individuals closer to 
equal hand skill (and consequently a reduction in hemispheric asymmetry) show deficits 
in verbal, non-verbal, and mathematical ability and reading comprehension as compared 
to those showing either strong left or right handedness (Crow, et al., 1998). Therefore, it 
is likely that higher intelligence (in particular verbal IQ) may go along with stronger 
laterality patterns. 
IQ and drug use 
Intelligence also seems to relate to drug use, with higher drug use being generally 
associated with lower IQ. For instance, higher IQ relates to later-life non-smoking status 
(Wennerstad et al., 2010). Using cannabis before the age of 18 years reduces peoples 
expected years of education (see Casadio, et al., 2011 for overview) suggesting lower 
educational attainment. It should be noted, that this phenomenon may depend on the 
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frequency of cannabis use and complementary nicotine use, as occasional cannabis use 
without additional nicotine consumption is associated with higher academic success 
(Suris, et al., 2007). The effect of chronic cannabis use on general intelligence over time 
seems rather unclear, with some studies reporting  a decline in general intelligence 
(Fried, et al., 2005), and others reporting no change (Lyketsos, Garrett, Liang, & 
Anthony, 1999). However, it seems feasible to assume that IQ is a protective factor for 
the adverse effects of drugs, and may therefore predict cognitive functioning more 
consistently than schizotypy and/or drug use. 
 
D. General limitations 
Apart from additional risk factors that could be relevant to studies on drug use and 
cognition along the schizophrenia spectrum (Rössler, Vetter, et al., 2011) the research 
studies conducted here have certain limitations that we would like to discuss in the 
following: i) the reliability of findings given the sample size and statistical methods 
chosen; ii) the validation of the O-LIFE; iii) the preselection of risk factors; and iv) the 
specificity of cognitive attenuations to schizophrenia.  
Regarding the first point, a general limitation to the current analyses could be the low 
sample size. It is difficult to determine the appropriate sample size, and guidelines vary. 
Green (S. B. Green, 1991) suggested the amount of variables included in the regression 
model should follow the formula (50 + 8x N variables; Field, 2009; Tabachnik & Fidell, 
2001). However, others suggest a minimum sample size of 10 participants per predictor 
variable (Harris, 1985), adding to the general variety of approaches and guidelines. 
Crucially, many studies do not pre-select participants according to relatively rare 
characteristics (in the present case the consumption of cannabis use only) enhancing the 
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ease with which to have a larger sample size, but at the same time adding unwanted 
noise. Fernandez et al (2011) reviewed the evidence on the specialized effects of a 
variety of drugs recently.  
According to their review, the sample sizes vary considerably in the published articles, 
reflecting the difficulties researchers face when trying to recruit minority samples (e.g. 
drug users in general), or pure users of individual drugs in particular (Fernández-
Serrano, et al., 2011). For instance, in relatively pure users of cannabis, recruitment 
rates may vary between 16-19 participants, or between five and 28 participants for 
MDMA/psychostimulant users. This implies that power analyses can result in the 
recommendation of unrealistically large sample sizes when dealing with minority 
samples.  
The difficulty of facing naturally low sample sizes also affects the choice of statistical 
analysis. In small samples, the population distribution of a variable cannot be estimated 
reliably. As such, using these parametric tests (assuming a normal distribution) may 
have resulted in less reliable results than non-parametric tests which do not assume a 
normal distribution of data (Field, 2009). Yet, the use of parametric tests such as 
ANOVAs and regressions, based on the assumption of normality, are fairly robust to 
violations of normality assumptions in general (Lindman, 1974; Schmider, Ziegler, 
Danay, Beyer, & Bühner, 2010), whereas the risk in non-parametric tests is often a false 
rejection of significant effects with small sample sizes (McCluskey & Lalkhen, 2007). 
Hence, parametric tests were given preference in our studies to reduce the risk of 
inflated false negative rates. 
On a similar note, the multiple comparisons performed in our analyses could have 
profited from a more conservative statistical approach, e.g. using Bonferroni-
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corrections. These were originally developed as part of the statistical test theory, 
proposed by Neyman and Pearson in 1928 (Neyman & Pearson, 1928). This theory was 
supposed to aid practical decision making in industrial settings, e.g. considering the 
rejection of lots (based on defective multiple samples within each lot, where an inflated 
rejection rate would lead to higher financial loss), but was actually not developed for 
assessing evidence in scientific data sets (Feise, 2002; Perneger, 1998). Whereas these 
methods reduce the risk of a type I error, they can be specifically problematic if a 
researcher is testing specific hypotheses in one study (Perneger, 1998). This is due to 
the fact that Bonferroni-corrections -whilst reducing the Type I risk- also inflate the 
false negative rates. Applying this method results in loss of power to detect significant 
differences to such an extent that behavioural studies with small to medium expected 
effect sizes have a lower than chance level likelihood to detect significant differences 
(Jennions & Møller, 2003; Nakagawa, 2004). Consequently, we abstained from 
applying a Bonferroni correction in our studies, as this would have likely resulted in 
rejection of important results. The fact that we drew comparable conclusions across our 
studies seems to justify using a less conservative approach.  
Regarding the second limitation: the original O-LIFE was developed using factor 
analyses of scales for item selection,  and internal consistency and reliability were 
verified (Mason, et al., 1995). The short version of this questionnaire that we used in the 
majority of our studies did not follow strict psychometric validation (Mason, et al., 
2005), and internal consistency ratings were rather low in the normative sample. 
Therefore, by not adhering to strict psychometric standards for validation of 
questionnaires (Alu a, Garc  a, Rossier, & Garc  a, 2005; Steinman & Teachman, 2011) 
there is a risk that the O-LIFE does not  reflect the concept of schizotypy very well. On 
the other hand, our own analysis on the O-LIFE scales indicate a rather sufficient 
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internal consistency (see Table 29 in Appendix). Moreover, a recent study would 
suggest that the short versions of the O-LIFE (Mason, et al., 2005) and the schizotypal 
personality questionnaire - another widely used schizotypy questionnaire (Raine & 
Benishay, 1995)- measure schizotypy in a similar way (Asai, Sugimori, Bando, & 
Tanno, 2011). This  may support the possibility that these questionnaires adequately 
measure the schizotypy construct, though direct evidence for this is still warranted 
(Compton, Goulding, Bakeman, & McClure-Tone, 2009). 
The third limitation concerns the multitude of factors associated with the development 
of psychosis, with higher risk for individuals that e.g. experienced  adverse life events 
(see Wiles et al., 2006 for overview), live in urban rather than rural surroundings (Takei, 
Sham, Ocallaghan, Glover, & Murray, 1995), and have a genetic predisposition to 
psychosis, e.g. a relative with a psychotic illness (K. W. Lee, Woon, Teo, & Sim, 2012). 
Our study on two preselected factors revealed that drug use is a more consistent 
predictor of cognitive attenuation than schizotypy. However, future studies should aim 
to incorporate a more encompassing selection of variables to disentangle their complex 
interactions, as well as detect those being particularly important for the development of 
psychotic-like cognitive profiles. 
Regarding the fourth point, another factor that could be potentially relevant is the 
specificity of cognitive impairments along the schizophrenia spectrum. Specificity is 
warranted as it can firstly help to identify the unique underlying pathophysiology of the 
disease, and secondly because once specific cognitive (dys-)functions are identified they 
could aid as diagnostic tools along the schizophrenia spectrum. Behavioural cognitive 
markers are relatively easy, quick and cheap to assess in comparison to lengthy 
diagnostic interviews usually required to diagnose any mental illness, or brain imaging 
techniques. Consequently, the convenience associated with using behavioural cognitive 
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functions as so-called “endophenotypes” for schizophrenia has fuelled a wealth of 
research in the past couple of years (see Allen, Griss, Folley, Hawkins, & Pearlson, 
2009 for overview). For any behavioural cognitive measure to qualify as cognitive 
vulnerability marker of the disease, it must fulfill certain criteria. Though definitions 
may vary (Cadenhead & Braff, 2002), they most likely include the following 
conditions: (i) association with the illness (higher rates of the endophenotype in people 
with the illness as compared to the general population or other psychiatric disorders); 
(ii) state independence (presence irrespective of the disease state); (iii) familial 
association (present at higher rates in unaffected family members than in the general 
population); (iv) co-segregation (higher prevalence in ill relatives of ill probands than in 
well relatives of ill probands); and (v) heritability (the extent of variation of the 
endophenotype that is attributable to the genetic variation; Gottesman & Gould, 2003).  
Among cognitive tasks, hemispheric asymmetry and frontal lobe/executive dysfunctions 
have been discussed as vulnerability markers. For instance, patients with schizophrenia 
often perform two standard deviations below healthy matched participants in tasks on 
frontal lobe/executive functioning (Heinrichs & Zakzanis, 1998; Saykin et al., 1991), 
and these deficits are present before the onset of the disorder (Erlenmeyer-Kimling et 
al., 2000). Moreover, they seem relatively stable over time (Albus et al., 2002). For 
hemispheric asymmetry the same picture emerges, with a reduction of hemispheric 
asymmetry usually being present to a higher degree in patients with schizophrenia and 
healthy relatives of patients with schizophrenia as compared to the general population 
(Crow, 2000; Sharma et al., 1999), being present before illness onset (Cannon, Jones, 
Murray, & Wadsworth, 1997; Crow, Done, & Sacker, 1996) and these reductions only 
normalize when patients are medically treated or in remission (Løberg, Jørgensen, & 
Hugdahl, 2002). Certainly problematic to the idea of such measures to be appropriate 
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endophenotypes, hypofrontality and reduced laterality have also been observed in 
patients suffering from other mental illnesses, such as depression (Heller, et al., 1995; 
Medved, Petrovic, Isgum, Szirovicza, & Hotujac, 2001; Oertel-Knöchel & Linden, 
2011; M. A. Rogers et al., 2004), or bipolar disorder (Borkowska & Rybakowski, 2001; 
Ketter et al., 2001; Oertel-Knöchel & Linden, 2011).  
Taken together, frontal lobe functioning and hemispheric asymmetry may not be 
particularly specific to schizophrenia, and therefore may not serve as reliable diagnostic 
tools along the schizophrenia spectrum. However, schizophrenia is a rather 
heterogeneous disease, and shares common features (e.g. psychotic symptoms) with 
other mental illnesses (Kendell, 1991). In the case of complex mental conditions, the 
cognitive dysfunctions are often numerous, and thus unspecific to schizophrenia, but 
specific to widespread brain dysfunctions (Keri & Janka, 2004). Hence, using 
unspecific cognitive markers may nevertheless be relevant to understand the etiology 
underlying the schizophrenia spectrum (Cadenhead & Braff, 2002; Tandon, Nasrallah, 
& Keshavan, 2009). 
 
E. Summary of conclusions 
Our research indicates that specific drugs, as well as general substance dependence may 
influence the relationship between schizotypy and cognition, suggesting that previous 
reports on attenuations in high schizotypes could be explained (at least partially) by 
enhanced substance use. This may also suggest that cognitive markers for the disease 
are rather unreliable as indicators of risk for psychosis pathology.  Additionally, more 
research is warranted to establish the nature of the relationship between drugs, psychotic 
(-like) thinking and cognition, and potential modulator variables such as IQ and 
III     General Discussion 
177 
 
depression. Subsequent studies in patient populations are deemed valuable to acquire 
this comprehensive overview over the most reliable predictors of pathological changes. 
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A. Questionnaires 
1. Compensatory behaviour questionnaire 
Please think about a rewarding habit you cannot imagine living without. This habit should 
be substance-based (like caffeine, chocolate, nicotine or illicit drugs).   
Please answer the following questions regarding your habit in the past month, using the 
scales below.   
Substance-based 
habit           
Do you need the habit in order to 
perform/ feel well? 
 
Never 
 
Sometimes 
 
Often 
 
Nearly always 
 
Always 
      
Do you find yourself thinking 
about when you will next be able 
to perform your habit? 
 
Never 
 
Sometimes 
 
Often 
 
Nearly always 
 
Always 
      
Does your pattern of performing 
your habit interfere with your 
social life? 
 
Never 
 
Sometimes 
 
Often 
 
Nearly always 
 
Always 
      
Do you plan your days around 
performing your habit? 
 
Never 
 
Sometimes 
 
Often 
 
Nearly always 
 
Always 
      
Do you feel that your need for 
performing this habit is too 
strong to control? 
 
Never 
 
Sometimes 
 
Often 
 
Nearly always 
 
Always 
      
Do you feel agitated or irritable 
when you cannot perform your 
habit? 
 
Never 
 
Sometimes 
 
Often 
 
Nearly always 
 
Always 
      
Do you need your habit in order 
to relieve stress? 
 
Never 
 
Sometimes 
 
Often 
 
Nearly  
 
Always 
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Is performing your habit more 
important than anything else you 
might do during the day? 
 
Never 
 
Sometimes 
 
Often 
 
Nearly always 
 
Always 
Do you feel you cannot cope 
with life without that habit? 
 
Never 
 
Sometimes 
 
Often 
 
Nearly always 
 
Always 
      
Are you feeling more positive 
about yourself and/or life after 
performing your habit? 
 
Never 
 
Sometimes 
 
Often 
 
Nearly always 
 
Always 
      
Do you perform your habit in 
higher amounts/ frequency than 
intended? 
 
Never 
 
Sometimes 
 
Often 
 
Nearly always 
 
Always 
      
Does your habit interfere with 
your study? 
 
Never 
 
Sometimes 
 
Often 
 
Nearly always 
 
Always 
      
Do you find it difficult to cope 
with life without your habit? 
 
Never 
 
Sometimes 
 
Often 
 
Nearly always 
 
Always 
      
Do you feel guilty about 
performing your habit? 
 
Never 
 
Sometimes 
 
Often 
 
Nearly always 
 
Always 
      
Do you have little energy for 
your family and friends due to 
your habit? 
 
Never 
 
Sometimes 
 
Often 
 
Nearly always 
 
Always 
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2. Oxford* - Liverpool Inventory of feelings and experiences (O-LIFE, 
original) 
 
Please Read the Instructions Before Continuing: 
This questionnaire contains questions that may relate to your thoughts, feelings, experiences and 
preferences.  There are no right or wrong answers or trick questions so please be as honest as 
possible. For each question place a circle around either the "YES" or the "NO".  Do not spend 
too much time deliberating any question but put the answer closest to your own. 
Please do not discuss the questionnaire with anyone who may also complete it as this may affect 
their answers.  It is best completed in private, without the need to hurry. 
 
*Prof G Claridge & Dr O Mason, Depart Exp Psychol, South Parks Road, Oxford 
1 Do you prefer reading to meeting people? YES NO 
2 Do you often hesitate when you are going to say something in a group of people whom 
you more or less know? 
YES NO 
3 Are you always willing to admit it when you have made a mistake? YES NO 
4 Do you hate being alone? YES NO 
5 Do you often overindulge in alcohol or food? YES NO 
6 Do you often feel that people have it in for you? YES NO 
7 Are the sounds you hear in your daydreams really clear and distinct? YES NO 
8 Do you enjoy many different kinds of play and recreation? YES NO 
9 Do your thoughts sometimes seem as real as actual events in your life? YES NO 
10 Does it often happen that nearly every thought immediately and automatically suggests 
an enormous number of ideas? 
YES NO 
11 When in a group of people do you usually prefer to let someone else be the centre of 
attention? 
YES NO 
12 If you say you will do something do you always keep your promise no matter how 
inconvenient it might be? 
YES NO 
13 Do you frequently have difficulty in starting to do things? YES NO 
14 Has dancing or the idea of it always seemed dull to you? YES NO 
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15 When you catch a train do you often arrive at the last minute? YES NO 
16 Is trying new foods something you have always enjoyed? YES NO 
17 Do you always wash before a meal? YES NO 
18 Do you believe in telepathy? YES NO 
19 Do you often change between intense liking and disliking of the same person? YES NO 
20 Have you ever cheated at a game? YES NO 
21 Are there very few things that you have ever really enjoyed doing? YES NO 
22 Do you at times have fits of laughing or crying that you can’t control? YES NO 
23 Do you at times have an urge to do something harmful or shocking? YES NO 
24 Do you often worry about things you should not have done or said? YES NO 
25 Are your thoughts sometimes so strong that you can almost hear them? YES NO 
26 Do you usually take the initiative in making new friends? YES NO 
27 Do your thoughts ever stop suddenly causing you to interrupt what you are saying? YES NO 
28 Are you usually in an average sort of mood, not too high and not too low? YES NO 
29 Would you take drugs which may have strange or dangerous effects? YES NO 
30 Do you think you could learn to read other’s minds if you wanted to? YES NO 
31 When in a crowded room, do you often have difficulty in following a conversation? YES NO 
32 No matter how hard you try to concentrate do unrelated thoughts always creep into 
your mind? 
YES NO 
33 Are you easily hurt when people find fault with you or the work you do? YES NO 
34 Do you stop to think things over before doing anything? YES NO 
35 Have you ever felt that you have special, almost magical powers? YES NO 
36 Are you much too independent to really get involved with other people? YES NO 
37 Do you ever get nervous when someone is walking behind you? YES NO 
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38 Do ideas and insights sometimes come to you so fast that you cannot express them all? YES NO 
39 Do you easily lose your courage when criticised or failing in something? YES NO 
40 Can some people make you aware of them just by thinking about you? YES NO 
41 Does a passing thought ever seem so real it frightens you? YES NO 
42 Do you always practice what you preach? YES NO 
43 Do you often have periods of such great restlessness that you aren’t able to sit still for 
more than a very short time?  
YES NO 
44 Have you ever blamed someone for doing something you know was really your fault? YES NO 
45 Are you a person whose mood goes up and down easily? YES NO 
46 Does your voice ever seem distant or faraway? YES NO 
47 Do you think having close friends is not as important as some people say? YES NO 
48 Do you like doing things in which you have to act quickly? YES NO 
49 Are you rather lively? YES NO 
50 Do you feel at times that people are talking about you? YES NO 
51 Are you sometimes so nervous that you are “blocked”? YES NO 
52 Do you find it difficult to keep interested in the same thing for a long time? YES NO 
53 Do you dread going into a room by yourself where other people have already gathered 
and are talking? 
YES NO 
54 Have you ever felt that you were communicating with someone telepathically? YES NO 
55 Does it often feel good to massage your muscles when they are tired or sore? YES NO 
56 Do you sometimes feel that your accidents are caused by mysterious forces? YES NO 
57 Do you like mixing with people? YES NO 
58 On seeing a soft thick carpet have you sometimes had the impulse to take off your 
shoes and walk barefoot on it? 
YES NO 
59 Do you frequently gamble money? YES NO 
60 Do you often have difficulties in controlling your thoughts? YES NO 
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61 Do you feel that you cannot get “close” to other people? YES NO 
62 Do the people in your daydreams seem so true to life that you sometimes think they are 
real? 
YES NO 
63 Do other people think of you as being very lively? YES NO 
64 Are people usually better off if they stay aloof from emotional involvements with 
people? 
YES NO 
65 Does life seem entirely hopeless? YES NO 
66 Can just being with friends make you feel really good? YES NO 
67 Do you enjoy meeting new people? YES NO 
68 Is your hearing sometimes so sensitive that ordinary sounds become uncomfortable? YES NO 
69 Have you often felt uncomfortable when your friends touch you? YES NO 
70 When things are bothering you do you like to talk to other people about it? YES NO 
71 Do you ever have the sensation that your body or a part of it is changing shape? YES NO 
72 Do you have many friends? YES NO 
73 Are all your habits good and desirable ones? YES NO 
74 Do you tend to keep in the background on social occasions? YES NO 
75 Would being in debt worry you? YES NO 
76 Have you ever felt when you looked in a mirror that your face seemed different? YES NO 
77 Do you think people spend too much time safeguarding their future with savings and 
insurance? 
YES NO 
78 Do you believe that dreams can come true? YES NO 
79 Do you ever have the urge to break or smash things? YES NO 
80 Do you often feel that there is no purpose to life? YES NO 
81 Do things sometimes feel as though they were not real? YES NO 
82 Do you worry about awful things that might happen? YES NO 
83 Have you ever felt the urge to injure yourself? YES NO 
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84 Would it make you nervous to play the clown in front of other people? YES NO 
85 Do you prefer watching television to going out with other people? YES NO 
86 Have you felt that you might cause something to happen just by thinking too much 
about it? 
YES NO 
87 Have you had very little fun from physical activities like walking, swimming or sports? YES NO 
88 Do you ever have suicidal thoughts? YES NO 
89 Have you ever said anything bad or nasty about anyone? YES NO 
90 Do you feel so good at controlling others that it sometimes scares you? YES NO 
91 Are you easily distracted from work by daydreams? YES NO 
92 Are you easily confused if too much happens at the same time? YES NO 
93 Do you ever have a sense of vague danger or sudden dread for  reasons that you do not 
understand? 
YES NO 
94 Is it true that your relationships with other people never get very intense? YES NO 
95 Do you feel that you have to be on your guard even with your friends? YES NO 
96 Have you sometimes had the feeling of gaining or losing energy when certain people 
look at you or touch you? 
YES NO 
97 When coming into a new situation have you ever felt strongly that it was a repeat of 
something that had happened before? 
YES NO 
98 Do you worry too long after an embarrassing experience? YES NO 
99 Do you love having your back massaged? YES NO 
100 Do you consider yourself to be pretty much an average kind of person? YES NO 
101 Have you ever taken advantage of someone? YES NO 
102 Would you like other people to be afraid of you? YES NO 
103 Have you ever thought you heard people talking only to discover that it was in fact 
some nondescript noise? 
YES NO 
104 Have you occasionally felt as though your body did not exist? YES NO 
105 Do you often feel lonely? YES NO 
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106 Do you often have an urge to hit someone? YES NO 
107 Do you often experience an overwhelming sense of emptiness? YES NO 
108 On occasions, have you seen a person’s face in front of you when no one was in fact 
there? 
YES NO 
109 Do you feel it is safer to trust nobody? YES NO 
110 Is it fun to sing with other people? YES NO 
111 Do you often have days when indoor lights seem so bright that they bother your eyes? YES NO 
112 Have you wondered whether the spirits of the dead can influence the living? YES NO 
113 Do people who try to get to know you better usually give up after a while? YES NO 
114  Do you often feel “fed up”? YES NO 
115 Have you felt as though your head or limbs were somehow not your own? YES NO 
116 Do you ever become oversensitive to light or noise? YES NO 
117 When you look in the mirror does your face sometimes seem quite different from 
usual? 
YES NO 
118 Do people who drive carefully annoy you? YES NO 
119 Do you like telling jokes and funny stories to your friends? YES NO 
120 Are your thoughts about sex often odd or bizarre? YES NO 
121 Are you very hurt by criticism? YES NO 
122 Do you feel lonely most of the time, even when you’re with people? YES NO 
123 Would you call yourself a nervous person? YES NO 
124 Can you usually let yourself go and enjoy yourself at a lively party? YES NO 
125 Do you ever feel that your thoughts don’t belong to you? YES NO 
126 Do you ever suddenly feel distracted by distant sounds that you are not normally aware 
of? 
YES NO 
127 As a child, did you do as you were told immediately and without grumbling? YES NO 
128 Do you sometimes talk about things you know nothing about? YES NO 
 227 
 
129 When you are worried or anxious do you have trouble with your bowels? YES NO 
130 When in the dark do you often see shapes and forms even though there’s nothing there? YES NO 
131 Do you often have vivid dreams that disturb your sleep? YES NO 
132 Do you like plenty of bustle and excitement around you? YES NO 
133 Have you sometimes sensed an evil presence around you, even though you could not 
see it? 
YES NO 
134 Is it hard for you to make decisions? YES NO 
135 Do you find the bright lights of a city exciting to look at? YES NO 
136 Does your sense of smell sometimes become unusually strong? YES NO 
137 Do you usually have very little desire to buy new kinds of food? YES NO 
138 Are you often bothered by the feeling that people are watching you? YES NO 
139 Do you ever feel that your speech is difficult to understand because the words are all 
mixed up and don’t make sense? 
YES NO 
140 Do you often feel like doing the opposite of what people suggest, even though you 
know they are right? 
YES NO 
141 Do you like going out a lot? YES NO 
142 Do you feel very close to your friends? YES NO 
143 Are you sometimes sure that other people can tell what you’re thinking? YES NO 
144 Do you ever feel sure that something is about to happen, even though there does not 
seem to be any reason for you thinking that? 
YES NO 
145 Do you often feel the impulse to spend money which you know you can’t afford? YES NO 
146 Are you easily distracted when you read or talk to someone? YES NO 
147 Are you a talkative person? YES NO 
148 Do everyday things sometimes seem unusually large or small? YES NO 
149 Do you feel that making new friends isn’t worth the energy it takes? YES NO 
150 Have you ever taken the praise for something you knew someone else had really done? YES NO 
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3. Oxford* - Liverpool Inventory of feelings and experiences (O-LIFE, short 
version) 
 
Please Read the Instructions Before Continuing: 
This questionnaire contains questions that may relate to your thoughts, feelings, experiences and 
preferences.  There are no right or wrong answers or trick questions so please be as honest as 
possible. For each question place a circle around either the "YES" or the "NO".  Do not spend 
too much time deliberating any question but put the answer closest to your own. 
Please do not discuss the questionnaire with anyone who may also complete it as this may affect 
their answers.  It is best completed in private, without the need to hurry. 
 
*Prof G Claridge & Dr O Mason, Depart Exp Psychol, South Parks Road, Oxford 
 
1 When in the dark do you often see shapes and forms even though there is nothing 
there? 
YES NO 
2 Are you easily confused if too much happens at the same time? YES NO 
3 Are you much too independent to get involved with other people? YES NO 
4 Do you at times have an urge to do something harmful or shocking? YES NO 
5 Is trying new foods something you have always enjoyed? YES NO 
6 Do you think that you could learn to read other’s minds if you wanted to? YES NO 
7 Have you ever felt the urge to injure yourself? YES NO 
8 Has dancing or the idea of it always seemed dull to you? YES NO 
9 Do you dread going into a room by yourself where other people have already gathered 
and are talking? 
YES NO 
10 Do you feel that your accidents are caused by mysterious forces? YES NO 
11 Do you often feel the impulse to spend money which you know you can’t afford? YES NO 
12 Do you ever feel that your speech is difficult to understand because the words are all 
mixed up and don’t make sense? 
YES NO 
13 Do you often overindulge in alcohol or food? YES NO 
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14 Have you often felt uncomfortable when your friends touch you? YES NO 
15 Do you ever have a sense of vague danger or sudden dread for reasons that you do not 
understand? 
YES NO 
16 Are you a person whose mood goes up and down easily? YES NO 
17 Do you often have difficulties in controlling your thoughts? YES NO 
18 Do ideas and insights sometimes come to you so fast that you cannot express them all? YES NO 
19 Do you feel very close to your friends? YES NO 
20 Would you like other people to be afraid of you? YES NO 
21 Do you prefer watching television to going out with people? YES NO 
22 Do you find it difficult to keep interested in the same thing for a long time? YES NO 
23 Can some people make you aware of them just by thinking about you? YES NO 
24 Do you stop to think things over before doing anything? YES NO 
25 Are there very few things that you have ever enjoyed doing? YES NO 
26 When in a crowded room, do you often have difficulty in following a conversation? YES NO 
27 Does a passing thought ever seem so real it frightens you? YES NO 
28 Do you love having your back massaged? YES NO 
29 
When you look in the mirror does your face sometimes seem quite different from 
usual? YES NO 
30 Are you usually in an average kind of mood, not too high and not too low? YES NO 
31 Do you find the bright lights of a city exciting to look at? YES NO 
32 Does your sense of smell sometimes become unusually strong? YES NO 
33 Are your thoughts sometimes so strong that you can almost hear them? YES NO 
34 Do you like mixing with people? YES NO 
35 
Do you often feel like doing the opposite of what other people suggest even though you 
know they are right? YES NO 
36 Are you easily distracted when you read or talk to someone? YES NO 
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37 Do you ever have the urge to break or smash things? YES NO 
38 Have you ever thought that you had special, almost magical powers? YES NO 
39 Do you frequently have difficulty in starting to do things? YES NO 
40 
Have you sometimes sensed an evil presence around you, even though you could not 
see it? YES NO 
41 Are you easily distracted from work by daydreams? YES NO 
42 Do you consider yourself to be pretty much an average sort of person? YES NO 
43 Is it hard for you to make decisions? YES NO 
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B. Regression Tables 
1. Nicotine paper 
 
Table 23. Group status 
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4. Stress paper 
Table 28. Full regression model.
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C. Cronbach’s Alpha Questionnaires 
Table 29. Internal consistency for the questionnaires used in the experiments. 
Questionnaire Cronbach's α 
O-LIFE
 a
 150 items 0.89 
O-LIFE 43 items 0.72 
SCB
b
 0.75 
PSS
c
 0.75 
SRI
d
 0.75 
a
Oxford - Liverpool Inventory of Feelings and Experiences; 
b
Substance-based 
compensatory behaviours; 
c
Perceived Stress Scale; 
d
Stress Response Inventory;
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D. Literature Review 
Table 30. Review of studies investigating psychometrically defined schizotypy and 
cognition, including their control for substance use. Results are sorted alphabetically by 
cognitive function*. All abbreviations used can be found below the table**. 
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* To note: Some studies reported more than one finding on schizotypy and cognition. This table 
represents a listing of findings, and as such the number of findings exceeds the number of studies. 
**Note: Abbreviations used in table 1 (sorted alphabetically). AHES = Auditory Hallucination 
Experience Scale (Onari, 1998); CF = Cognitive flexibility; C&L = Categories and letters; CS = 
composite score for discrepancy between left and right hemisphere dominant task (language laterality); 
CSS = Cognitive Slippage Scale (Miers & Raulin, 1987); CVLT = California Verbal learning test (verbal 
learning); DL = Dichotic Listening (language laterality); DVFT = Divided visual field task (language 
laterality); EPQ = Eysencks Personality Questionnaire (Eysenck & Eysenck, 1975); EPS = Extrasensory 
perception Scale; FDT = Facial decision Task (Face processing, Laterality); HP = hallucinatory 
predisposition (Launay & Slade, 1981); IED = Intra–extradimensional set shift (cognitive flexibility); 
ImpNC = Impulsive Non-conformity scale (L. J. Chapman et al., 1984); IWL = incidental word learning 
(verbal learning); L = Letters only; LAT = Laterality; LNS = letter number sequencing (working 
memory); LNST = letter number span task (verbal memory); MIS = Magical Ideation Scale (Eckblad & 
Chapman, 1983); MSTQ = Multidimensional Schizotypal Traits Questionnaire (Rawlings & MacFarlane, 
1994); MUT = memory updating task (working memory); n/a = not applicable; O-LIFE = Oxford and 
Liverpool Inventory for Feelings and Experiences (Mason, et al., 1995); O-LIFE -B = Oxford and 
Liverpool Inventory for Feelings and Experiences - Brief (Mason, et al., 2005); PA = Physical Anhedonia 
(L. J. Chapman, et al., 1976); PAS = Perceptual Abberation Scale (L. J. Chapman, et al., 1978); PDI = 
Peters Delusional Inventory (Peters, et al., 1999); RSAS = Revised Social Anhedonia Scales (Eckblad, et 
al., 1982); SchzPhr = schizophrenism (Faily & Venables, 1986); SP = Semantic priming (Language 
laterality); SPQ = Schizotypal Personality Questionnaire (Raine, 1991); SPQ -B = Schizotypal 
Personality Questionnaire - Brief  (Raine & Benishay, 1995); SR = Story recall (verbal memory); STA = 
Schizotypy Traits Questionnaire (Claridge & Broks, 1984); SWM = Spatial working memory task; TMT 
= Trail making task (cognitive flexibility); UnEx = Unusual Experiences Scale; VF = Verbal fluency; VL 
= Verbal Learning; VM = Verbal memory; VWM = Visual working memory; WAIS-R = Wechsler adult 
intelligence scale verbal memory task; WCST = Wisconsin Card Sorting Test (cognitive flexibility); 
WM = Working memory; WR = word recall (verbal memory). 
 
*** „↓“ = Relatively decreased performance as a function of schizotypy; „=“ = Equal performance as a 
function of schizotypy; „↑“ = Relatively elevated performance as a function of schizotypy;To note: the 
direction of effect (increase, decrease or equal performance) is related to Table 30, and does not 
necessarily represent within-subjects effects. 
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